+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

List of PDF Full Texts available from EurekaMag Chapter 51550

Chapter 51550 contains a list of PDF Full Texts available from EurekaMag.





Kurihara, T.; Ozawa, Y.; Nagai, N.; Shinoda, K.; Noda, K.; Imamura, Y.; Tsubota, K.; Okano, H.; Oike, Y.; Ishida, S., 2008:
Angiotensin II type 1 receptor signaling contributes to synaptophysin degradation and neuronal dysfunction in the diabetic retina

Yamamoto, R.; Akazawa, H.; Fujihara, H.; Ozasa, Y.; Yasuda, N.; Ito, K.; Kudo, Y.; Qin, Y.; Ueta, Y.; Komuro, I., 2011:
Angiotensin II type 1 receptor signaling regulates feeding behavior through anorexigenic corticotropin-releasing hormone in hypothalamus

Jeppesen, P.Lindgren.; Christensen, G.Lund.; Schneider, M.; Nossent, A.Yaël.; Jensen, H.Brønnum.; Andersen, D.Caroline.; Eskildsen, T.; Gammeltoft, S.; Hansen, J.Lerche.; Sheikh, Søren.Paludan., 2012:
Angiotensin II type 1 receptor signalling regulates microRNA differentially in cardiac fibroblasts and myocytes

Kishi, T.; Hirooka, Y.; Konno, S.; Ogawa, K.; Sunagawa, K., 2010:
Angiotensin II type 1 receptor-activated caspase-3 through ras/mitogen-activated protein kinase/extracellular signal-regulated kinase in the rostral ventrolateral medulla is involved in sympathoexcitation in stroke-prone spontaneously hypertensive rats

Zhang, Z.; Dzau, V.J., 2010:
Angiotensin II type 1 receptor-associated protein is an endogenous inhibitor of angiotensin II type 1 receptor action in cardiac hypertrophy: role in check and balance

Min, L-Juan.; Mogi, M.; Tamura, K.; Iwanami, J.; Sakata, A.; Fujita, T.; Tsukuda, K.; Jing, F.; Iwai, M.; Horiuchi, M., 2010:
Angiotensin II type 1 receptor-associated protein prevents vascular smooth muscle cell senescence via inactivation of calcineurin/nuclear factor of activated T cells pathway

Giani, J.F.; Fuchs, S.; Gonzalez-Villalobos, R.A., 2013:
Angiotensin II type 1 receptor-associated protein: a novel modulator of angiotensin II actions in the nephron

Chan, Y.Cheung.; Leung, P.Sing., 2007:
Angiotensin II type 1 receptor-dependent nuclear factor-kappaB activation-mediated proinflammatory actions in a rat model of obstructive acute pancreatitis

Wong, W.Tak.; Tian, X.Yu.; Xu, A.; Ng, C.Fai.; Lee, H.Kay.; Chen, Z.Yu.; Au, C.Leung.; Yao, X.; Huang, Y., 2010:
Angiotensin II type 1 receptor-dependent oxidative stress mediates endothelial dysfunction in type 2 diabetic mice

Rong, X.; Li, Y.; Ebihara, K.; Zhao, M.; Naowaboot, J.; Kusakabe, T.; Kuwahara, K.; Murray, M.; Nakao, K., 2016:
Angiotensin II type 1 receptor-independent beneficial effects of telmisartan on dietary-induced obesity, insulin resistance and fatty liver in mice

Shao, W.; Seth, D.M.; Navar, L.Gabriel., 2010:
Angiotensin II type 1 receptor-mediated augmentation of urinary excretion of endogenous angiotensin II in Val5-angiotensin II-infused rats

Xia, H.; Feng, Y.; Obr, T.D.; Hickman, P.J.; Lazartigues, E., 2009:
Angiotensin II type 1 receptor-mediated reduction of angiotensin-converting enzyme 2 activity in the brain impairs baroreflex function in hypertensive mice

Hotta, H.; Miura, T.; Miki, T.; Togashi, N.; Maeda, T.; Kim, S.Jai.; Tanno, M.; Yano, T.; Kuno, A.; Itoh, T.; Satoh, T.; Terashima, Y.; Ishikawa, S.; Shimamoto, K., 2010:
Angiotensin II type 1 receptor-mediated upregulation of calcineurin activity underlies impairment of cardioprotective signaling in diabetic hearts

Tang, H.; Pavel, J.; Saavedra, J.M.; Brimijoin, S., 2008:
Angiotensin II type 1 receptors may not influence response of spinal autonomic neurons to axonal damage

Nishiyama, A.; Matsusaka, T.; Miyata, T., 2010:
Angiotensin II type 1A receptor deficiency and longevity

Amano, H.; Ito, Y.; Ogawa, F.; Eshima, K.; Suzuki, T.; Oba, K.; Matsui, Y.; Kato, S.; Fukui, T.; Nakamura, M.; Kitasato, H.; Fukamizu, A.; Majima, M., 2013:
Angiotensin II type 1A receptor signaling facilitates tumor metastasis formation through P-selectin-mediated interaction of tumor cells with platelets and endothelial cells

Sparks, M.A.; Parsons, K.K.; Stegbauer, J.; Gurley, S.B.; Vivekanandan-Giri, A.; Fortner, C.N.; Snouwaert, J.; Raasch, E.W.; Griffiths, R.C.; Haystead, T.A.J.; Le, T.H.; Pennathur, S.; Koller, B.; Coffman, T.M., 2011:
Angiotensin II type 1A receptors in vascular smooth muscle cells do not influence aortic remodeling in hypertension

Naito, Y.; Sawada, H.; Hirotani, S.; Iwasaku, T.; Okuhara, Y.; Eguchi, A.; Miki, K.; Ohyanagi, M.; Tsujino, T.; Masuyama, T., 2014:
Angiotensin II type 1a receptor signaling is implicated in erythropoietin production in response to iron deficiency in mice

Yasuno, S.; Kuwahara, K.; Kinoshita, H.; Yamada, C.; Nakagawa, Y.; Usami, S.; Kuwabara, Y.; Ueshima, K.; Harada, M.; Nishikimi, T.; Nakao, K., 2014:
Angiotensin II type 1a receptor signalling directly contributes to the increased arrhythmogenicity in cardiac hypertrophy

Nahmod, K.A.; Geffner, J.R.; Walther, T., 2010:
Angiotensin II type 1a-deficient bone marrow-derived dendritic cells produce higher levels of monocyte chemoattractant protein 1

Anand, U.; Facer, P.; Yiangou, Y.; Sinisi, M.; Fox, M.; McCarthy, T.; Bountra, C.; Korchev, Y.E.; Anand, P., 2014:
Angiotensin II type 2 receptor (AT2 R) localization and antagonist-mediated inhibition of capsaicin responses and neurite outgrowth in human and rat sensory neurons

Dorrance, A.M., 2013:
Angiotensin II type 2 receptor agonists as therapies for ischemic stroke

Verdonk, K.; Danser, A.H.Jan.; van Esch, J.H.M., 2012:
Angiotensin II type 2 receptor agonists: where should they be applied?

Waseda, Y.; Yasui, M.; Nishizawa, Y.; Inuzuka, K.; Takato, H.; Ichikawa, Y.; Tagami, A.; Fujimura, M.; Nakao, S., 2008:
Angiotensin II type 2 receptor antagonist reduces bleomycin-induced pulmonary fibrosis in mice

Porrello, E.R.; D'Amore, A.; Curl, C.L.; Allen, A.M.; Harrap, S.B.; Thomas, W.G.; Delbridge, L.M.D., 2009:
Angiotensin II type 2 receptor antagonizes angiotensin II type 1 receptor-mediated cardiomyocyte autophagy

Izu, Y.; Mizoguchi, F.; Kawamata, A.; Hayata, T.; Nakamoto, T.; Nakashima, K.; Inagami, T.; Ezura, Y.; Noda, M., 2008:
Angiotensin II type 2 receptor blockade increases bone mass

Wang, D.; Hu, S.; Zhu, J.; Yuan, J.; Wu, J.; Zhou, A.; Wu, Y.; Zhao, W.; Huang, Q.; Chang, Y.; Wang, Q.; Sun, W.; Wei, W., 2014:
Angiotensin II type 2 receptor correlates with therapeutic effects of losartan in rats with adjuvant-induced arthritis

Maiolino, G.; Naso, E.; Calò, L.A., 2014:
Angiotensin II type 2 receptor effects: lesson from a human model of vascular hyporeactivity. Letter regarding Kemp et al

Zhu, Y.; Qiu, H-bo.; Yang, Y.; Liu, L.; Zhao, M-ming.; Chen, Q-hua.; Guo, T., 2008:
Angiotensin II type 2 receptor expression and its modulation in angiotensin II induced acute lung injury in rat

Balmforth, A.J., 2010:
Angiotensin II type 2 receptor gene polymorphisms in cardiovascular disease

Wagenaar, G.T.M.; Sengers, R.M.A.; Laghmani, E.Houari.; Chen, X.; Lindeboom, M.P.H.A.; Roks, A.J.M.; Folkerts, G.; Walther, F.J., 2014:
Angiotensin II type 2 receptor ligand PD123319 attenuates hyperoxia-induced lung and heart injury at a low dose in newborn rats

He, M.; Zhang, L.; Shao, Y.; Xue, H.; Zhou, L.; Wang, X-Fang.; Yu, C.; Yao, T.; Lu, L-Min., 2010:
Angiotensin II type 2 receptor mediated angiotensin II and high glucose induced decrease in renal prorenin/renin receptor expression

Viegas, V.U.; Liu, Z.Z.; Nikitina, T.; Perlewitz, A.; Zavaritskaya, O.; Schlichting, J.; Persson, P.B.; Regitz-Zagrosek, V.; Patzak, A.; Sendeski, M.M., 2012:
Angiotensin II type 2 receptor mediates sex differences in mice renal interlobar arteries response to angiotensin II

Shum, Mël.; Pinard, S.; Guimond, M-Odile.; Labbé, Sébastien.M.; Roberge, C.; Baillargeon, J-Patrice.; Langlois, M-France.; Alterman, M.; Wallinder, C.; Hallberg, A.; Carpentier, Aé.C.; Gallo-Payet, N., 2013:
Angiotensin II type 2 receptor promotes adipocyte differentiation and restores adipocyte size in high-fat/high-fructose diet-induced insulin resistance in rats

Ereso, A.Q.; Ramirez, Ré.M.; Sadjadi, J.; Cripps, M.W.; Cureton, E.L.; Curran, B.; Victorino, G.P., 2007:
Angiotensin II type 2 receptor provides an endogenous brake during inflammation-induced microvascular fluid leak

Wei, Y.; Liao, Y.; Zavilowitz, B.; Ren, J.; Liu, W.; Chan, P.; Rohatgi, R.; Estilo, G.; Jackson, E.K.; Wang, W-Hui.; Satlin, L.M., 2014:
Angiotensin II type 2 receptor regulates ROMK-like K⁺ channel activity in the renal cortical collecting duct during high dietary K⁺ adaptation

Leung, K.Keung.; Liang, J.; Zhao, S.; Chan, W.Yee.; Leung, P.Sing., 2014:
Angiotensin II type 2 receptor regulates the development of pancreatic endocrine cells in mouse embryos

Doi, C.; Egashira, N.; Kawabata, A.; Maurya, D.Kumar.; Ohta, N.; Uppalapati, D.; Ayuzawa, R.; Pickel, L.; Isayama, Y.; Troyer, D.; Takekoshi, S.; Tamura, M., 2010:
Angiotensin II type 2 receptor signaling significantly attenuates growth of murine pancreatic carcinoma grafts in syngeneic mice

Leblanc, S.; Battista, M-Claude.; Noll, C.; Hallberg, A.; Gallo-Payet, N.; Carpentier, Aé.C.; Vine, D.F.; Baillargeon, J-Patrice., 2014:
Angiotensin II type 2 receptor stimulation improves fatty acid ovarian uptake and hyperandrogenemia in an obese rat model of polycystic ovary syndrome

McCarthy, C.A.; Vinh, A.; Broughton, B.R.S.; Sobey, C.G.; Callaway, J.K.; Widdop, R.E., 2013:
Angiotensin II type 2 receptor stimulation initiated after stroke causes neuroprotection in conscious rats

Kaschina, E.; Grzesiak, A.; Li, J.; Foryst-Ludwig, A.; Timm, M.; Rompe, F.; Sommerfeld, M.; Kemnitz, U.Rudolf.; Curato, C.; Namsolleck, P.; Tschöpe, C.; Hallberg, A.; Alterman, M.; Hucko, T.; Paetsch, I.; Dietrich, T.; Schnackenburg, B.; Graf, K.; Dahlöf, Börn.; Kintscher, U.; Unger, T.; Steckelings, U.Muscha., 2008:
Angiotensin II type 2 receptor stimulation: a novel option of therapeutic interference with the renin-angiotensin system in myocardial infarction?

Taguchi, K.; Matsumoto, T.; Kamata, K.; Kobayashi, T., 2012:
Angiotensin II type 2 receptor-dependent increase in nitric oxide synthase activity in the endothelium of db/db mice is mediated via a MEK pathway

Brouwers, S.; Smolders, I.; Massie, A.; Dupont, A.G., 2013:
Angiotensin II type 2 receptor-mediated and nitric oxide-dependent renal vasodilator response to compound 21 unmasked by angiotensin-converting enzyme inhibition in spontaneously hypertensive rats in vivo

Sasaoka, T.; Egi, Y.; Tawa, M.; Yamamoto, A.; Ohkita, M.; Takaoka, M.; Maruyama, T.; Akira, T.; Matsumura, Y., 2008:
Angiotensin II type 2 receptor-mediated inhibition of norepinephrine release in isolated rat hearts

Zhu, L.; Carretero, O.A.; Xu, J.; Wang, L.; Harding, P.; Rhaleb, N-Eddine.; Yang, J.J.; Sumners, C.; Yang, X-Ping., 2012:
Angiotensin II type 2 receptor-stimulated activation of plasma prekallikrein and bradykinin release: role of SHP-1

Coleman, C.G.; Anrather, J.; Iadecola, C.; Pickel, V.M., 2009:
Angiotensin II type 2 receptors have a major somatodendritic distribution in vasopressin-containing neurons in the mouse hypothalamic paraventricular nucleus

Calò, L.A., 2012:
Angiotensin II type 2 receptors mediating both vasoconstriction and vasodilation in humans: support from data in a human model of endogenous angiotensin II type 1 receptor antagonism

Zhou, J.; Xu, X.; Liu, J-Jun.; Lin, Y-Xi.; Gao, G-Dao., 2008:
Angiotensin II type 2 receptors participate in the regulation of inflammatory cytokine secretion in adult rat hypertrophied cardiomyocytes

Chai, W.; Zhang, W.; Jin, Z.; Feng, Y.; Kuang, Y.; Zhi, J., 2013:
Angiotensin II type I receptor agonistic autoantibody-induced apoptosis in neonatal rat cardiomyocytes is dependent on the generation of tumor necrosis factor-α

Li, L-xin.; Chen, D-zhi.; He, Q.; Fan, H.; Jin, Z-kui.; Li, P.; Kou, J-tao.; Xie, D-hong., 2007:
Angiotensin II type I receptor antisense gene therapy causes inhibition of collagen I mRNA expression and proliferation of cultured hepatic stellate cells

Kinoshita, Y.; Kondo, S.; Urushihara, M.; Suga, K.; Matsuura, S.; Takamatsu, M.; Shimizu, M.; Nishiyama, A.; Kawachi, H.; Kagami, S., 2011:
Angiotensin II type I receptor blockade suppresses glomerular renin-angiotensin system activation, oxidative stress, and progressive glomerular injury in rat anti-glomerular basement membrane glomerulonephritis

Ainscough, J.F.X.; Drinkhill, M.J.; Sedo, A.; Turner, N.A.; Brooke, D.A.; Balmforth, A.J.; Ball, S.G., 2008:
Angiotensin II type-1 receptor activation in the adult heart causes blood pressure-independent hypertrophy and cardiac dysfunction

Wang, F.; Xia, Z-Fan.; Chen, X-Lin.; Jia, Y-Tao.; Wang, Y-Jie.; Ma, B., 2010:
Angiotensin II type-1 receptor antagonist attenuates LPS-induced acute lung injury

Kimura, K.; Eguchi, S., 2009:
Angiotensin II type-1 receptor regulates RhoA and Rho-kinase/ROCK activation via multiple mechanisms. Focus on "Angiotensin II induces RhoA activation through SHP2-dependent dephosphorylation of the RhoGAP p190A in vascular smooth muscle cells"

Chang, L.; Yang, R.; Wang, M.; Liu, J.; Wang, Y.; Zhang, H.; Li, Y., 2012:
Angiotensin II type-1 receptor-JAK/STAT pathway mediates the induction of visfatin in angiotensin II-induced cardiomyocyte hypertrophy

Tedesco, A.; Ally, A., 2009:
Angiotensin II type-2 (AT2) receptor antagonism alters cardiovascular responses to static exercise and simultaneously changes glutamate/GABA levels within the ventrolateral medulla

Li, Y.; Li, X-Hui.; Yuan, H., 2012:
Angiotensin II type-2 receptor-specific effects on the cardiovascular system

Ishii, H.; Tsukada, T.; Yoshida, M., 2008:
Angiotensin II type-I receptor blocker, candesartan, improves brachial-ankle pulse wave velocity independent of its blood pressure lowering effects in type 2 diabetes patients

Apostolakis, S.; Vlata, Z.; Vogiatzi, K.; Krambovitis, E.; Spandidos, D.A., 2010:
Angiotensin II up-regulates CX3CR1 expression in THP-1 monocytes: impact on vascular inflammation and atherogenesis

Bose, S.K.; Gibson, W.; Giri, S.; Nath, N.; Donald, C.D., 2009:
Angiotensin II up-regulates PAX2 oncogene expression and activity in prostate cancer via the angiotensin II type I receptor

Ning, Q.; Jiang, X., 2014:
Angiotensin II upregulated the expression of microRNA-224 but not microRNA-21 in adult rat cardiac fibroblasts

Wang, W.; Pang, L.; Palade, P., 2011:
Angiotensin II upregulates Ca(V)1.2 protein expression in cultured arteries via endothelial H(2)O(2) production

Rüster, C.; Bondeva, T.; Franke, S.; Tanaka, N.; Yamamoto, H.; Wolf, G., 2009:
Angiotensin II upregulates RAGE expression on podocytes: role of AT2 receptors

Wu, J.; Yang, X.; Zhang, Y-Fang.; Zhou, S-Feng.; Zhang, R.; Dong, X-Qing.; Fan, J-Jin.; Liu, M.; Yu, X-Qing., 2009:
Angiotensin II upregulates Toll-like receptor 4 and enhances lipopolysaccharide-induced CD40 expression in rat peritoneal mesothelial cells

Kanome, T.; Watanabe, T.; Nishio, K.; Takahashi, K.; Hongo, S.; Miyazaki, A., 2008:
Angiotensin II upregulates acyl-CoA:cholesterol acyltransferase-1 via the angiotensin II Type 1 receptor in human monocyte-macrophages

Zhang, X.; Wu, M.; Jiang, H.; Hao, J.; Zhang, Q.; Zhu, Q.; Saren, G.; Zhang, Y.; Meng, X.; Yue, X., 2015:
Angiotensin II upregulates endothelial lipase expression via the NF-kappa B and MAPK signaling pathways

Wei, S-Guang.; Yu, Y.; Zhang, Z-Hua.; Felder, R.B., 2009:
Angiotensin II upregulates hypothalamic AT1 receptor expression in rats via the mitogen-activated protein kinase pathway

Tabony, A.Michael.; Yoshida, T.; Galvez, S.; Higashi, Y.; Sukhanov, S.; Chandrasekar, B.; Mitch, W.E.; Delafontaine, P., 2011:
Angiotensin II upregulates protein phosphatase 2Cα and inhibits AMP-activated protein kinase signaling and energy balance leading to skeletal muscle wasting

Coppo, M.; Boddi, M.; Bandinelli, M.; Degl'innocenti, D.; Ramazzotti, M.; Marra, F.; Galastri, S.; Abbate, R.; Gensini, G.Franco.; Poggesi, L., 2008:
Angiotensin II upregulates renin-angiotensin system in human isolated T lymphocytes

Pan, P.; Fu, H.; Zhang, L.; Huang, H.; Luo, F.; Wu, W.; Guo, Y.; Liu, X., 2010:
Angiotensin II upregulates the expression of placental growth factor in human vascular endothelial cells and smooth muscle cells

Guo, B.; Li, Y.; Han, R.; Zhou, H.; Wang, M., 2011:
Angiotensin II upregulation of cardiomyocyte adiponectin production is nitric oxide/cyclic GMP dependent

Chen, Y-xin.; Yao, Y-jie.; Nie, R-qiong.; Zhou, S-xian.; Wang, J-feng., 2009:
Angiotensin II vaccine promising for patients with chronic heart failure

Miller, S.A.; Accardi, J.Roger.; St Onge, E.L., 2008 :
Angiotensin II vaccine: a novel approach in the treatment of hypertension

Johnson, P.L.; Sajdyk, T.J.; Fitz, S.D.; Hale, M.W.; Lowry, C.A.; Hay-Schmidt, A.; Shekhar, A., 2013:
Angiotensin II's role in sodium lactate-induced panic-like responses in rats with repeated urocortin 1 injections into the basolateral amygdala: amygdalar angiotensin receptors and panic

Kasal, D.Arthur.B.; Schiffrin, E.L., 2012:
Angiotensin II, Aldosterone, and Anti-Inflammatory Lymphocytes: Interplay and Therapeutic Opportunities

Nguyen Dinh Cat, A.; Montezano, A.C.; Burger, D.; Touyz, R.M., 2014:
Angiotensin II, NADPH oxidase, and redox signaling in the vasculature

Gallo-Payet, N.; Guimond, M-Odile.; Bilodeau, L.; Wallinder, C.; Alterman, M.; Hallberg, A., 2011:
Angiotensin II, a Neuropeptide at the Frontier between Endocrinology and Neuroscience: Is There a Link between the Angiotensin II Type 2 Receptor and Alzheimer's Disease?

Vukelic, S.; Griendling, K.K., 2014:
Angiotensin II, from vasoconstrictor to growth factor: a paradigm shift

Arnold, A.C.; Okamoto, L.E.; Gamboa, A.; Shibao, C.; Raj, S.R.; Robertson, D.; Biaggioni, I., 2013:
Angiotensin II, independent of plasma renin activity, contributes to the hypertension of autonomic failure

Lacolley, P.; Safar, M.E.; Regnault, V.; Frohlich, E.D., 2009:
Angiotensin II, mechanotransduction, and pulsatile arterial hemodynamics in hypertension

de Cavanagh, E.Mv.; Ferder, M.; Inserra, F.; Ferder, L., 2009:
Angiotensin II, mitochondria, cytoskeletal, and extracellular matrix connections: an integrating viewpoint

Davisson, R.L.; Zimmerman, M.C., 2010 :
Angiotensin II, oxidant signaling, and hypertension: down to a T?

Sukhanov, S.; Semprun-Prieto, L.; Yoshida, T.; Michael Tabony, A.; Higashi, Y.; Galvez, S.; Delafontaine, P., 2011:
Angiotensin II, oxidative stress and skeletal muscle wasting

Siqueira, L.Carvalho.; Barreta, M.Henrique.; Gasperin, B.; Bohrer, R.; Santos, J.Tonellotto.; Buratini, Jé.; Oliveira, Jão.Francisco.; Gonçalves, P.Bayard., 2012:
Angiotensin II, progesterone, and prostaglandins are sequential steps in the pathway to bovine oocyte nuclear maturation

Celi, A.; Cianchetti, S.; Dell'Omo, G.; Pedrinelli, R., 2011:
Angiotensin II, tissue factor and the thrombotic paradox of hypertension

Alique, M.; Sánchez-López, E.; Rayego-Mateos, S.; Egido, Jús.; Ortiz, A.; Ruiz-Ortega, M., 2016:
Angiotensin II, via angiotensin receptor type 1/nuclear factor-κB activation, causes a synergistic effect on interleukin-1-β-induced inflammatory responses in cultured mesangial cells

Shah, D.I.; Sharma, M.; Bansal, Y.; Bansal, G.; Singh, M., 2007:
Angiotensin II--AT1 receptor antagonists: design, synthesis and evaluation of substituted carboxamido benzimidazole derivatives

Li, Y-Long., 2014:
Angiotensin II-Superoxide Signaling and Arterial Baroreceptor Function in Type-1 Diabetes Mellitus

Shapiro, B.A.; Olala, L.; Arun, S.Nathan.; Parker, P.M.; George, M.V.; Bollag, W.B., 2010:
Angiotensin II-activated protein kinase D mediates acute aldosterone secretion

Batenburg, W.W.; Jansen, P.M.; van den Bogaerdt, A.J.; J Danser, A.H., 2012:
Angiotensin II-aldosterone interaction in human coronary microarteries involves GPR30, EGFR, and endothelial NO synthase

Arsenault, M.; Zendaoui, A.; Roussel, E.; Drolet, M-Claude.; Dhahri, W.; Grenier, A.; Gascon, S.; Sarrhini, O.; Rousseau, J.A.; Lecomte, R.; Couet, J., 2013:
Angiotensin II-converting enzyme inhibition improves survival, ventricular remodeling, and myocardial energetics in experimental aortic regurgitation

Gallo, E.M.; Loch, D.C.; Habashi, J.P.; Calderon, J.F.; Chen, Y.; Bedja, D.; van Erp, C.; Gerber, E.E.; Parker, S.J.; Sauls, K.; Judge, D.P.; Cooke, S.K.; Lindsay, M.E.; Rouf, R.; Myers, L.; ap Rhys, C.M.; Kent, K.C.; Norris, R.A.; Huso, D.L.; Dietz, H.C., 2014:
Angiotensin II-dependent TGF-β signaling contributes to Loeys-Dietz syndrome vascular pathogenesis

Freeman, E.J.; Sheakley, M.L.; Clements, R.J., 2010:
Angiotensin II-dependent growth of vascular smooth muscle cells requires transactivation of the epidermal growth factor receptor via a cytosolic phospholipase A(2)-mediated release of arachidonic acid

Gebhard, S.; Steil, L.; Peters, B.; Gesell-Salazar, M.; Hammer, E.; Kuttler, B.; Clemetson, K.J.; Scharf, C.; Peters, Jörg.; Völker, U.; Rettig, R.; Greinacher, A., 2012:
Angiotensin II-dependent hypertension causes reversible changes in the platelet proteome

Silva, G.B.; Garvin, J.L., 2008:
Angiotensin II-dependent hypertension increases Na transport-related oxygen consumption by the thick ascending limb

Mufti, S.; Wenzel, S.; Euler, G.; Piper, H.Michael.; Schlüter, K-Dieter., 2008:
Angiotensin II-dependent loss of cardiac function: mechanisms and pharmacological targets attenuating this effect

Massey, K.J.; Li, Q.; Rossi, N.F.; Mattingly, R.R.; Yingst, D.R., 2012:
Angiotensin II-dependent phosphorylation at Ser11/Ser18 and Ser938 shifts the E2 conformations of rat kidney Na+/K+-ATPase

Welch, W.J., 2008:
Angiotensin II-dependent superoxide: effects on hypertension and vascular dysfunction

Meier, R.K.; Clark, B.J., 2012:
Angiotensin II-dependent transcriptional activation of human steroidogenic acute regulatory protein gene by a 25-kDa cAMP-responsive element modulator protein isoform and Yin Yang 1

Mai, J.; Qiu, Q.; Lin, Y.Qing.; Luo, N.Sang.; Zhang, H.Feng.; Wen, Z.Zhi.; Wang, J.Feng.; YangXin, C., 2015:
Angiotensin II-derived reactive oxygen species promote angiogenesis in human late endothelial progenitor cells through heme oxygenase-1 via ERK1/2 and AKT/PI3K pathways

Carl-McGrath, S.; Gräntzdörffer, I.; Lendeckel, U.; Ebert, M.P.; Röcken, C., 2010:
Angiotensin II-generating enzymes, angiotensin-converting enzyme (ACE) and mast cell chymase (CMA1), in gastric inflammation may be regulated by H. pylori and associated cytokines

Pereira, M.G.A.G.; Souza, L.L.; Becari, C.; Duarte, D.A.; Camacho, F.R.B.; Oliveira, Jé.Antônio.C.; Gomes, M.D.; Oliveira, E.B.; Salgado, M.Cristina.O.; Garcia-Cairasco, N.; Costa-Neto, C.M., 2013:
Angiotensin II-independent angiotensin-(1-7) formation in rat hippocampus: involvement of thimet oligopeptidase

Pons, M.; Cousins, S.W.; Alcazar, O.; Striker, G.E.; Marin-Castaño, M.E., 2011:
Angiotensin II-induced MMP-2 activity and MMP-14 and basigin protein expression are mediated via the angiotensin II receptor type 1-mitogen-activated protein kinase 1 pathway in retinal pigment epithelium: implications for age-related macular degeneration

Song, R.; Spera, M.; Garrett, C.; Yosypiv, I.V., 2010:
Angiotensin II-induced activation of c-Ret signaling is critical in ureteric bud branching morphogenesis

Gyires, Kára.; Rónai, Aás.Z.; Zádori, Zán.S.; Tóth, Vória.E.; Németh, József.; Szekeres, Mária.; Hunyady, László., 2014:
Angiotensin II-induced activation of central AT1 receptors exerts endocannabinoid-mediated gastroprotective effect in rats

Do, K.Hun.; Kim, M.Sung.; Kim, J.Ho.; Rhim, B.Yong.; Lee, W.Suk.; Kim, C.Dae.; Bae, S.Sik., 2009:
Angiotensin II-induced aortic ring constriction is mediated by phosphatidylinositol 3-kinase/L-type calcium channel signaling pathway

Helle, F.; Hultström, M.; Skogstrand, T.; Palm, F.; Iversen, B.M., 2008:
Angiotensin II-induced contraction is attenuated by nitric oxide in afferent arterioles from the nonclipped kidney in 2K1C

Morinelli, T.A.; Kendall, R.T.; Luttrell, L.M.; Walker, L.P.; Ullian, M.E., 2009:
Angiotensin II-induced cyclooxygenase 2 expression in rat aorta vascular smooth muscle cells does not require heterotrimeric G protein activation

Kim, Y.Mi.; Jeon, E.Su.; Kim, M.Ra.; Jho, S.Kug.; Ryu, S.Woo.; Kim, J.Ho., 2008:
Angiotensin II-induced differentiation of adipose tissue-derived mesenchymal stem cells to smooth muscle-like cells

Gomolak, J.R.; Didion, S.P., 2014:
Angiotensin II-induced endothelial dysfunction is temporally linked with increases in interleukin-6 and vascular macrophage accumulation

Szekeres, Mária.; Nádasy, Görgy.L.; Turu, Gábor.; Süpeki, K.; Szidonya, László.; Buday, László.; Chaplin, T.; Clark, A.J.L.; Hunyady, László., 2010:
Angiotensin II-induced expression of brain-derived neurotrophic factor in human and rat adrenocortical cells

Olson, E.R.; Shamhart, P.E.; Naugle, J.E.; Meszaros, J.Gary., 2008:
Angiotensin II-induced extracellular signal-regulated kinase 1/2 activation is mediated by protein kinase Cdelta and intracellular calcium in adult rat cardiac fibroblasts

Utsugisawa, K.; Nagane, Y., 2007:
Angiotensin II-induced facilitation of hypoxic neuronal damage through PKCdelta activation

Ramseyer, V.D.; Gonzalez-Vicente, A.; Carretero, O.A.; Garvin, J.L., 2015:
Angiotensin II-induced hypertension blunts thick ascending limb NO production by reducing NO synthase 3 expression and enhancing threonine 495 phosphorylation

Milner, T.A.; Drake, C.T.; Lessard, A.; Waters, E.M.; Torres-Reveron, A.; Graustein, B.; Mitterling, K.; Frys, K.; Iadecola, C., 2008:
Angiotensin II-induced hypertension differentially affects estrogen and progestin receptors in central autonomic regulatory areas of female rats

Brand, S.; Amann, K.; Schupp, N., 2013:
Angiotensin II-induced hypertension dose-dependently leads to oxidative stress and DNA damage in mouse kidneys and hearts

Hattori, Y.; Ubukata, H.; Kawano, K.; Maitani, Y., 2011:
Angiotensin II-induced hypertension enhanced therapeutic efficacy of liposomal doxorubicin in tumor-bearing mice

Gonzalez-Vicente, A.; Garvin, J.L., 2014:
Angiotensin II-induced hypertension increases plasma membrane Na pump activity by enhancing Na entry in rat thick ascending limbs

Dal-Ros, Séphanie.; Bronner, C.; Schott, C.; Kane, M.O.; Chataigneau, M.; Schini-Kerth, V.B.; Chataigneau, T., 2008:
Angiotensin II-induced hypertension is associated with a selective inhibition of endothelium-derived hyperpolarizing factor-mediated responses in the rat mesenteric artery

Cardinale, J.P.; Sriramula, S.; Mariappan, N.; Agarwal, D.; Francis, J., 2012:
Angiotensin II-induced hypertension is modulated by nuclear factor-κBin the paraventricular nucleus

Praddaude, Fçoise.; Cousins, S.W.; Pêcher, C.; Marin-Castaño, M.E., 2009:
Angiotensin II-induced hypertension regulates AT1 receptor subtypes and extracellular matrix turnover in mouse retinal pigment epithelium

Castro-Chaves, P.; Fontes-Carvalho, R.; Pintalhao, M.; Pimentel-Nunes, P.; Leite-Moreira, A.F., 2009:
Angiotensin II-induced increase in myocardial distensibility and its modulation by the endocardial endothelium in the rabbit heart

Mugabe, B.E.; Yaghini, F.A.; Song, C.Young.; Buharalioglu, C.K.; Waters, C.M.; Malik, K.U., 2010:
Angiotensin II-induced migration of vascular smooth muscle cells is mediated by p38 mitogen-activated protein kinase-activated c-Src through spleen tyrosine kinase and epidermal growth factor receptor transactivation

Kim, S-Mi.; Kim, Y-Gyun.; Jeong, K-Hwan.; Lee, S-Ho.; Lee, T-Won.; Ihm, C-Gyoo.; Moon, J-Young., 2013:
Angiotensin II-induced mitochondrial Nox4 is a major endogenous source of oxidative stress in kidney tubular cells

Lijnen, P.J.; Piccart, Y.; Coenen, T.; Prihadi, J.S., 2013:
Angiotensin II-induced mitochondrial reactive oxygen species and peroxiredoxin-3 expression in cardiac fibroblasts

Li, M.; Liu, J-Tian.; Han, C-Jie., 2013:
Angiotensin II-induced monocyte/macrophage inflammatory effects and drug intervention

Wei, Y.; Clark, S.E.; Morris, E.Matthew.; Thyfault, J.P.; Uptergrove, G.M.E.; Whaley-Connell, A.T.; Ferrario, C.M.; Sowers, J.R.; Ibdah, J.A., 2008:
Angiotensin II-induced non-alcoholic fatty liver disease is mediated by oxidative stress in transgenic TG(mRen2)27(Ren2) rats

Abe, K.; Nakashima, H.; Ishida, M.; Miho, N.; Sawano, M.; Soe, N.Nwe.; Kurabayashi, M.; Chayama, K.; Yoshizumi, M.; Ishida, T., 2008:
Angiotensin II-induced osteopontin expression in vascular smooth muscle cells involves Gq/11, Ras, ERK, Src and Ets-1

Palomeque, J.; Rueda, O.Velez.; Sapia, L.; Valverde, C.A.; Salas, M.; Petroff, M.Vila.; Mattiazzi, A., 2009:
Angiotensin II-induced oxidative stress resets the Ca2+ dependence of Ca2+-calmodulin protein kinase II and promotes a death pathway conserved across different species

Liu, Q.; Wang, G.; Zhou, G.; Tan, Y.; Wang, X.; Wei, W.; Liu, L.; Xue, W.; Feng, W.; Cai, L., 2009:
Angiotensin II-induced p53-dependent cardiac apoptotic cell death: its prevention by metallothionein

Dikalov, S.I.; Nazarewicz, R.R., 2014:
Angiotensin II-induced production of mitochondrial reactive oxygen species: potential mechanisms and relevance for cardiovascular disease

Lijnen, P., 2008:
Angiotensin II-induced proliferation of neonatal and adult rat cardiac fibroblasts

Olala, L.O.; Choudhary, V.; Johnson, M.H.; Bollag, W.B., 2014:
Angiotensin II-induced protein kinase D activates the ATF/CREB family of transcription factors and promotes StAR mRNA expression

Ortiz, R.M.; Kobori, H.; Conte, D.; Navar, L.Gabriel., 2011:
Angiotensin II-induced reduction in body mass is Ang II receptor mediated in association with elevated corticosterone

Ishizaka, N.; Saito, K.; Furuta, K.; Matsuzaki, G.; Koike, K.; Noiri, E.; Nagai, R., 2007:
Angiotensin II-induced regulation of the expression and localization of iron metabolism-related genes in the rat kidney

Marrero, M.B.; Fulton, D.; Stepp, D.; Stern, D.M., 2008:
Angiotensin II-induced signaling pathways in diabetes

Wei, Y.; Sowers, J.R.; Clark, S.E.; Li, W.; Ferrario, C.M.; Stump, C.S., 2007:
Angiotensin II-induced skeletal muscle insulin resistance mediated by NF-kappaB activation via NADPH oxidase

Jung, H.Ok.; Uhm, J.Sun.; Seo, S.Min.; Kim, J.Hee.; Youn, H-Joong.; Baek, S.Hong.; Chung, W.Sung.; Seung, K.Bae., 2011:
Angiotensin II-induced smooth muscle cell migration is mediated by LDL receptor-related protein 1 via regulation of matrix metalloproteinase 2 expression

Mitra, A.K.; Gao, L.; Zucker, I.H., 2010:
Angiotensin II-induced upregulation of AT(1) receptor expression: sequential activation of NF-kappaB and Elk-1 in neurons

Kossmann, S.; Schwenk, M.; Hausding, M.; Karbach, S.H.; Schmidgen, M.I.; Brandt, M.; Knorr, M.; Hu, H.; Kröller-Schön, S.; Schönfelder, T.; Grabbe, S.; Oelze, M.; Daiber, A.; Münzel, T.; Becker, C.; Wenzel, P., 2013:
Angiotensin II-induced vascular dysfunction depends on interferon-γ-driven immune cell recruitment and mutual activation of monocytes and NK-cells

Yaghini, F.A.; Song, C.Young.; Lavrentyev, E.N.; Ghafoor, H.U.B.; Fang, X.R.; Estes, A.M.; Campbell, W.B.; Malik, K.U., 2010:
Angiotensin II-induced vascular smooth muscle cell migration and growth are mediated by cytochrome P450 1B1-dependent superoxide generation

Tan, N.Y.; Li, J-Mei.; Stocker, R.; Khachigian, L.M., 2009:
Angiotensin II-inducible smooth muscle cell apoptosis involves the angiotensin II type 2 receptor, GATA-6 activation, and FasL-Fas engagement

Ferrington, L.; Miners, J.Scott.; Palmer, L.E.; Bond, S.M.; Povey, J.E.; Kelly, P.At.; Love, S.; Horsburgh, K.J.; Kehoe, P.G., 2011:
Angiotensin II-inhibiting drugs have no effect on intraneuronal Aβ or oligomeric Aβ levels in a triple transgenic mouse model of Alzheimer's disease

Ferrington, L.; Palmer, L.E.; Love, S.; Horsburgh, K.J.; Kelly, P.At.; Kehoe, P.G., 2012:
Angiotensin II-inhibition: effect on Alzheimer's pathology in the aged triple transgenic mouse

Xie, J-Yuan.; Chen, N.; Ren, H.; Wang, W-Ming., 2010:
Angiotensin II-mediated activation of fibrotic pathways through ERK1/2 in rat peritoneal mesothelial cells

Gusev, K.; Domenighetti, A.A.; Delbridge, L.M.D.; Pedrazzini, T.; Niggli, E.; Egger, M., 2009:
Angiotensin II-mediated adaptive and maladaptive remodeling of cardiomyocyte excitation-contraction coupling

Raizada, V.; Hillerson, D.; Amaram, J.Sheela.; Skipper, B., 2013:
Angiotensin II-mediated left ventricular abnormalities in chronic kidney disease

Senchenkova, E.Y.; Russell, J.; Almeida-Paula, L.D.; Harding, J.W.; Granger, D.Neil., 2010:
Angiotensin II-mediated microvascular thrombosis

Kiryu, M.; Niwano, S.; Niwano, H.; Kishihara, J.; Aoyama, Y.; Fukaya, H.; Masaki, Y.; Izumi, T., 2013:
Angiotensin II-mediated up-regulation of connective tissue growth factor promotes atrial tissue fibrosis in the canine atrial fibrillation model

Ognibene, D.T.; Oliveira, P.R.B.; Marins de Carvalho, L.C.R.; Costa, C.A.; Espinoza, L.A.; Criddle, D.N.; Tano, T.; Soares de Moura, R.; Resende, A.C., 2008:
Angiotensin II-mediated vasodilation is reduced in adult spontaneously hypertensive rats despite enhanced expression of AT2 receptors

Rascher, W., 2011:
Angiotensin II-receptor (type AT1)-antagonists and fetal impairment

Meerum Terwogt, J.M.; Koopmans, R.P.; Roos, Y.B.W.E.M.; van Montfrans, G.A., 2008:
Angiotensin II-receptor antagonists compared to other antihypertensives: still insufficient evidence for reducing the risk of cerebrovascular incidents

Kemp, J.R.; Unal, H.; Desnoyer, R.; Yue, H.; Bhatnagar, A.; Karnik, S.S., 2015:
Angiotensin II-regulated microRNA 483-3p directly targets multiple components of the renin-angiotensin system

Romero, D.G.; Gomez-Sanchez, E.P.; Gomez-Sanchez, C.E., 2011:
Angiotensin II-regulated transcription regulatory genes in adrenal steroidogenesis

Marin Garcia, P.Jesus.; Marin-Castaño, M.Encarna., 2014:
Angiotensin II-related hypertension and eye diseases

Che, Z-qian.; Gao, P-jin.; Shen, W-li.; Fan, C-ling.; Liu, J-jun.; Zhu, D-liang., 2008:
Angiotensin II-stimulated collagen synthesis in aortic adventitial fibroblasts is mediated by connective tissue growth factor

Matsukawa, T.; Miyamoto, T., 2011:
Angiotensin II-stimulated secretion of arginine vasopressin is inhibited by atrial natriuretic peptide in humans

Wei, S-Guang.; Yu, Y.; Zhang, Z-Hua.; Weiss, R.M.; Felder, R.B., 2008:
Angiotensin II-triggered p44/42 mitogen-activated protein kinase mediates sympathetic excitation in heart failure rats

Zhao, Y.; Chen, X.; Cai, L.; Yang, Y.; Sui, G.; Fu, S., 2010:
Angiotensin II/angiotensin II type I receptor (AT1R) signaling promotes MCF-7 breast cancer cells survival via PI3-kinase/Akt pathway

Schlüter, K-D.; Wenzel, S., 2008:
Angiotensin II: a hormone involved in and contributing to pro-hypertrophic cardiac networks and target of anti-hypertrophic cross-talks

Palomeque, J.; Delbridge, L.; Petroff, M.Vila., 2009:
Angiotensin II: a regulator of cardiomyocyte function and survival

Finnerup, N.Brix.; Baastrup, C., 2014:
Angiotensin II: from blood pressure to pain control

Demurtas, P.; Corrias, M.; Zucca, I.; Maxia, C.; Piras, F.; Sirigu, P.; Perra, M.T., 2015:
Angiotensin II: immunohistochemical study in Sardinian pterygium

Mueller, C.F.H.; Nickenig, G., 2007:
Angiotensin II: one driving force behind atherogenesis

Cabello-Verrugio, C.; Córdova, G.; Salas, Jé.Diego., 2013:
Angiotensin II: role in skeletal muscle atrophy

O'Reilly, M.A., 2013:
Angiotensin II: tapping the cell cycle machinery to kill endothelial cells

Kamińska, M.; Musiał, Włodzimierz.; Chabielska, E., 2013 :
Angiotensin II: the risk factor for arterial thrombosis

Kandalam, U.; Sarmiento, N.; Haspula, D.; Clark, M.A., 2016:
Angiotensin III induces signal transducer and activator of transcription 3 and interleukin-6 mRNA levels in cultured rat astrocytes

Pelegrini-da-Silva, A.; Rosa, E.; Guethe, L.M.; Juliano, M.A.; Prado, W.A.; Martins, A.R., 2010:
Angiotensin III modulates the nociceptive control mediated by the periaqueductal gray matter

Khudaverdiev, A.S., 2009:
Angiotensin III participation in mechanisms of development of an alcoholism and other kinds of behavioural activity

Yatabe, J.; Yoneda, M.; Yatabe, M.S.; Watanabe, T.; Felder, R.A.; Jose, P.A.; Sanada, H., 2011:
Angiotensin III stimulates aldosterone secretion from adrenal gland partially via angiotensin II type 2 receptor but not angiotensin II type 1 receptor

De Bundel, D.; Smolders, I.; Yang, R.; Albiston, A.L.; Michotte, Y.; Chai, S.Yeen., 2009:
Angiotensin IV and LVV-haemorphin 7 enhance spatial working memory in rats: effects on hippocampal glucose levels and blood flow

Björkman, E.; Edebo, A.; Fändriks, L.; Casselbrant, A., 2016:
Angiotensin IV and the human esophageal mucosa: An exploratory study in healthy subjects and gastroesophageal reflux disease patients

Demaegdt, H.; De Backer, J-Paul.; Lukaszuk, A.; Tóth, Géza.; Szemenyei, Eébet.; Tourwé, D.; Vauquelin, G., 2012:
Angiotensin IV displays only low affinity for native insulin-regulated aminopeptidase (IRAP)

Beyer, C.E.; Dwyer, J.M.; Platt, B.J.; Neal, S.; Luo, B.; Ling, H-Ping.; Lin, Q.; Mark, R.J.; Rosenzweig-Lipson, S.; Schechter, L.E., 2010:
Angiotensin IV elevates oxytocin levels in the rat amygdala and produces anxiolytic-like activity through subsequent oxytocin receptor activation

Malinauskas, M.; Stankevičius, E.; Casselbrant, A., 2015:
Angiotensin IV induced contractions in human jejunal wall musculature in vitro

Manzel, A.; Domenig, O.; Ambrosius, B.; Kovacs, A.; Stegbauer, J.; Poglitsch, M.; Mueller, D.N.; Gold, R.; Linker, R.A., 2016:
Angiotensin IV is induced in experimental autoimmune encephalomyelitis but fails to influence the disease

Wang, D.; Xue, P.; Chen, X.Lan.; Xie, Z.Sheng.; Yang, F.Quan.; Zheng, L.; Xu, T., 2014:
Angiotensin IV upregulates the activity of protein phosphatase 1α in Neura-2A cells

Vinh, A.; Widdop, R.E.; Chai, S.Yeen.; Gaspari, T.A., 2008:
Angiotensin IV-evoked vasoprotection is conserved in advanced atheroma

Rastghalam, R.; Nematbakhsh, M.; Bahadorani, M.; Eshraghi-Jazi, F.; Talebi, A.; Moeini, M.; Ashrafi, F.; Shirdavani, S., 2014:
Angiotensin Type-1 Receptor Blockade May Not Protect Kidney against Cisplatin-Induced Nephrotoxicity in Rats

Schwartz, J.A.; Reilly, N.S.; Knuepfer, M.M., 2008:
Angiotensin and NMDA receptors in the median preoptic nucleus mediate hemodynamic response patterns to stress

Schultz, H.D., 2011:
Angiotensin and carotid body chemoreception in heart failure

Smith, G.Robert., 2013:
Angiotensin and systems thinking: wrapping your mind around the big picture

Coppo, R.; Amore, A.; Peruzzi, L.; Mancuso, D.; Camilla, R., 2007:
Angiotensin antagonists and fish oil for treating IgA nephropathy

Alachkar, N.; Gupta, G.; Montgomery, R.A., 2013:
Angiotensin antibodies and focal segmental glomerulosclerosis

White, J., 2018:
Auditory-Verbal Therapy

Augoustides, J.G.T., 2008:
Angiotensin blockade and general anesthesia: so little known, so far to go

Morano, S.; Cipriani, R.; Santangelo, C.; Fallarino, M.; Carnovale, A.; Mandosi, E.; Gatti, A.; Sensi, M.; Di Mario, U., 2008:
Angiotensin blockade and matrix synthesis by glomerular epithelial cells in high glucose: a further experimental insight into the pathophysiology of diabetic nephropathy

Kjaergaard, K.Dybtved.; Peters, C.Daugaard.; Jespersen, B.; Tietze, I.Nørager.; Madsen, J.Kristian.; Pedersen, B.Bang.; Novosel, M.Kristina.; Laursen, K.Skaaning.; Bibby, B.Martin.; Strandhave, C.; Jensen, J.Dam., 2015:
Angiotensin blockade and progressive loss of kidney function in hemodialysis patients: a randomized controlled trial

Pavlatou, M.G.; Mastorakos, G.; Margeli, A.; Kouskouni, E.; Tentolouris, N.; Katsilambros, N.; Chrousos, G.P.; Papassotiriou, I., 2011:
Angiotensin blockade in diabetic patients decreases insulin resistance-associated low-grade inflammation

Torres, V.E.; Abebe, K.Z.; Chapman, A.B.; Schrier, R.W.; Braun, W.E.; Steinman, T.I.; Winklhofer, F.T.; Brosnahan, G.; Czarnecki, P.G.; Hogan, M.C.; Miskulin, D.C.; Rahbari-Oskoui, F.F.; Grantham, J.J.; Harris, P.C.; Flessner, M.F.; Moore, C.G.; Perrone, R.D.; Steinman, T.; Wei, J.; Czarnecki, P.; Pedrosa, I.; Braun, W.; Nurko, S.; Remer, E.; Chapman, A.; Martin, D.; Rahbari-Oskoui, F.; Mittal, P.; Torres, V.; Hogan, M.C.; El-Zoghby, Z.; Harris, P.; Glockner, J.; King, B.; Perrone, R.; Halin, N., 2015:
Angiotensin blockade in late autosomal dominant polycystic kidney disease

Stevens, K.K.; Patel, R.K.; Clancy, M.; Jardine, A.G., 2010:
Angiotensin blockade is associated with early graft dysfunction after live donor renal transplantation

Susic, D.; Zhou, X.; Frohlich, E.D., 2009:
Angiotensin blockade prevents salt-induced injury of the renal circulation in spontaneously hypertensive rats

Schmieder, R.E.; Martin, S.; Lang, G.E.; Bramlage, P.; Böhm, M., 2009:
Angiotensin blockade to reduce microvascular damage in diabetes mellitus

Ram, C.Venkata.S., 2008:
Angiotensin blockade with eprosartan: vascular and functional implications

Clarke, N.E.; Fisher, M.J.; Porter, K.E.; Lambert, D.W.; Turner, A.J., 2012:
Angiotensin converting enzyme (ACE) and ACE2 bind integrins and ACE2 regulates integrin signalling

Shahid, S.Muhammad.; Fatima, S.Nuzhat.; Mahboob, T., 2013:
Angiotensin converting enzyme (ACE) gene expression in experimentally induced liver cirrhosis in rats

Tippisetty, S.; Ishaq, M.; Komaravalli, P.Latha.; Jahan, P., 2011:
Angiotensin converting enzyme (ACE) gene polymorphism in vitiligo: protective and predisposing effects of genotypes in disease susceptibility and progression

Li, E.C.K.; Heran, B.S.; Wright, J.M., 2014:
Angiotensin converting enzyme (ACE) inhibitors versus angiotensin receptor blockers for primary hypertension

De Leo, F.; Panarese, S.; Gallerani, R.; Ceci, L.R., 2010:
Angiotensin converting enzyme (ACE) inhibitory peptides: production and implementation of functional food

Liu, X.; Zhang, M.; Zhang, C.; Liu, C., 2013:
Angiotensin converting enzyme (ACE) inhibitory, antihypertensive and antihyperlipidaemic activities of protein hydrolysates from Rhopilema esculentum

Tsantes, A.; Tsangaris, I.; Kopterides, P.; Nikolopoulos, G.; Kalamara, E.; Antonakos, G.; Kapsimali, V.; Gialeraki, A.; Dimopoulou, I.; Orfanos, S.; Dima, K.; Travlou, A.; Armaganidis, A., 2012 :
Angiotensin converting enzyme (ACE) insertion/deletion (I/D) polymorphism and circulating ACE levels are not associated with outcome in critically ill septic patients

Lubel, J.S.; Herath, C.B.; Velkoska, E.; Casley, D.J.; Burrell, L.M.; Angus, P.W., 2009:
Angiotensin converting enzyme 2 (ACE2) activity in fetal calf serum: implications for cell culture research

Soler, Mía.José.; Lloveras, J.; Batlle, D., 2008:
Angiotensin converting enzyme 2 and its emerging role in the regulation of the renin angiotensin system

Gupte, M.; Thatcher, S.E.; Boustany-Kari, C.M.; Shoemaker, R.; Yiannikouris, F.; Zhang, X.; Karounos, M.; Cassis, L.A., 2012:
Angiotensin converting enzyme 2 contributes to sex differences in the development of obesity hypertension in C57BL/6 mice

Ohtsuki, M.; Morimoto, S-Ichiro.; Izawa, H.; Ismail, T.F.; Ishibashi-Ueda, H.; Kato, Y.; Horii, T.; Isomura, T.; Suma, H.; Nomura, M.; Hishida, H.; Kurahashi, H.; Ozaki, Y., 2011:
Angiotensin converting enzyme 2 gene expression increased compensatory for left ventricular remodeling in patients with end-stage heart failure

Pinheiro, S.Veloso.Brant.; Simões E Silva, A.Cristina., 2012:
Angiotensin converting enzyme 2, Angiotensin-(1-7), and receptor MAS axis in the kidney

Zheng, J-Lin.; Li, G-Ze.; Chen, S-Zhen.; Wang, J-Ju.; Olson, J.E.; Xia, H-Jing.; Lazartigues, E.; Zhu, Y-Lan.; Chen, Y-Fang., 2014:
Angiotensin converting enzyme 2/Ang-(1-7)/mas axis protects brain from ischemic injury with a tendency of age-dependence

Niu, W.; Qi, Y.; Gao, P.; Zhu, D., 2010:
Angiotensin converting enzyme D allele is associated with an increased risk of type 2 diabetes: evidence from a meta-analysis

Morsy, M-Mofeed.Fawaz.; Abdelaziz, N.Abdelmohsen.Mohamed.; Boghdady, A.Mohamed.; Ahmed, H.; Abu Elfadl, E.Mohamed.; Ismail, M.Ali., 2011:
Angiotensin converting enzyme DD genotype is associated with development of rheumatic heart disease in Egyptian children

Shafiee, S.Mohammad.; Firoozrai, M.; Salimi, S.; Zand, H.; Hesabi, B.; Mohebbi, A., 2010:
Angiotensin converting enzyme DD genotype not associated with increased risk of coronary artery disease in the Iranian population

Turgut, S.; Akın, F.; Akcılar, R.; Ayada, C.; Turgut, Günfer., 2011:
Angiotensin converting enzyme I/D, angiotensinogen M235T and AT1-R A/C1166 gene polymorphisms in patients with acromegaly

Huskić, J.; Culo, F.; Dautović, S.; Mulabegović, N., 2007:
Angiotensin converting enzyme activity and nitric oxide level in serum patients with dehydration

Namazi, M.Reza.; Ashraf, A.; Handjani, F.; Eftekhar, E.; Kalafi, A., 2014:
Angiotensin converting enzyme activity in alopecia areata

Babić, N.; Huskić, J.; Nakas-Ićindić, E., 2007:
Angiotensin converting enzyme activity in compensatory renal hypertrophy

Kugaevskaia, E.V., 2013:
Angiotensin converting enzyme and Alzheimer's disease

Karabulut, A.; Turgut, S.; Turgut, Günfer., 2010:
Angiotensin converting enzyme gene insertion/deletion polymorphism in patients with polycystic ovary syndrome

Das, M.; Pal, S.; Ghosh, A., 2009:
Angiotensin converting enzyme gene polymorphism (insertion/deletion) and hypertension in adult Asian Indians: a population-based study from Calcutta, India

Siddharth, K.M.; Kapur, S.; Ram, C.Venkata.S., 2013:
Angiotensin converting enzyme gene polymorphism and hypertension: no ace yet in the pack of cards

Arman, Q., 2011:
Angiotensin converting enzyme gene polymorphism and influence of ACE inhibition

Eryüksel, E.; Ceyhan, B.Bağci.; Bircan, R.; Avşar, M.; Cirakoğlu, B., 2009:
Angiotensin converting enzyme gene polymorphism in Turkish asthmatic patients

Naresh, V.V.S.; Reddy, A.L.K.; Sivaramakrishna, G.; Sarma, P.V.G.K.; Vardhan, R.V.; Kumar, V.S., 2010:
Angiotensin converting enzyme gene polymorphism in type 2 diabetics with nephropathy

Naresh, V.V.S.; Reddy, A.L.K.; Sivaramakrishna, G.; Sharma, P.V.G.K.; Vardhan, R.V.; Kumar, V.Siva., 2010:
Angiotensin converting enzyme gene polymorphism in type II diabetics with nephropathy

Tahir, M.; Sharma, S.K.; Ashraf, S.; Mishra, H.K., 2008:
Angiotensin converting enzyme genotype affects development and course of sarcoidosis in Asian Indians

Stridh, S.; Kerjaschki, D.; Chen, Y.; Rügheimer, L.; Astrand, A.B.M.; Johnsson, C.; Friberg, P.; Olerud, J.; Palm, F.; Takahashi, T.; Ikegami-Kawai, M.; Hansell, P., 2011:
Angiotensin converting enzyme inhibition blocks interstitial hyaluronan dissipation in the neonatal rat kidney via hyaluronan synthase 2 and hyaluronidase 1

Asselbergs, F.W.; van Gilst, W.H., 2007:
Angiotensin converting enzyme inhibition in cardiovascular risk populations: a practical approach to identify the patient who will benefit most

Weisinger, R.S.; Stanley, T.K.; Begg, D.P.; Weisinger, H.S.; Spark, K.J.; Jois, M., 2009:
Angiotensin converting enzyme inhibition lowers body weight and improves glucose tolerance in C57BL/6J mice maintained on a high fat diet

Cudnoch-Jedrzejewska, A.; Czarzasta, K.; Puchalska, L.; Dobruch, J.; Borowik, O.; Pachucki, J.; Szczepanska-Sadowska, E., 2015:
Angiotensin converting enzyme inhibition reduces cardiovascular responses to acute stress in myocardially infarcted and chronically stressed rats

Baker, J.V.; Huppler Hullsiek, K.; Prosser, R.; Duprez, D.; Grimm, R.; Tracy, R.P.; Rhame, F.; Henry, K.; Neaton, J.D., 2013:
Angiotensin converting enzyme inhibitor and HMG-CoA reductase inhibitor as adjunct treatment for persons with HIV infection: a feasibility randomized trial

Lorgis, L.; Richard, C.; Gudjoncik, Aélie.; Zeller, M.; Buffet, P.; L'Huillier, I.; Cottin, Y., 2012:
Angiotensin converting enzyme inhibitor and calcium antagonist combination. Which place in patients with a stable coronary artery disease?

Alaei, H.; Hosseini, M., 2007:
Angiotensin converting enzyme inhibitor captopril modifies conditioned place preference induced by morphine and morphine withdrawal signs in rats

Hoover, T.; Lippmann, M.; Grouzmann, E.; Marceau, F.; Herscu, P., 2010:
Angiotensin converting enzyme inhibitor induced angio-oedema: a review of the pathophysiology and risk factors

Bouillet, L., 2013:
Angiotensin converting enzyme inhibitor induced angioedema: a collateral damage?

Chen, C-Chu.; Chiang, A-Na.; Hsieh, M-Huang., 2011:
Angiotensin converting enzyme inhibitor or angiotensin II receptor blocker for the prevention of type 2 diabetes mellitus?

Gapon, L.I., 2011:
Angiotensin converting enzyme inhibitor perindopril in the treatment of patients with arterial hypertension and renal failure

Glicklich, D.; Gordillo, R.; Supe, K.; Tapia, R.; Woroniecki, R.; Solorzano, C.; Coco, M., 2012:
Angiotensin converting enzyme inhibitor use soon after renal transplantation: a randomized, double-blinded placebo-controlled safety study

Benson, B.C.; Smith, C.; Laczek, J.T., 2014:
Angiotensin converting enzyme inhibitor-induced gastrointestinal angioedema: a case series and literature review

Okada, H., 2012:
Angiotensin converting enzyme inhibitor-modulated microRNAs targeting renal fibrosis

Chan, N.J.; Soliman, A.M.S., 2015:
Angiotensin converting enzyme inhibitor-related angioedema: onset, presentation, and management

Qiu, W.Wei.Qiao.; Lai, A.; Mon, T.; Mwamburi, M.; Taylor, W.; Rosenzweig, J.; Kowall, N.; Stern, R.; Zhu, H.; Steffens, D.C., 2014:
Angiotensin converting enzyme inhibitors and Alzheimer disease in the presence of the apolipoprotein E4 allele

Levine, M.J.; Schweitzer, P., 2011:
Angiotensin converting enzyme inhibitors and angiotensin II receptor blockers in atrial fibrillation

Mogi, M.; Horiuchi, M., 2007:
Angiotensin converting enzyme inhibitors and angiotensin II type 1 receptor blockers

Ritter, J.M., 2011:
Angiotensin converting enzyme inhibitors and angiotensin receptor blockers in hypertension

Verdecchia, P.; Angeli, F.; Mazzotta, G.; Ambrosio, G.; Reboldi, G., 2011:
Angiotensin converting enzyme inhibitors and angiotensin receptor blockers in the treatment of hypertension: should they be used together?

Boutouyrie, P., 2010:
Angiotensin converting enzyme inhibitors and calcium antagonists: a synergistic action for a better prevention of cardiovascular events

Hajjar, I.M.; Keown, M.; Lewis, P.; Almor, A., 2008:
Angiotensin converting enzyme inhibitors and cognitive and functional decline in patients with Alzheimer's disease: an observational study

Martiniuc, C.; Braniste, A.; Braniste, T., 2013:
Angiotensin converting enzyme inhibitors and pulmonary hypertension

Qiu, W.Qiao.; Mwamburi, M.; Besser, L.M.; Zhu, H.; Li, H.; Wallack, M.; Phillips, L.; Qiao, L.; Budson, A.E.; Stern, R.; Kowall, N., 2014:
Angiotensin converting enzyme inhibitors and the reduced risk of Alzheimer's disease in the absence of apolipoprotein E4 allele

Karpov, I.A., 2008:
Angiotensin converting enzyme inhibitors and treatment of stable ischemic heart disease: afterword for the European Society of Cardiology recommendations

Shahin, Y.; Khan, J.Alam.; Samuel, N.; Chetter, I., 2011:
Angiotensin converting enzyme inhibitors effect on endothelial dysfunction: a meta-analysis of randomised controlled trials

Geng, D-feng.; Jin, D-mei.; Wu, W.; Liang, Y-de.; Wang, J-feng., 2014:
Angiotensin converting enzyme inhibitors for prevention of new-onset type 2 diabetes mellitus: a meta-analysis of 72,128 patients

Kma, L.; Gao, F.; Fish, B.L.; Moulder, J.E.; Jacobs, E.R.; Medhora, M., 2012:
Angiotensin converting enzyme inhibitors mitigate collagen synthesis induced by a single dose of radiation to the whole thorax

Bar, J.; Hod, M.; Merlob, P., 1997:
Angiotensin converting enzyme inhibitors use in the first trimester of pregnancy

Makkink, J.L.; Greeff, O.B.W., 2014:
Angiotensin converting enzyme inhibitors v. angiotensin receptor blockers in the management of hypertension: a funder's perspective

Maione, A.; Nicolucci, A.; Craig, J.C.; Tognoni, G.; Moschetta, A.; Palasciano, G.; Pugliese, G.; Procaccini, D.A.; Gesualdo, L.; Pellegrini, F.; Strippoli, G.F.M., 2007:
Angiotensin converting enzyme inhibitors, angiotensin receptor blockers and combined therapy in microalbuminuric patients with one or more cardiovascular risk factors. Protocol of the Long-term Impact of RAS Inhibition on Cardiorenal Outcomes randomized trial (LIRICO).

Margatan, W.; Ruud, K.; Wang, Q.; Markowski, T.; Ismail, B., 2013:
Angiotensin converting enzyme inhibitory activity of soy protein subjected to selective hydrolysis and thermal processing

Murray, B.A.; FitzGerald, R.J., 2007:
Angiotensin converting enzyme inhibitory peptides derived from food proteins: biochemistry, bioactivity and production

Moradzadegan, A.; Vaisi-Raygani, A.; Nikzamir, A.; Rahimi, Z., 2016:
Angiotensin converting enzyme insertion/deletion (I/D) (rs4646994) and Vegf polymorphism (+405G/C; rs2010963) in type II diabetic patients: Association with the risk of coronary artery disease

du Cheyron, D.; Fradin, S.; Ramakers, M.; Terzi, N.; Guillotin, D.; Bouchet, B.; Daubin, Cédric.; Charbonneau, P., 2008:
Angiotensin converting enzyme insertion/deletion genetic polymorphism: its impact on renal function in critically ill patients

Ruggenenti, P.; Bettinaglio, P.; Pinares, F.; Remuzzi, G., 2008:
Angiotensin converting enzyme insertion/deletion polymorphism and renoprotection in diabetic and nondiabetic nephropathies

Lemes, Vícius.A.F.; Neves, A.Luísa.; Guazzelli, I.C.; Frazzatto, E.; Nicolau, C.; Corrêa-Giannella, M.Lúcia.; Velho, G.; Villares, S.M.F., 2013:
Angiotensin converting enzyme insertion/deletion polymorphism is associated with increased adiposity and blood pressure in obese children and adolescents

Häupl, T.; Zimmermann, M.; Kalus, U.; Yürek, S.; Koscielny, Jürgen.; Hoppe, B., 2016:
Angiotensin converting enzyme intron 16 insertion/deletion genotype is associated with plasma C-reactive protein concentration in uteroplacental dysfunction

Lu, L.; Guo, L.; Xie, T-Ting.; Xin, H-Li., 2015:
Angiotensin converting enzyme is involved in the cardiac hypertrophy induced by sinoaortic denervation in rats

Lovren, F.; Pan, Y.; Quan, A.; Teoh, H.; Wang, G.; Shukla, P.C.; Levitt, K.S.; Oudit, G.Y.; Al-Omran, M.; Stewart, D.J.; Slutsky, A.S.; Peterson, M.D.; Backx, P.H.; Penninger, J.M.; Verma, S., 2008:
Angiotensin converting enzyme-2 confers endothelial protection and attenuates atherosclerosis

Li, X.; Molina-Molina, M.; Abdul-Hafez, A.; Uhal, V.; Xaubet, A.; Uhal, B.D., 2008:
Angiotensin converting enzyme-2 is protective but downregulated in human and experimental lung fibrosis

Sueyoshi, R.; Ignatoski, K.M.Woods.; Daignault, S.; Okawada, M.; Teitelbaum, D.H., 2013:
Angiotensin converting enzyme-inhibitor reduces colitis severity in an IL-10 knockout model

Papageorgiou, P.C.; Simos, D.; Boomsma, F.; Rojkjaer, R.; Osmond, D.H., 2009:
Angiotensin converting enzyme-regulated, noncholinergic sympathoadrenal catecholamine release mediates the cardiovascular actions of human 'new pressor protein' related to coagulation beta-factor XIIa

Ozaydin, M.; Peker, O., 2011:
Angiotensin converting-enzyme inhibitors and candesartan have no effects on atrial fibrillation after cardiac surgery: Reply

M'Bride, P., 1881:
Auditory Vertigo

Beierwaltes, W.H., 2015:
Angiotensin induces a pressor regulating role for collecting duct renin

Thornton, S.N., 2011:
Angiotensin inhibition and longevity: a question of hydration

Hackam, D.G.; Duong-Hua, M.L.; Mamdani, M.; Li, P.; Tobe, S.W.; Spence, J.David.; Garg, A.X., 2008:
Angiotensin inhibition in renovascular disease: a population-based cohort study

Storka, A.; Vojtassakova, E.; Mueller, M.; Kapiotis, S.; Haider, D.G.; Jungbauer, A.; Wolzt, M., 2008:
Angiotensin inhibition stimulates PPARgamma and the release of visfatin

Olszanecki, R.; Madej, J.; Suski, M.; Gebska, A.; Bujak-Gizycka, B.; Korbut, R., 2009:
Angiotensin metabolism in rat stomach wall: prevalence of angiotensin-(1-7) formation

Gembardt, F.; Grajewski, S.; Vahl, M.; Schultheiss, H-Peter.; Walther, T., 2008:
Angiotensin metabolites can stimulate receptors of the Mas-related genes family

Frenkel, L.; Suárez, L.Daniel.; Maldonado, Héctor.; Delorenzi, A., 2011:
Angiotensin modulates long-term memory expression but not long-term memory storage in the crab Chasmagnathus

Bourassa, E.A.; Sved, A.F.; Speth, R.C., 2009:
Angiotensin modulation of rostral ventrolateral medulla (RVLM) in cardiovascular regulation

Diz, D.I.; Arnold, A.C.; Nautiyal, M.; Isa, K.; Shaltout, H.A.; Tallant, E.Ann., 2011:
Angiotensin peptides and central autonomic regulation

Gallagher, P.E.; Cook, K.; Soto-Pantoja, D.; Menon, J.; Tallant, E.Ann., 2011:
Angiotensin peptides and lung cancer

Patel, K.P.; Schultz, H.D., 2014:
Angiotensin peptides and nitric oxide in cardiovascular disease

Ptasińska-Wnuk, D.; Lawnicka, H.; Fryczak, J.; Kunert-Radek, J.; Pawlikowski, M., 2008:
Angiotensin peptides regulate angiogenic activity in rat anterior pituitary tumour cell cultures

Pereira, H.J.V.; Souza, L.L.; Salgado, M.Cristina.O.; Oliveira, E.B., 2008:
Angiotensin processing is partially carried out by carboxypeptidases in the rat mesenteric arterial bed perfusate

Clancy, P.; Koblar, S.A.; Golledge, J., 2015:
Angiotensin receptor 1 blockade reduces secretion of inflammation associated cytokines from cultured human carotid atheroma and vascular cells in association with reduced extracellular signal regulated kinase expression and activation

Siddiqui, A.H.; Irani, R.A.; Blackwell, S.C.; Ramin, S.M.; Kellems, R.E.; Xia, Y., 2010:
Angiotensin receptor agonistic autoantibody is highly prevalent in preeclampsia: correlation with disease severity

Siddiqui, A.H.; Irani, R.A.; Zhang, W.; Wang, W.; Blackwell, S.C.; Kellems, R.E.; Xia, Y., 2013:
Angiotensin receptor agonistic autoantibody-mediated soluble fms-like tyrosine kinase-1 induction contributes to impaired adrenal vasculature and decreased aldosterone production in preeclampsia

Zhou, C.Chenyi.; Irani, R.A.; Zhang, Y.; Blackwell, S.C.; Mi, T.; Wen, J.; Shelat, H.; Geng, Y-Jian.; Ramin, S.M.; Kellems, R.E.; Xia, Y., 2010:
Angiotensin receptor agonistic autoantibody-mediated tumor necrosis factor-alpha induction contributes to increased soluble endoglin production in preeclampsia

Mancia, G., 2011:
Angiotensin receptor antagonists and increased risk of cancer. Further evidence against

Francia, P.; Palano, F.; Tocci, G.; Adduci, C.; Ricotta, A.; Semprini, L.; Caprinozzi, M.; Balla, C.; Volpe, M., 2014:
Angiotensin receptor antagonists to prevent sudden death in heart failure: does the dose matter?

Schindler, B., 2008:
Angiotensin receptor antagonists. No advantage for hypertensives with diastolic dysfunction

Mondello, S., 2012:
Angiotensin receptor antagonists: a potential neuroprotective strategy after brain trauma*

Podowski, M.; Calvi, C.; Metzger, S.; Misono, K.; Poonyagariyagorn, H.; Lopez-Mercado, A.; Ku, T.; Lauer, T.; McGrath-Morrow, S.; Berger, A.; Cheadle, C.; Tuder, R.; Dietz, H.C.; Mitzner, W.; Wise, R.; Neptune, E., 2012:
Angiotensin receptor blockade attenuates cigarette smoke-induced lung injury and rescues lung architecture in mice

Ferreira, J.C.B.; Moreira, J.B.N.; Campos, J.C.; Pereira, M.G.; Mattos, K.C.; Coelho, M.A.; Brum, P.C., 2011:
Angiotensin receptor blockade improves the net balance of cardiac Ca(2+) handling-related proteins in sympathetic hyperactivity-induced heart failure

Sandset, E.Charlotte.; Murray, G.; Boysen, G.; Jatuzis, D.; Kõrv, J.; Lüders, S.; Richter, P.S.; Roine, R.O.; Terént, A.; Thijs, V.; Berge, E.; Sandset, P.M.; Terént, A.; Carlberg, B.; Lindgren, A.; Wahlgren, N.G.; Boysen, G.; Andersen, G.; Iversen, H.; Russell, D.; Kjeldsen, S.E.; Thomassen, L.; Bruun Wyller, T.; Indredavik, B.; Bath, P.; Murray, G.; Thijs, V.; Vanhooren, G.; Desfontaines, P.; Roine, R.O.; Kõrv, J.; Jatuzis, D.; Richter, P.; Lüders, S.; Schrader, J.; Sandset, E.C.; Berge,, 2011:
Angiotensin receptor blockade in acute stroke. The Scandinavian Candesartan Acute Stroke Trial: rationale, methods and design of a multicentre, randomised- and placebo-controlled clinical trial (NCT00120003)

Schlaich, M.P., 2011:
Angiotensin receptor blockade in diabetic women of childbearing potential: an acceptable risk?

Moss, S.E.; Klein, R.; Sjølie, A.Katrin.; Chaturvedi, N.; Malm, A.R.; Fuller, J.H.; Porta, M., 2011:
Angiotensin receptor blockade not related to history of dry eye symptoms and treatment in The Diabetic Retinopathy Candesartan Trials (DIRECT)

Montez, P.; Vázquez-Medina, Jé.Pablo.; Rodríguez, Rén.; Thorwald, M.A.; Viscarra, Jé.A.; Lam, L.; Peti-Peterdi, J.; Nakano, D.; Nishiyama, A.; Ortiz, R.M., 2013:
Angiotensin receptor blockade recovers hepatic UCP2 expression and aconitase and SDH activities and ameliorates hepatic oxidative damage in insulin resistant rats

Oshikawa, J.; Toya, Y.; Morita, S.; Taguri, M.; Hanaoka, K.; Hasegawa, T.; Kaizu, K.; Kamata, K.; Kobayashi, S.; Ohtake, T.; Sato, T.; Yasuda, G.; Kimura, K.; Umemura, S., 2015:
Angiotensin receptor blocker (ARB)-diuretic versus ARB-calcium channel blocker combination therapy for hypertension uncontrolled by ARB monotherapy

Rasi Hashemi, S.; Noshad, H.; Tabrizi, A.; Mobasseri, M.; Tayebi Khosroshahi, H.; Heydarnejad, M.; Khalaj, M.Reza.; Aghamohammadzadeh, N., 2012:
Angiotensin receptor blocker and N-acetyl cysteine for reduction of proteinuria in patients with type 2 diabetes mellitus

Oparil, S.; Weber, M., 2009:
Angiotensin receptor blocker and dihydropyridine calcium channel blocker combinations: an emerging strategy in hypertension therapy

Kamezaki, F.; Tasaki, H.; Yamashita, K.; Shibata, K.; Hirakawa, N.; Tsutsui, M.; Kouzuma, R.; Nagatomo, T.; Adachi, T.; Otsuji, Y., 2007:
Angiotensin receptor blocker improves coronary flow velocity reserve in hypertensive patients: comparison with calcium channel blocker

Yang, J.Hoon.; Hahn, J-Yong.; Song, Y.Bin.; Choi, S-Hyuk.; Choi, J-Ho.; Lee, S.Hoon.; Jeong, M-Ho.; Choi, D-Joo.; Park, J.Seon.; Park, H.Sik.; Gwon, H-Cheol., 2015:
Angiotensin receptor blocker in patients with ST segment elevation myocardial infarction with preserved left ventricular systolic function: prospective cohort study

Takeda, S.; Sato, N.; Takeuchi, D.; Kurinami, H.; Shinohara, M.; Niisato, K.; Kano, M.; Ogihara, T.; Rakugi, H.; Morishita, R., 2009:
Angiotensin receptor blocker prevented beta-amyloid-induced cognitive impairment associated with recovery of neurovascular coupling

Matsusaka, T.; Asano, T.; Niimura, F.; Kinomura, M.; Shimizu, A.; Shintani, A.; Pastan, I.; Fogo, A.B.; Ichikawa, I., 2010:
Angiotensin receptor blocker protection against podocyte-induced sclerosis is podocyte angiotensin II type 1 receptor-independent

Seeman, Tás.; Pohl, M.; Misselwitz, J.; John, U., 2010:
Angiotensin receptor blocker reduces proteinuria independently of blood pressure in children already treated with Angiotensin-converting enzyme inhibitors

Cioni, A.; Sordini, C.; Cavallini, I.; Bigazzi, R.; Campese, V.M., 2011:
Angiotensin receptor blocker telmisartan improves insulin sensitivity in peritoneal dialysis patients

Teo, K.K., 2014:
Angiotensin receptor blocker therapy and risk of cancer

Mehta, P.A.; McDonagh, S.; Phillips, J.; Grocott-Mason, R.; Dubrey, S.W., 2009:
Angiotensin receptor blocker therapy for heart failure patients: is combination treatment a feasible prospect?

Bloch, M.J.; Basile, J.N., 2010:
Angiotensin receptor blocker use may decrease the incidence and progression of Alzheimer's disease and dementia in older men but the strength of the evidence is questionable

Shiga, T.; Kasanuki, H.; Hagiwara, N.; Sumiyoshi, T.; Honda, T.; Haze, K.; Takagi, A.; Kawana, M.; Origasa, H.; Ogawa, H., 2011:
Angiotensin receptor blocker-based therapy and cardiovascular events in hypertensive patients with coronary artery disease and impaired renal function

Sowers, J.R.; Raij, L.; Jialal, I.; Egan, B.M.; Ofili, E.O.; Samuel, R.; Zappe, D.H.; Purkayastha, D.; Deedwania, P.C., 2010:
Angiotensin receptor blocker/diuretic combination preserves insulin responses in obese hypertensives

Gellad, W.F.; Good, C.Bernie., 2011:
Angiotensin receptor blockers (ARBs)

Aalbers, J., 2010:
Angiotensin receptor blockers (ARBs) in hypertension patients: earlier use of these better-tolerated medications is warranted

Sabbah, Z.Al.; Mansoor, A.; Kaul, U., 2014:
Angiotensin receptor blockers - advantages of the new sartans

Willis, L.M.; El-Remessy, A.B.; Somanath, P.R.; Deremer, D.L.; Fagan, S.C., 2011:
Angiotensin receptor blockers and angiogenesis: clinical and experimental evidence

Kjeldsen, S.E.; Hedner, T.; Oparil, S.; Narkiewicz, K., 2011:
Angiotensin receptor blockers and cancer - Relationship dismissed by VALUE data while waiting for EMA and FDA reports

Hobbs, F.D.Richard., 2011:
Angiotensin receptor blockers and cardiovascular outcomes

Ram, C.Venkata.S.; Deedwania, P.C., 2008:
Angiotensin receptor blockers and cardiovascular protection: are we ONTARGET?

Arai, T.; Ohashi, H., 2008:
Angiotensin receptor blockers and microalbuminuria in hypertensive patients with early (microalbuminuric) stage diabetic nephropathy

Zoghi, M., 2011:
Angiotensin receptor blockers and risk of cancer

Bhaskaran, K.; Douglas, I.; Evans, S.; van Staa, T.; Smeeth, L., 2012:
Angiotensin receptor blockers and risk of cancer: cohort study among people receiving antihypertensive drugs in UK General Practice Research Database

Goh, K.L.; Bhaskaran, K.; Minassian, C.; Evans, S.J.W.; Smeeth, L.; Douglas, I.J., 2015:
Angiotensin receptor blockers and risk of dementia: cohort study in UK Clinical Practice Research Datalink

Bangalore, S.; Kumar, S.; Wetterslev, Jørn.; Messerli, F.H., 2011:
Angiotensin receptor blockers and risk of myocardial infarction: meta-analyses and trial sequential analyses of 147 020 patients from randomised trials

Dowlatshahi, D.; Hill, M.D., 2009:
Angiotensin receptor blockers and secondary stroke prevention: the MOSES study

Yang, D.; Yuan, J.; Liu, G.; Ling, Z.; Zeng, H.; Chen, Y.; Zhang, Y.; She, Q.; Zhou, X., 2014:
Angiotensin receptor blockers and statins could alleviate atrial fibrosis via regulating platelet-derived growth factor/Rac1/nuclear factor-kappa B Axis

Donnan, G.A.; Davis, S.M., 2009:
Angiotensin receptor blockers and stroke therapy: it is all about the blood pressure

Sica, D.A., 2010:
Angiotensin receptor blockers and the risk of malignancy: a note of caution

Côté, N.; Couture, C.; Pibarot, P.; Després, J-Pierre.; Mathieu, P., 2012:
Angiotensin receptor blockers are associated with a lower remodelling score of stenotic aortic valves

Côté, N.; Mahmut, A.; Fournier, D.; Boulanger, M-Chloé.; Couture, C.; Després, J-Pierre.; Trahan, S.; Bossé, Y.; Pagé, S.; Pibarot, P.; Mathieu, P., 2014:
Angiotensin receptor blockers are associated with reduced fibrosis and interleukin-6 expression in calcific aortic valve disease

Kim, M.Young.; Baik, S.Koo.; Park, D.Hun.; Jang, Y.Ok.; Suk, K.Tae.; Yea, C.Jin.; Lee, I.Young.; Kim, J.Woo.; Kim, H.Soo.; Kwon, S.Ok.; Cho, M.Yun.; Ko, S.Baik.; Chang, S.Jin.; Um, S.Ho.; Han, K-Hyub., 2008:
Angiotensin receptor blockers are superior to angiotensin-converting enzyme inhibitors in the suppression of hepatic fibrosis in a bile duct-ligated rat model

Kehoe, P.G., 2010:
Angiotensin receptor blockers associated with decreased incidence and progression of dementia in older men with cardiovascular disease

Rhoney, D.H.; Moser, L.R., 2011:
Angiotensin receptor blockers following acute stroke

Heran, B.S.; Musini, V.M.; Bassett, K.; Taylor, R.S.; Wright, J.M., 2012:
Angiotensin receptor blockers for heart failure

Catanzaro, D.F.; Frishman, W.H., 2010:
Angiotensin receptor blockers for management of hypertension

Geng, D-feng.; Jin, D-mei.; Wu, W.; Xu, Y.; Wang, J-feng., 2012:
Angiotensin receptor blockers for prevention of new-onset type 2 diabetes: a meta-analysis of 59,862 patients

Bichu, P.; Nistala, R.; Khan, A.; Sowers, J.R.; Whaley-Connell, A., 2009:
Angiotensin receptor blockers for the reduction of proteinuria in diabetic patients with overt nephropathy: results from the AMADEO study

Rocchini, A.P., 2012:
Angiotensin receptor blockers for the treatment of hypertension in children

Jarvis, S., 2012:
Angiotensin receptor blockers in clinical practice--implications of the ONTARGET study

Sharma, A.Kumar.; Wardhan, H., 2013:
Angiotensin receptor blockers in myocardial infarction and ARB-MI paradox

Pitt, B., 2010:
Angiotensin receptor blockers in patients with heart failure and a reduced left ventricular ejection fraction. Implications of the HEAAL trial

Celik, T.; Iyisoy, A., 2007:
Angiotensin receptor blockers in the prevention of atrial fibrillation recurrence: need for a definitive trial

Georgescu, E.Florin., 2008:
Angiotensin receptor blockers in the treatment of NASH/NAFLD: could they be a first-class option?

Perry, M.E.; Chee, M.M.; Ferrell, W.R.; Lockhart, J.C.; Sturrock, R.D., 2008:
Angiotensin receptor blockers reduce erythrocyte sedimentation rate levels in patients with rheumatoid arthritis

Yang, L-Ya.; Ge, X.; Wang, Y-Li.; Ma, K-Ling.; Liu, H.; Zhang, X-Liang.; Liu, B-Cheng., 2013:
Angiotensin receptor blockers reduce left ventricular hypertrophy in dialysis patients: a meta-analysis

Sato, R.; Mizuno, M.; Miura, T.; Kato, Y.; Watanabe, S.; Fuwa, D.; Ogiyama, Y.; Tomonari, T.; Ota, K.; Ichikawa, T.; Shirasawa, Y.; Ito, A.; Yoshida, A.; Fukuda, M.; Kimura, G., 2014:
Angiotensin receptor blockers regulate the synchronization of circadian rhythms in heart rate and blood pressure

Strauss, M.H.; Hall, A., 2009:
Angiotensin receptor blockers should be regarded as first-line drugs for stroke prevention in both primary and secondary prevention settings: no

Verma, S.; Mamdani, M.M.; Al-Omran, M.; Melo, M.; Rouleau, J.L., 2007:
Angiotensin receptor blockers vs. angiotensin converting enzyme inhibitors and acute coronary syndrome outcomes in elderly patients: a population-based cohort study (UMPIRE study results)

Marina, Iñaki.; Krakoff, L.R., 2011:
Angiotensin receptor blockers, cancer, and smoking

Ruilope, L.M., 2008:
Angiotensin receptor blockers: RAAS blockade and renoprotection

Loeys, B.L., 2015:
Angiotensin receptor blockers: a panacea for Marfan syndrome and related disorders?

Rao, G.Adamane.; Mann, J.R.; Shoaibi, A.; Pai, S.G.; Bottai, M.; Sutton, S.Scott.; Haddock, K.Sue.; Bennett, C.Lee.; Hebert, J.R., 2014 :
Angiotensin receptor blockers: are they related to lung cancer?

Messerli, F.H.; Bangalore, S.; Ruschitzka, F., 2010:
Angiotensin receptor blockers: baseline therapy in hypertension?

Kumar, S.; Ram, C.Venkata.S., 2009:
Angiotensin receptor blockers: current status and future prospects

Sarzani, R.; Dessì-Fulgheri, P.; Rappelli, A., 2008:
Angiotensin receptor blockers: dose does matter

Javed, U.; Deedwania, P.C., 2008:
Angiotensin receptor blockers: novel role in high-risk patients

Taylor, A.A.; Siragy, H.; Nesbitt, S., 2012:
Angiotensin receptor blockers: pharmacology, efficacy, and safety

Basile, J.; Toth, P.P., 2009:
Angiotensin receptor blockers: role in hypertension management, cardiovascular risk reduction, and nephropathy

Savoia, C.; Volpe, M., 2011:
Angiotensin receptor modulation and cardiovascular remodeling

Packer, M.; McMurray, J.J.V.; Desai, A.S.; Gong, J.; Lefkowitz, M.P.; Rizkala, A.R.; Rouleau, J.L.; Shi, V.C.; Solomon, S.D.; Swedberg, K.; Zile, M.; Andersen, K.; Arango, J.Luis.; Arnold, J.Malcolm.; Bělohlávek, J.; Böhm, M.; Boytsov, S.; Burgess, L.J.; Cabrera, W.; Calvo, C.; Chen, C-Huan.; Dukat, A.; Duarte, Y.Carlos.; Erglis, A.; Fu, M.; Gomez, E.; Gonzàlez-Medina, A.; Hagège, A.A.; Huang, J.; Katova, T.; Kiatchoosakun, S.; Kim, K-Sik.; Kozan, Ömer.; Llamas, E.Bayram.; Martinez, F.; Me, 2015:
Angiotensin receptor neprilysin inhibition compared with enalapril on the risk of clinical progression in surviving patients with heart failure

von Lueder, T.G.; Wang, B.H.; Kompa, A.R.; Huang, L.; Webb, R.; Jordaan, P.; Atar, D.; Krum, H., 2015 :
Angiotensin receptor neprilysin inhibitor LCZ696 attenuates cardiac remodeling and dysfunction after myocardial infarction by reducing cardiac fibrosis and hypertrophy

Wright, J.W.; Yamamoto, B.J.; Harding, J.W., 2007:
Angiotensin receptor subtype mediated physiologies and behaviors: new discoveries and clinical targets

Günther, J.; Kill, A.; Becker, M.Oliver.; Heidecke, H.; Rademacher, J.; Siegert, E.; Radić, M.; Burmester, G-Rüdiger.; Dragun, D.; Riemekasten, G., 2015:
Angiotensin receptor type 1 and endothelin receptor type A on immune cells mediate migration and the expression of IL-8 and CCL18 when stimulated by autoantibodies from systemic sclerosis patients

Wu, X.; Kihara, T.; Hongo, H.; Akaike, A.; Niidome, T.; Sugimoto, H., 2010:
Angiotensin receptor type 1 antagonists protect against neuronal injury induced by oxygen-glucose depletion

Umschweif, G.; Liraz-Zaltsman, S.; Shabashov, D.; Alexandrovich, A.; Trembovler, V.; Horowitz, M.; Shohami, E., 2015:
Angiotensin receptor type 2 activation induces neuroprotection and neurogenesis after traumatic brain injury

Sasamura, H.; Azegami, T.; Itoh, H., 2011:
Angiotensin receptor vaccines

Kjeldsen, S.E.; Hedner, T.; Narkiewicz, K.; Oparil, S., 2013:
Angiotensin receptor--neprilysin inhibiton (ARNI)--a novel therapeutic concept for management of hypertension and heart failure

Castrop, H., 2013:
Angiotensin receptor-associated proteins: local modulators of the renin-angiotensin system

Maeda, A.; Tamura, K.; Wakui, H.; Dejima, T.; Ohsawa, M.; Azushima, K.; Kanaoka, T.; Uneda, K.; Matsuda, M.; Yamashita, A.; Miyazaki, N.; Yatsu, K.; Hirawa, N.; Toya, Y.; Umemura, S., 2014:
Angiotensin receptor-binding protein ATRAP/Agtrap inhibits metabolic dysfunction with visceral obesity

Vázquez-Medina, Jé.Pablo.; Popovich, I.; Thorwald, M.A.; Viscarra, J.A.; Rodriguez, R.; Sonanez-Organis, J.G.; Lam, L.; Peti-Peterdi, J.; Nakano, D.; Nishiyama, A.; Ortiz, R.M., 2013:
Angiotensin receptor-mediated oxidative stress is associated with impaired cardiac redox signaling and mitochondrial function in insulin-resistant rats

Steckelings, U.Muscha.; Unger, T., 2009:
Angiotensin receptors and autophagy: live and let die

Alcorn, D.; McCausland, J.E.; Maric, C., 2011:
Angiotensin receptors and development: the kidney

Cassis, P.; Conti, S.; Remuzzi, G.; Benigni, A., 2010:
Angiotensin receptors as determinants of life span

Nataatmadja, M.; Passmore, M.; Russell, F.D.; Prabowo, S.; Corley, A.; Fraser, J.F., 2015:
Angiotensin receptors as sensitive markers of acute bronchiole injury after lung transplantation

Sidorkiewicz, Młgorzata.; Rebas, E.; Szymajda, M.; Ławnicka, H.; Pawlikowski, M.; Lachowicz, A., 2009:
Angiotensin receptors in hormone-independent prostate cancer cell line DU145: presence of two variants of angiotensin type 1 receptor

Vaajanen, A.; Lakkisto, Päivi.; Virtanen, I.; Kankuri, E.; Oksala, O.; Vapaatalo, H.; Tikkanen, I., 2010:
Angiotensin receptors in the eyes of arterial hypertensive rats

Vinturache, A.E.; Smith, F.G., 2014:
Angiotensin receptors modulate the renal hemodynamic effects of nitric oxide in conscious newborn lambs

Funder, J.W., 2014:
Angiotensin retains sodium by dephosphorylating mineralocorticoid receptors in renal intercalated cells

Keizman, D.; Huang, P.; Eisenberger, M.A.; Pili, R.; Kim, J.J.; Antonarakis, E.S.; Hammers, H.; Carducci, M.A., 2011:
Angiotensin system inhibitors and outcome of sunitinib treatment in patients with metastatic renal cell carcinoma: a retrospective examination

Miyoshi, M.; Miyano, K.; Moriyama, N.; Taniguchi, M.; Watanabe, T., 2008:
Angiotensin type 1 receptor antagonist inhibits lipopolysaccharide-induced stimulation of rat microglial cells by suppressing nuclear factor kappaB and activator protein-1 activation

Shekhar, A., 2014:
Angiotensin type 1 receptor antagonists-a novel approach to augmenting posttraumatic stress disorder and phobia therapies?

Sakairi, A.; Ishida, J.; Honjo, K.; Inaba, S.; Nakamura, S.; Sugiyama, F.; Yagami, K-Ichi.; Fukamizu, A., 2009:
Angiotensin type 1 receptor blockade prevents cardiac remodeling in mice with pregnancy-associated hypertension

Yamashita, T.; Sekiguchi, A.; Kato, T.; Tsuneda, T.; Iwasaki, Y-ki.; Sagara, K.; Iinuma, H.; Sawada, H.; Aizawa, T., 2007:
Angiotensin type 1 receptor blockade prevents endocardial dysfunction of rapidly paced atria in rats

Muñoz, A.; Garrido-Gil, P.; Dominguez-Meijide, A.; Labandeira-Garcia, J.L., 2014:
Angiotensin type 1 receptor blockage reduces l-dopa-induced dyskinesia in the 6-OHDA model of Parkinson's disease. Involvement of vascular endothelial growth factor and interleukin-1β

Marino, F.; Guasti, L.; Tozzi, M.; Consuelo Maio, R.; Castiglioni, L.; Rasini, E.; Schembri, L.; Maroni, L.; Legnaro, M.; De Leo, A.; Piffaretti, G.; Castelli, P.; Venco, A.; Lecchini, S.; Cosentino, M., 2010:
Angiotensin type 1 receptor expression and interleukin-8 production in polymorphonuclear leukocytes of patients with peripheral arterial disease

Marvar, P.J.; Goodman, J.; Fuchs, S.; Choi, D.C.; Banerjee, S.; Ressler, K.J., 2014:
Angiotensin type 1 receptor inhibition enhances the extinction of fear memory

Diniz, G.Placoná.; Carneiro-Ramos, M.Sorelli.; Barreto-Chaves, M.Luiza.Morais., 2009:
Angiotensin type 1 receptor mediates thyroid hormone-induced cardiomyocyte hypertrophy through the Akt/GSK-3beta/mTOR signaling pathway

Jancovski, N.; Carter, D.A.; Connelly, A.A.; Stevens, E.; Bassi, J.K.; Menuet, C.; Allen, A.M., 2015:
Angiotensin type 1A receptor expression in C1 neurons of the rostral ventrolateral medulla contributes to the development of angiotensin-dependent hypertension

Chen, D.; Jancovski, N.; Bassi, J.K.; Nguyen-Huu, T-Phuc.; Choong, Y-Ting.; Palma-Rigo, K.; Davern, P.J.; Gurley, S.B.; Thomas, W.G.; Head, G.A.; Allen, A.M., 2012:
Angiotensin type 1A receptors in C1 neurons of the rostral ventrolateral medulla modulate the pressor response to aversive stress

Yamato, F.; Takaya, J.; Tsuji, S.; Hasui, M.; Kaneko, K., 2012:
Angiotensin type 1a receptor signaling is not necessary for the production of reactive oxygen species in polymorphonuclear leukocytes

Yong, Q.Chen.; Thomas, C.M.; Seqqat, R.; Chandel, N.; Baker, K.M.; Kumar, R., 2014:
Angiotensin type 1a receptor-deficient mice develop diabetes-induced cardiac dysfunction, which is prevented by renin-angiotensin system inhibitors

de Kloet, A.D.; Pati, D.; Wang, L.; Hiller, H.; Sumners, C.; Frazier, C.J.; Seeley, R.J.; Herman, J.P.; Woods, S.C.; Krause, E.G., 2013:
Angiotensin type 1a receptors in the paraventricular nucleus of the hypothalamus protect against diet-induced obesity

Villela, D.; Leonhardt, J.; Patel, N.; Joseph, J.; Kirsch, S.; Hallberg, A.; Unger, T.; Bader, M.; Santos, R.A.; Sumners, C.; Steckelings, U.Muscha., 2015:
Angiotensin type 2 receptor (AT2R) and receptor Mas: a complex liaison

Naito, T.; Ma, L-Jun.; Yang, H.; Zuo, Y.; Tang, Y.; Han, J.Young.; Kon, V.; Fogo, A.B., 2010:
Angiotensin type 2 receptor actions contribute to angiotensin type 1 receptor blocker effects on kidney fibrosis

Savoia, C.; D'Agostino, M.; Lauri, F.; Volpe, M., 2011:
Angiotensin type 2 receptor in hypertensive cardiovascular disease

Shao, C.; Zucker, I.H.; Gao, L., 2014:
Angiotensin type 2 receptor in pancreatic islets of adult rats: a novel insulinotropic mediator

Johansson, M.E.; Fagerberg, Börn.; Bergström, Göran., 2008:
Angiotensin type 2 receptor is expressed in human atherosclerotic lesions

Yoshida, T.; Huq, T.S.; Delafontaine, P., 2015:
Angiotensin type 2 receptor signaling in satellite cells potentiates skeletal muscle regeneration

Lauer, D.; Slavic, S.; Sommerfeld, M.; Thöne-Reineke, C.; Sharkovska, Y.; Hallberg, A.; Dahlöf, B.; Kintscher, U.; Unger, T.; Steckelings, U.Muscha.; Kaschina, E., 2014:
Angiotensin type 2 receptor stimulation ameliorates left ventricular fibrosis and dysfunction via regulation of tissue inhibitor of matrix metalloproteinase 1/matrix metalloproteinase 9 axis and transforming growth factor β1 in the rat heart

Hilliard, L.M.; Chow, C.L.E.; Mirabito, K.M.; Steckelings, U.Muscha.; Unger, T.; Widdop, R.E.; Denton, K.M., 2014:
Angiotensin type 2 receptor stimulation increases renal function in female, but not male, spontaneously hypertensive rats

Li, H.; Qi, Y.; Li, C.; Braseth, L.N.; Gao, Y.; Shabashvili, A.E.; Katovich, M.J.; Sumners, C., 2010:
Angiotensin type 2 receptor-mediated apoptosis of human prostate cancer cells

Chao, J.; Gao, J.; Parbhu, K-Jaya.K.; Gao, L., 2015:
Angiotensin type 2 receptors in the intermediolateral cell column of the spinal cord: negative regulation of sympathetic nerve activity and blood pressure

Yoshioka, I.; Tsujihata, M.; Akanae, W.; Nonomura, N.; Okuyama, A., 2011:
Angiotensin type-1 receptor blocker candesartan inhibits calcium oxalate crystal deposition in ethylene glycol-treated rat kidneys

Downie, L.E.; Hatzopoulos, K.M.; Pianta, M.J.; Vingrys, A.J.; Wilkinson-Berka, J.L.; Kalloniatis, M.; Fletcher, E.L., 2010:
Angiotensin type-1 receptor inhibition is neuroprotective to amacrine cells in a rat model of retinopathy of prematurity

Campbell, D.J., 2009:
Angiotensin vaccination: what is the prospect of success?

Liu, H-zhi.; Gao, C-yu.; Wang, X-qing.; Fu, H-xia.; Yang, H-hui.; Wang, X-pei.; Liu, Y-hao.; Li, M-wei.; Niu, Z-min.; Dai, G-you.; Qi, D-tun.; Zhang, Y., 2013:
Angiotensin(1-7) attenuates left ventricular dysfunction and myocardial apoptosis on rat model of adriamycin-induced dilated cardiomyopathy

Mercure, C.; Yogi, A.; Callera, G.E.; Aranha, A.B.; Bader, M.; Ferreira, A.J.; Santos, R.A.S.; Walther, T.; Touyz, R.M.; Reudelhuber, T.L., 2008:
Angiotensin(1-7) blunts hypertensive cardiac remodeling by a direct effect on the heart

Thornton, S.N., 2010:
Angiotensin, the hormone to be blocked by antithypertensive drugs, and perhaps why they don't work

Thornton, S.N., 2008:
Angiotensin, the hypovolaemia hormone, aggravates hypertension, obesity, diabetes and cancer

Giani, J.F.; Gironacci, M.M.; Muñoz, M.C.; Peña, C.; Turyn, D.; Dominici, F.P., 2007:
Angiotensin-(1 7) stimulates the phosphorylation of JAK2, IRS-1 and Akt in rat heart in vivo: role of the AT1 and Mas receptors

Arakawa, H.; Kawabe, K.; Sapru, H.N., 2013:
Angiotensin-(1-12) in the rostral ventrolateral medullary pressor area of the rat elicits sympathoexcitatory responses

Arnold, A.C.; Isa, K.; Shaltout, H.A.; Nautiyal, M.; Ferrario, C.M.; Chappell, M.C.; Diz, D.I., 2010:
Angiotensin-(1-12) requires angiotensin converting enzyme and AT1 receptors for cardiovascular actions within the solitary tract nucleus

Ahmad, S.; Varagic, J.; Groban, L.; Dell'Italia, L.J.; Nagata, S.; Kon, N.D.; Ferrario, C.M., 2014:
Angiotensin-(1-12): a chymase-mediated cellular angiotensin II substrate

Santos, R.Augusto., 2014:
Angiotensin-(1-7)

Alzayadneh, E.M.; Chappell, M.C., 2015:
Angiotensin-(1-7) abolishes AGE-induced cellular hypertrophy and myofibroblast transformation via inhibition of ERK1/2

Gava, E.; Samad-Zadeh, A.; Zimpelmann, J.; Bahramifarid, N.; Kitten, G.T.; Santos, R.A.; Touyz, R.M.; Burns, K.D., 2009:
Angiotensin-(1-7) activates a tyrosine phosphatase and inhibits glucose-induced signalling in proximal tubular cells

Zimpelmann, J.; Burns, K.D., 2008:
Angiotensin-(1-7) activates growth-stimulatory pathways in human mesangial cells

Pei, Z.; Meng, R.; Li, G.; Yan, G.; Xu, C.; Zhuang, Z.; Ren, J.; Wu, Z., 2010:
Angiotensin-(1-7) ameliorates myocardial remodeling and interstitial fibrosis in spontaneous hypertension: role of MMPs/TIMPs

Shan, T.; Zhang, L.; Zhao, C.; Chen, W.; Zhang, Y.; Li, G., 2015:
Angiotensin-(1-7) and angiotensin Ⅱ induce the transdifferentiation of human endometrial epithelial cells in vitro

McKinney, C.A.; Fattah, C.; Loughrey, C.M.; Milligan, G.; Nicklin, S.A., 2014:
Angiotensin-(1-7) and angiotensin-(1-9): function in cardiac and vascular remodelling

Zhou, L-Min.; Shi, Z.; Gao, J.; Han, Y.; Yuan, N.; Gao, X-Ya.; Zhu, G-Qing., 2010 :
Angiotensin-(1-7) and angiotension II in the rostral ventrolateral medulla modulate the cardiac sympathetic afferent reflex and sympathetic activity in rats

Tsuda, K., 2013:
Angiotensin-(1-7) and bradykinin in baroreceptor reflex sensitivity in hypertension

Dilauro, M.; Burns, K.D., 2009:
Angiotensin-(1-7) and its effects in the kidney

Velkoska, E.; Patel, S.K.; Burrell, L.M., 2013:
Angiotensin-(1-7) and kidney disease: friend or foe

Durand, M.J.; Raffai, Gábor.; Weinberg, B.D.; Lombard, J.H., 2010:
Angiotensin-(1-7) and low-dose angiotensin II infusion reverse salt-induced endothelial dysfunction via different mechanisms in rat middle cerebral arteries

Esteban, V.; Heringer-Walther, S.; Sterner-Kock, A.; de Bruin, R.; van den Engel, S.; Wang, Y.; Mezzano, S.; Egido, J.; Schultheiss, H-Peter.; Ruiz-Ortega, M.; Walther, T., 2009:
Angiotensin-(1-7) and the g protein-coupled receptor MAS are key players in renal inflammation

Cangussu, L.Michelle.; de Castro, U.Guilherme.Mendes.; do Pilar Machado, R.; Silva, M.Eustáquio.; Ferreira, Pícia.Maria.; dos Santos, R.Augusto.Souza.; Campagnole-Santos, M.José.; Alzamora, Aéia.Carvalho., 2010:
Angiotensin-(1-7) antagonist, A-779, microinjection into the caudal ventrolateral medulla of renovascular hypertensive rats restores baroreflex bradycardia

van Twist, D.J.L.; Kroon, A.A.; de Leeuw, P.W., 2015:
Angiotensin-(1-7) as a strategy in the treatment of hypertension?

Katovich, M.J.; Grobe, J.L.; Raizada, M.K., 2008:
Angiotensin-(1-7) as an antihypertensive, antifibrotic target

McCollum, L.T.; Gallagher, P.E.; Ann Tallant, E., 2012 :
Angiotensin-(1-7) attenuates angiotensin II-induced cardiac remodeling associated with upregulation of dual-specificity phosphatase 1

Tao, X.; Fan, J.; Kao, G.; Zhang, X.; Su, L.; Yin, Y.; Zrenner, B., 2014:
Angiotensin-(1-7) attenuates angiotensin II-induced signalling associated with activation of a tyrosine phosphatase in Sprague-Dawley rats cardiac fibroblasts

Tian, J.; Zhang, L.; Zhou, Y.; Xiao, J.; Li, S.; Chen, Y.; Qiao, Z.; Niu, J.; Gu, Y., 2015:
Angiotensin-(1-7) attenuates damage to podocytes induced by preeclamptic serum through MAPK pathways

Shah, A.; Oh, Y-Bin.; Shan, G.; Song, C.Ho.; Park, B-Hyun.; Kim, S.Hee., 2010:
Angiotensin-(1-7) attenuates hyposmolarity-induced ANP secretion via the Na+-K+ pump

Chen, Q.; Yang, Y.; Huang, Y.; Pan, C.; Liu, L.; Qiu, H., 2014:
Angiotensin-(1-7) attenuates lung fibrosis by way of Mas receptor in acute lung injury

Krishnan, B.; Smith, T.L.; Dubey, P.; Zapadka, M.E.; Torti, F.M.; Willingham, M.C.; Tallant, E.Ann.; Gallagher, P.E., 2013:
Angiotensin-(1-7) attenuates metastatic prostate cancer and reduces osteoclastogenesis

Kangussu, L.M.; Almeida-Santos, A.F.; Bader, M.; Alenina, N.; Fontes, M.Antônio.P.; Santos, R.A.S.; Aguiar, D.C.; Campagnole-Santos, M.José., 2014:
Angiotensin-(1-7) attenuates the anxiety and depression-like behaviors in transgenic rats with low brain angiotensinogen

Modgil, A.; Zhang, Q.; Pingili, A.; Singh, N.; Yao, F.; Ge, J.; Guo, L.; Xuan, C.; O'Rourke, S.T.; Sun, C., 2012:
Angiotensin-(1-7) attenuates the chronotropic response to angiotensin II via stimulation of PTEN in the spontaneously hypertensive rat neurons

Raffai, Gábor.; Khang, G.; Vanhoutte, P.M., 2014:
Angiotensin-(1-7) augments endothelium-dependent relaxations of porcine coronary arteries to bradykinin by inhibiting angiotensin-converting enzyme 1

Benter, I.F.; Yousif, M.H.M.; Al-Saleh, F.M.; Raghupathy, R.; Chappell, M.C.; Diz, D.I., 2011:
Angiotensin-(1-7) blockade attenuates captopril- or hydralazine-induced cardiovascular protection in spontaneously hypertensive rats treated with NG-nitro-L-arginine methyl ester

Souza, L.L.; Costa-Neto, C.M., 2012:
Angiotensin-(1-7) decreases LPS-induced inflammatory response in macrophages

Wang, H-Joe.; Lo, W-Yu.; Lin, L-Jen., 2013:
Angiotensin-(1-7) decreases glycated albumin-induced endothelial interleukin-6 expression via modulation of miR-146a

Cisternas, F.; Morales, Mía.Gabriela.; Meneses, C.; Simon, F.; Brandan, E.; Abrigo, J.; Vazquez, Y.; Cabello-Verrugio, C., 2015:
Angiotensin-(1-7) decreases skeletal muscle atrophy induced by angiotensin II through a Mas receptor-dependent mechanism

Nie, W.; Yan, H.; Li, S.; Zhang, Y.; Yu, F.; Zhu, W.; Fan, F.; Zhu, J., 2008:
Angiotensin-(1-7) enhances angiotensin II induced phosphorylation of ERK1/2 in mouse bone marrow-derived dendritic cells

Giani, J.F.; Muñoz, M.C.; Mayer, M.A.; Veiras, L.C.; Arranz, C.; Taira, C.A.; Turyn, D.; Toblli, J.E.; Dominici, F.P., 2010:
Angiotensin-(1-7) improves cardiac remodeling and inhibits growth-promoting pathways in the heart of fructose-fed rats

Xie, W.; Zhu, D.; Ji, L.; Tian, M.; Xu, C.; Shi, J., 2015:
Angiotensin-(1-7) improves cognitive function in rats with chronic cerebral hypoperfusion

Zimmerman, D.; Burns, K.D., 2012:
Angiotensin-(1-7) in kidney disease: a review of the controversies

Han, Y.; Sun, H-Jian.; Li, P.; Gao, Q.; Zhou, Y-bo.; Zhang, F.; Gao, X-Ya.; Zhu, G-Qing., 2013:
Angiotensin-(1-7) in paraventricular nucleus modulates sympathetic activity and cardiac sympathetic afferent reflex in renovascular hypertensive rats

Tsuda, K., 2014:
Angiotensin-(1-7) in the central nervous system regulation of blood pressure and renin-angiotensin system

Yang, R-Fang.; Yin, J-Xiang.; Li, Y-Long.; Zimmerman, M.C.; Schultz, H.D., 2011:
Angiotensin-(1-7) increases neuronal potassium current via a nitric oxide-dependent mechanism

Jiang, T.; Yu, J-Tai.; Zhu, X-Chen.; Zhang, Q-Quan.; Tan, M-Shan.; Cao, L.; Wang, H-Fu.; Lu, J.; Gao, Q.; Zhang, Y-Dong.; Tan, L., 2015:
Angiotensin-(1-7) induces cerebral ischaemic tolerance by promoting brain angiogenesis in a Mas/eNOS-dependent pathway

Costa, A.C.O.; Becker, L.K.; Moraes, E.R.; Romero, T.R.L.; Guzzo, L.; Santos, R.A.S.; Duarte, I.D.G., 2012:
Angiotensin-(1-7) induces peripheral antinociception through mas receptor activation in an opioid-independent pathway

Velkoska, E.; Dean, R.G.; Griggs, K.; Burchill, L.; Burrell, L.M., 2011:
Angiotensin-(1-7) infusion is associated with increased blood pressure and adverse cardiac remodelling in rats with subtotal nephrectomy

Akhtar, S.; Yousif, M.H.M.; Dhaunsi, G.S.; Chandrasekhar, B.; Al-Farsi, O.; Benter, I.F., 2012:
Angiotensin-(1-7) inhibits epidermal growth factor receptor transactivation via a Mas receptor-dependent pathway

Ren, T.; He, H.; Yu, X.; Fan, J.; Tan, J.; Liu, J., 2013:
Angiotensin-(1-7) inhibits hypoxia-induced renal tubular epithelial-to-mesenchymal transition in rats

Ni, L.; Feng, Y.; Wan, H.; Ma, Q.; Fan, L.; Qian, Y.; Li, Q.; Xiang, Y.; Gao, B., 2012:
Angiotensin-(1-7) inhibits the migration and invasion of A549 human lung adenocarcinoma cells through inactivation of the PI3K/Akt and MAPK signaling pathways

Soto-Pantoja, D.R.; Menon, J.; Gallagher, P.E.; Tallant, E.Ann., 2009:
Angiotensin-(1-7) inhibits tumor angiogenesis in human lung cancer xenografts with a reduction in vascular endothelial growth factor

Wu, J-G.; Tang, H.; Liu, Z-J.; Ma, Z-F.; Tang, A-L.; Zhang, X-J.; Gao, X-R.; Ma, H., 2012:
Angiotensin-(1-7) inhibits vascular remodelling in rat jugular vein grafts via reduced ERK1/2 and p38 MAPK activity

Mendonça, Lís.; Mendes-Ferreira, P.; Bento-Leite, A.; Cerqueira, R.; Amorim, Mário.Jorge.; Pinho, P.; Brás-Silva, Cármen.; Leite-Moreira, A.F.; Castro-Chaves, P., 2015:
Angiotensin-(1-7) modulates angiotensin II-induced vasoconstriction in human mammary artery

Potthoff, S.A.; Fähling, M.; Clasen, T.; Mende, S.; Ishak, B.; Suvorava, T.; Stamer, S.; Thieme, M.; Sivritas, S.H.; Kojda, G.; Patzak, A.; Rump, L.C.; Stegbauer, J., 2014:
Angiotensin-(1-7) modulates renal vascular resistance through inhibition of p38 mitogen-activated protein kinase in apolipoprotein E-deficient mice

Jiang, T.; Gao, L.; Shi, J.; Lu, J.; Wang, Y.; Zhang, Y., 2013:
Angiotensin-(1-7) modulates renin-angiotensin system associated with reducing oxidative stress and attenuating neuronal apoptosis in the brain of hypertensive rats

Wang, X.; Li, G., 2015:
Angiotensin-(1-7) prevent atrial tachycardia induced sodium channel remodeling

Benter, I.F.; Yousif, M.H.M.; Dhaunsi, G.S.; Kaur, J.; Chappell, M.C.; Diz, D.I., 2007:
Angiotensin-(1-7) prevents activation of NADPH oxidase and renal vascular dysfunction in diabetic hypertensive rats

Carver, K.A.; Smith, T.L.; Gallagher, P.E.; Tallant, E.Ann., 2015:
Angiotensin-(1-7) prevents angiotensin II-induced fibrosis in cremaster microvessels

Liu, E.; Yang, S.; Xu, Z.; Li, J.; Yang, W.; Li, G., 2010 :
Angiotensin-(1-7) prevents atrial fibrosis and atrial fibrillation in long-term atrial tachycardia dogs

Gomes, Eéas.R.M.; Lara, A.A.; Almeida, P.W.M.; Guimarães, D.; Resende, R.R.; Campagnole-Santos, M.J.; Bader, M.; Santos, R.A.S.; Guatimosim, S., 2010:
Angiotensin-(1-7) prevents cardiomyocyte pathological remodeling through a nitric oxide/guanosine 3',5'-cyclic monophosphate-dependent pathway

Dhaunsi, G.S.; Yousif, M.H.M.; Akhtar, S.; Chappell, M.C.; Diz, D.I.; Benter, I.F., 2010:
Angiotensin-(1-7) prevents diabetes-induced attenuation in PPAR-gamma and catalase activities

Moore, E.D.; Kooshki, M.; Metheny-Barlow, L.J.; Gallagher, P.E.; Robbins, M.E., 2015:
Angiotensin-(1-7) prevents radiation-induced inflammation in rat primary astrocytes through regulation of MAP kinase signaling

Klein, N.; Gembardt, F.; Supé, S.; Kaestle, S.M.; Nickles, H.; Erfinanda, L.; Lei, X.; Yin, J.; Wang, L.; Mertens, M.; Szaszi, K.; Walther, T.; Kuebler, W.M., 2013:
Angiotensin-(1-7) protects from experimental acute lung injury

Jawien, J.; Toton-Zuranska, J.; Gajda, M.; Niepsuj, A.; Gebska, A.; Kus, K.; Suski, M.; Pyka-Fosciak, G.; Nowak, B.; Guzik, T.J.; Marcinkiewicz, J.; Olszanecki, R.; Korbut, R., 2012:
Angiotensin-(1-7) receptor Mas agonist ameliorates progress of atherosclerosis in apoE-knockout mice

Fu, Z.; Zhao, L.; Aylor, K.W.; Carey, R.M.; Barrett, E.J.; Liu, Z., 2014:
Angiotensin-(1-7) recruits muscle microvasculature and enhances insulin's metabolic action via mas receptor

Zeng, W-tao.; Chen, W-yan.; Leng, X-yu.; He, J-gui.; Ma, H., 2011:
Angiotensin-(1-7) reduced postangioplasty vascular fibrosis in abdominal aorta of rabbits

Cook, K.L.; Metheny-Barlow, L.J.; Tallant, E.Ann.; Gallagher, P.E., 2010:
Angiotensin-(1-7) reduces fibrosis in orthotopic breast tumors

Krishnan, B.; Torti, F.M.; Gallagher, P.E.; Tallant, E.Ann., 2013:
Angiotensin-(1-7) reduces proliferation and angiogenesis of human prostate cancer xenografts with a decrease in angiogenic factors and an increase in sFlt-1

Giani, J.F.; Muñoz, M.C.; Pons, R.A.; Cao, G.; Toblli, J.E.; Turyn, D.; Dominici, F.P., 2011:
Angiotensin-(1-7) reduces proteinuria and diminishes structural damage in renal tissue of stroke-prone spontaneously hypertensive rats

Herath, C.B.; Mak, K.; Burrell, L.M.; Angus, P.W., 2013:
Angiotensin-(1-7) reduces the perfusion pressure response to angiotensin II and methoxamine via an endothelial nitric oxide-mediated pathway in cirrhotic rat liver

Singh, N.; Vasam, G.; Pawar, R.; Jarajapu, Y.P.R., 2015:
Angiotensin-(1-7) reverses angiogenic dysfunction in corpus cavernosum by acting on the microvasculature and bone marrow-derived cells in diabetes

Heringer-Walther, S.; Eckert, K.; Schumacher, S-Mai.; Uharek, L.; Wulf-Goldenberg, A.; Gembardt, F.; Fichtner, I.; Schultheiss, H-Peter.; Rodgers, K.; Walther, T., 2009:
Angiotensin-(1-7) stimulates hematopoietic progenitor cells in vitro and in vivo

Shah, A.; Gul, R.; Yuan, K.; Gao, S.; Oh, Y-Bin.; Kim, U-Hyun.; Kim, S.Hee., 2010:
Angiotensin-(1-7) stimulates high atrial pacing-induced ANP secretion via Mas/PI3-kinase/Akt axis and Na+/H+ exchanger

Muñoz, M.C.; Giani, J.F.; Dominici, F.P., 2010:
Angiotensin-(1-7) stimulates the phosphorylation of Akt in rat extracardiac tissues in vivo via receptor Mas

Wang, K.; Hu, X.; Du, C.; Tu, S.; Zhang, F.; Xie, X., 2012:
Angiotensin-(1-7) suppresses the number and function of the circulating fibrocytes by upregulating endothelial nitric oxide synthase expression

Rodgers, K.E.; Espinoza, T.B.; Roda, N.; Meeks, C.J.; diZerega, G.S., 2014 :
Angiotensin-(1-7) synergizes with colony-stimulating factors in hematopoietic recovery

Lopez Verrilli, Mía.A.; Pirola, C.J.; Pascual, M.M.; Dominici, F.P.; Turyn, D.; Gironacci, M.M., 2009:
Angiotensin-(1-7) through AT receptors mediates tyrosine hydroxylase degradation via the ubiquitin-proteasome pathway

Yang, H-Yu.; Bian, Y-Fei.; Zhang, H-Ping.; Gao, F.; Xiao, C-Shi.; Liang, B.; Li, J.; Zhang, N-Na.; Yang, Z-Ming., 2014:
Angiotensin-(1-7) treatment ameliorates angiotensin II-induced apoptosis of human umbilical vein endothelial cells

Liang, B.; Wang, X.; Yan, F.; Bian, Y-F.; Liu, M.; Bai, R.; Yang, H-Y.; Zhang, N-N.; Yang, Z-M.; Xiao, C-S., 2015:
Angiotensin-(1-7) upregulates (ATP-binding cassette transporter A1) ABCA1 expression through cyclic AMP signaling pathway in RAW 264.7 macrophages

Costa, Mía.A.; Lopez Verrilli, Mía.A.; Gomez, K.A.; Nakagawa, P.; Peña, C.; Arranz, C.; Gironacci, M.M., 2010:
Angiotensin-(1-7) upregulates cardiac nitric oxide synthase in spontaneously hypertensive rats

Liang, B.; Wang, X.; Bian, Y.; Yang, H.; Liu, M.; Bai, R.; Yang, Z.; Xiao, C., 2015:
Angiotensin-(1-7) upregulates expression of adenosine triphosphate-binding cassette transporter A1 and adenosine triphosphate-binding cassette transporter G1 through the Mas receptor through the liver X receptor alpha signalling pathway in THP-1 macrophages treated with angiotensin-II

Kluskens, L.D.; Nelemans, S.Adriaan.; Rink, R.; de Vries, L.; Meter-Arkema, A.; Wang, Y.; Walther, T.; Kuipers, A.; Moll, G.N.; Haas, M., 2008:
Angiotensin-(1-7) with thioether bridge: an angiotensin-converting enzyme-resistant, potent angiotensin-(1-7) analog

Lubel, J.S.; Herath, C.B.; Tchongue, J.; Grace, J.; Jia, Z.; Spencer, K.; Casley, D.; Crowley, P.; Sievert, W.; Burrell, L.M.; Angus, P.W., 2009:
Angiotensin-(1-7), an alternative metabolite of the renin-angiotensin system, is up-regulated in human liver disease and has antifibrotic activity in the bile-duct-ligated rat

Reis, F.M.; Bouissou, D.R.; Pereira, V.M.; Camargos, A.F.; dos Reis, A.M.; Santos, R.A., 2011:
Angiotensin-(1-7), its receptor Mas, and the angiotensin-converting enzyme type 2 are expressed in the human ovary

Gwathmey, T.M.; Pendergrass, K.D.; Reid, S.D.; Rose, J.C.; Diz, D.I.; Chappell, M.C., 2010:
Angiotensin-(1-7)-angiotensin-converting enzyme 2 attenuates reactive oxygen species formation to angiotensin II within the cell nucleus

van Twist, D.J.L.; Houben, A.J.H.M.; de Haan, M.W.; Mostard, G.J.M.; Kroon, A.A.; de Leeuw, P.W., 2013:
Angiotensin-(1-7)-induced renal vasodilation in hypertensive humans is attenuated by low sodium intake and angiotensin II co-infusion

Van Twist, D.J.L.; Houben, A.J.H.M.; De Haan, M.W.; Mostard, G.J.M.; De Leeuw, P.W.; Kroon, A.A., 2016:
Angiotensin-(1-7)-induced renal vasodilation is reduced in human kidneys with renal artery stenosis

Gomes, Eéas.R.M.; Santos, R.A.S.; Guatimosim, S., 2012:
Angiotensin-(1-7)-mediated signaling in cardiomyocytes

Ferreira, A.J.; Santos, R.A.S.; Raizada, M.K., 2012:
Angiotensin-(1-7)/angiotensin-converting enzyme 2/mas receptor axis and related mechanisms

Li, Y.; Li, G.; Liu, T., 2011:
Angiotensin-(1-7): a new therapeutic strategy in the management of atrial fibrillation

Gallagher, P.E.; Arter, A.L.; Deng, G.; Tallant, E.A., 2015:
Angiotensin-(1-7): a peptide hormone with anti-cancer activity

Passos-Silva, D.G.; Verano-Braga, T.; Santos, R.A.S., 2013:
Angiotensin-(1-7): beyond the cardio-renal actions

Trask, A.J.; Ferrario, C.M., 2007:
Angiotensin-(1-7): pharmacology and new perspectives in cardiovascular treatments

Ocaranza, M.Paz.; Lavandero, S.; Jalil, J.E.; Moya, J.; Pinto, M.; Novoa, U.; Apablaza, F.; Gonzalez, L.; Hernandez, C.; Varas, M.; Lopez, R.; Godoy, I.; Verdejo, H.; Chiong, M., 2010:
Angiotensin-(1-9) regulates cardiac hypertrophy in vivo and in vitro

Ocaranza, M.Paz.; Moya, J.; Barrientos, V.; Alzamora, R.; Hevia, D.; Morales, C.; Pinto, M.; Escudero, Nás.; García, L.; Novoa, U.; Ayala, P.; Díaz-Araya, G.; Godoy, I.; Chiong, M.; Lavandero, S.; Jalil, J.E.; Michea, L., 2014:
Angiotensin-(1-9) reverses experimental hypertension and cardiovascular damage by inhibition of the angiotensin converting enzyme/Ang II axis

Kramkowski, K.; Mogielnicki, A.; Leszczynska, A.; Buczko, W., 2010:
Angiotensin-(1-9), the product of angiotensin I conversion in platelets, enhances arterial thrombosis in rats

Axelband, F.; Dias, J.; Miranda, F.; Ferrão, F.M.; Reis, R.I.; Costa-Neto, C.M.; Lara, L.S.; Vieyra, A., 2012:
Angiotensin-(3-4) counteracts the Angiotensin II inhibitory action on renal Ca2+-ATPase through a cAMP/PKA pathway

Jayapalan, J.J.; Muniandy, S.; Chan, S.P., 2008:
Angiotensin-1 converting enzyme I/D gene polymorphism: scenario in Malaysia

Ortega-Pierres, L.Elena.; Gómez García, A.; Rodríguez-Ayala, E.; Figueroa-Núñez, B.; Farias-Rodríguez, Víctor.Manuel.; Higareda-Mendoza, A.Edith.; Pardo-Galván, M.Aurelio.; Cortés-García, J.Carlos.; López-Meza, J.Edmundo.; Alvarez-Aguilar, C., 2007:
Angiotensin-1 converting enzyme insertion/deletion gene polymorphism in a Mexican population with diabetic nephropathy

Dolley-Hitze, T.; Verhoest, Gégory.; Jouan, F.; Le Pogamp, P.; Arlot-Bonnemains, Y.; Oger, E.; Belaud-Rotureau, M-Antoine.; Rioux-Leclercq, N.; Vigneau, Cécile., 2014:
Angiotensin-2 type 1 receptors (AT1R) and cancers

Barro-Soria, R.; Stindl, J.; Müller, C.; Foeckler, R.; Todorov, V.; Castrop, H.; Strauß, O., 2013:
Angiotensin-2-mediated Ca2+ signaling in the retinal pigment epithelium: role of angiotensin-receptor-associated-protein and TRPV2 channel

Ong, H.Teik.; Ong, L.Meng.; Ho, J.Judith., 2013:
Angiotensin-Converting Enzyme Inhibitors (ACEIs) and Angiotensin-Receptor Blockers (ARBs) in Patients at High Risk of Cardiovascular Events: A Meta-Analysis of 10 Randomised Placebo-Controlled Trials

Ponte, C.D.; Doyle, G.A., 2016:
Angiotensin-Converting Enzyme Inhibitors--Are They Worth Their Salt?

Kobayashi, Y.; Yamauchi, T.; Katsuda, T.; Yamaji, H.; Katoh, S., 2008:
Angiotensin-I converting enzyme (ACE) inhibitory mechanism of tripeptides containing aromatic residues

Masuyer, G.; Yates, C.J.; Sturrock, E.D.; Acharya, K.Ravi., 2015:
Angiotensin-I converting enzyme (ACE): structure, biological roles, and molecular basis for chloride ion dependence

Eleni, S.; Dimitrios, K.; Vaya, P.; Areti, M.; Norma, V.; Magdalini, G., 2008:
Angiotensin-I converting enzyme gene and I/D polymorphism distribution in the Greek population and a comparison with other European populations

Cheung, I.W.Y.; Nakayama, S.; Hsu, M.N.K.; Samaranayaka, A.G.P.; Li-Chan, E.C.Y., 2010:
Angiotensin-I converting enzyme inhibitory activity of hydrolysates from oat (Avena sativa) proteins by in silico and in vitro analyses

Segura Campos, M.R.; Chel Guerrero, L.A.; Betancur Ancona, D.A., 2011:
Angiotensin-I converting enzyme inhibitory and antioxidant activities of peptide fractions extracted by ultrafiltration of cowpea Vigna unguiculata hydrolysates

Wijesekara, I.; Kim, S-Kwon., 2010:
Angiotensin-I-converting enzyme (ACE) inhibitors from marine resources: prospects in the pharmaceutical industry

Wang, Z.; Zhang, S.; Jin, H.; Wang, W.; Huo, J.; Zhou, L.; Wang, Y.; Feng, F.; Zhang, L., 2011:
Angiotensin-I-converting enzyme inhibitory peptides: Chemical feature based pharmacophore generation

Ishikawa, T.; Ushiki, T.; Kamimura, H.; Togashi, T.; Tsuchiya, A.; Watanabe, K.; Seki, K.; Ohta, H.; Yoshida, T.; Takeda, K.; Kamimura, T., 2007:
Angiotensin-II administration is useful for the detection of liver metastasis from pancreatic cancer during pharmacoangiographic computed tomography

Kalwa, H.; Sartoretto, J.L.; Sartoretto, S.M.; Michel, T., 2012:
Angiotensin-II and MARCKS: a hydrogen peroxide- and RAC1-dependent signaling pathway in vascular endothelium

Solini, A.; Rossi, C.; Santini, E.; Madec, S.; Salvati, A.; Ferrannini, E., 2012:
Angiotensin-II and rosuvastatin influence matrix remodeling in human mesangial cells via metalloproteinase modulation

Pushpakumar, S.; Kundu, S.; Pryor, T.; Givvimani, S.; Lederer, E.; Tyagi, S.C.; Sen, U., 2015:
Angiotensin-II induced hypertension and renovascular remodelling in tissue inhibitor of metalloproteinase 2 knockout mice

Vedantam, S.; Atreja, S.K.; Garg, M., 2012:
Angiotensin-II induced nitric oxide production during buffalo sperm capacitation and acrosome reaction

Wang, Z.; Ren, Z.; Hu, Z.; Hu, X.; Zhang, H.; Wu, H.; Zhang, M., 2015:
Angiotensin-II induces phosphorylation of ERK1/2 and promotes aortic adventitial fibroblasts differentiating into myofibroblasts during aortic dissection formation

Nielsen, J.A.; Steephen, A.; Lewin, M., 2014:
Angiotensin-II inhibitor (olmesartan)-induced collagenous sprue with resolution following discontinuation of drug

Bond, J.E.; Bergeron, A.; Thurlow, P.; Selim, M.Angelica.; Bowers, E.V.; Kuang, A.; Levinson, H., 2012:
Angiotensin-II mediates nonmuscle myosin II activation and expression and contributes to human keloid disease progression

Kumai, Y.; Bernier, N.J.; Perry, S.F., 2014:
Angiotensin-II promotes Na+ uptake in larval zebrafish, Danio rerio, in acidic and ion-poor water

Oppermann, M.; Padberg, S.; Kayser, A.; Weber-Schoendorfer, C.; Schaefer, C., 2013:
Angiotensin-II receptor 1 antagonist fetopathy--risk assessment, critical time period and vena cava thrombosis as a possible new feature

Anonymous, 2007:
Angiotensin-II receptor antagonist + diuretic + NSAID = danger!

González-Hernández, M.de.Lourdes.; Godínez-Hernández, D.; Bobadilla-Lugo, R.A.; López-Sánchez, P., 2011:
Angiotensin-II type 1 receptor (AT1R) and alpha-1D adrenoceptor form a heterodimer during pregnancy-induced hypertension

Shanmugam, P.; Valente, A.J.; Prabhu, S.D.; Venkatesan, B.; Yoshida, T.; Delafontaine, P.; Chandrasekar, B., 2011:
Angiotensin-II type 1 receptor and NOX2 mediate TCF/LEF and CREB dependent WISP1 induction and cardiomyocyte hypertrophy

Granzow, M.; Schierwagen, R.; Klein, S.; Kowallick, B.; Huss, S.; Linhart, M.; Mazar, I.G.Reza.; Görtzen, J.; Vogt, A.; Schildberg, F.A.; Gonzalez-Carmona, M.A.; Wojtalla, A.; Krämer, B.; Nattermann, J.; Siegmund, Sören.V.; Werner, N.; Fürst, D.O.; Laleman, W.; Knolle, P.; Shah, V.H.; Sauerbruch, T.; Trebicka, J., 2014:
Angiotensin-II type 1 receptor-mediated Janus kinase 2 activation induces liver fibrosis

Paletas, K.; Sailer, X.; Rizeq, L.; Dimitriadi, A.; Koliakos, G.; Kaloyianni, M., 2008:
Angiotensin-II-dependent NHE1 activation in human monocytes

López-Sánchez, P.; Valdés, I.Bracho.; Godínez-Hernández, D.; Bobadilla-Lugo, R.A., 2010:
Angiotensin-II-dependent changes in alpha-1 adrenoceptor vascular expression in pregnant rats

de Queiroz, T.M.; Monteiro, M.M.O.; Braga, V.A., 2013 :
Angiotensin-II-derived reactive oxygen species on baroreflex sensitivity during hypertension: new perspectives

Rainey, W.E.; Bird, I.M.; Mason, J.I., 2012:
Angiotensin-II-directed glomerulosa cell function in fetal adrenal cells

Lee, Y.H.; Mungunsukh, O.; Tutino, R.L.; Marquez, A.P.; Day, R.M., 2010:
Angiotensin-II-induced apoptosis requires regulation of nucleolin and Bcl-xL by SHP-2 in primary lung endothelial cells

Braga, V.A.; Medeiros, I.A.; Ribeiro, T.P.; França-Silva, M.S.; Botelho-Ono, M.S.; Guimarães, D.D., 2012:
Angiotensin-II-induced reactive oxygen species along the SFO-PVN-RVLM pathway: implications in neurogenic hypertension

Asfar, P.; Chawla, L.; Lerolle, N.; Radermacher, P., 2015:
Angiotensin-II: more than just another vasoconstrictor to treat septic shock-induced hypotension?*

Uhal, B.D.; Kim, J.Kyong.; Li, X.; Molina-Molina, M., 2007:
Angiotensin-TGF-beta 1 crosstalk in human idiopathic pulmonary fibrosis: autocrine mechanisms in myofibroblasts and macrophages

Chan, K.H.; Chen, Y.H.; Zhang, Y.; Wong, Y.H.; Dun, N.J., 2014:
Angiotensin-[1-12] interacts with angiotensin type I receptors

Krajina-Andricević, M.; Zibar, L.; Glavas-Obrovac-, L.; Stefanić, M.; Avdicević, M.; Barbić, J., 2012:
Angiotensin-converting enyme insertion/deletion polymorphism and blood pressure regulation in type 2 diabetic patients

Liu, R.; Qi, H.; Wang, J.; Wang, Y.; Cui, L.; Wen, Y.; Yin, C., 2015:
Angiotensin-converting enzyme (ACE and ACE2) imbalance correlates with the severity of cerulein-induced acute pancreatitis in mice

Liu, C.Xi.; Hu, Q.; Wang, Y.; Zhang, W.; Ma, Z.Yong.; Feng, J.Bo.; Wang, R.; Wang, X.Ping.; Dong, B.; Gao, F.; Zhang, M.Xiang.; Zhang, Y., 2011:
Angiotensin-converting enzyme (ACE) 2 overexpression ameliorates glomerular injury in a rat model of diabetic nephropathy: a comparison with ACE inhibition

Kawajiri, M.; Mogi, M.; Higaki, N.; Matsuoka, T.; Ohyagi, Y.; Tsukuda, K.; Kohara, K.; Horiuchi, M.; Miki, T.; Kira, J.I., 2009:
Angiotensin-converting enzyme (ACE) and ACE2 levels in the cerebrospinal fluid of patients with multiple sclerosis

Mansoor, Q.; Javaid, A.; Bilal, N.; Ismail, M., 2013:
Angiotensin-converting enzyme (ACE) gene II genotype protects against the development of diabetic peripheral neuropathy in type 2 diabetes mellitus

Li, Y-Feng.; Zhu, X-Ming.; Liu, F.; Xiao, C-Shi.; Bian, Y-Fei.; Li, H.; Cai, J.; Li, R-Shan.; Yang, X-Chun., 2012:
Angiotensin-converting enzyme (ACE) gene insertion/deletion polymorphism and ACE inhibitor-related cough: a meta-analysis

Seripa, D.; Paroni, G.; Matera, M.G.; Gravina, C.; Scarcelli, C.; Corritore, M.; D'Ambrosio, L.P.; Urbano, M.; D'Onofrio, G.; Copetti, M.; Kehoe, P.G.; Panza, F.; Pilotto, A., 2012:
Angiotensin-converting enzyme (ACE) genotypes and disability in hospitalized older patients

Roberts, J.R.; Lee, J.J.; Marthers, D.A., 2012:
Angiotensin-converting enzyme (ACE) inhibitor angioedema: the silent epidemic

Harford-Wright, E.; Thornton, E.; Vink, R., 2010:
Angiotensin-converting enzyme (ACE) inhibitors exacerbate histological damage and motor deficits after experimental traumatic brain injury

Kohlstedt, K.; Gershome, C.; Trouvain, C.; Hofmann, W-Karsten.; Fichtlscherer, S.; Fleming, I., 2009:
Angiotensin-converting enzyme (ACE) inhibitors modulate cellular retinol-binding protein 1 and adiponectin expression in adipocytes via the ACE-dependent signaling cascade

Miners, J.S.; Ashby, E.; Van Helmond, Z.; Chalmers, K.A.; Palmer, L.E.; Love, S.; Kehoe, P.G., 2007 :
Angiotensin-converting enzyme (ACE) levels and activity in Alzheimer's disease, and relationship of perivascular ACE-1 to cerebral amyloid angiopathy

Gürkan, A.; Emingil, Gülnur.; Saygan, B.Han.; Atilla, Gül.; Köse, T.; Baylas, H.; Berdeli, A., 2010:
Angiotensin-converting enzyme (ACE), angiotensinogen (AGT), and angiotensin II type 1 receptor (AT1R) gene polymorphisms in generalized aggressive periodontitis

Kancabaş, Aı.; Karakaya, S., 2013:
Angiotensin-converting enzyme (ACE)-inhibitory activity of boza, a traditional fermented beverage

Korcz, A.; Mikołajczyk-Stecyna, J.; Gabriel, M.; Zowczak-Drabarczyk, Młosława.; Pawlaczyk, K.; Kalafirov, M.; Oszkinis, G.; Słomski, R., 2008:
Angiotensin-converting enzyme (ACE, I/D) gene polymorphism and susceptibility to abdominal aortic aneurysm or aortoiliac occlusive disease

Jokubaitis, V.J.; Sinka, L.; Driessen, R.; Whitty, G.; Haylock, D.N.; Bertoncello, I.; Smith, I.; Péault, B.; Tavian, M.; Simmons, P.J., 2007:
Angiotensin-converting enzyme (CD143) marks hematopoietic stem cells in human embryonic, fetal, and adult hematopoietic tissues

Kalita, J.; Misra, U.K.; Bindu, I.S.; Kumar, B.; Mittal, B., 2011:
Angiotensin-converting enzyme (rs4646994) and α ADDUCIN (rs4961) gene polymorphisms' study in primary spontaneous intracerebral hemorrhage

Qiu, Y.; Shil, P.Kumar.; Zhu, P.; Yang, H.; Verma, A.; Lei, B.; Li, Q., 2014:
Angiotensin-converting enzyme 2 (ACE2) activator diminazene aceturate ameliorates endotoxin-induced uveitis in mice

Sluimer, J.C.; Gasc, J.M.; Hamming, I.; van Goor, H.; Michaud, A.; van den Akker, L.H.; Jütten, B.; Cleutjens, J.; Bijnens, A.P.J.J.; Corvol, P.; Daemen, M.J.A.P.; Heeneman, S., 2008:
Angiotensin-converting enzyme 2 (ACE2) expression and activity in human carotid atherosclerotic lesions

Xu, L.; Zhang, Y.; Liu, Y.; Chen, Z.; Deng, H.; Ma, Z.; Wang, H.; Hu, Z.; Deng, F., 2009:
Angiotensin-converting enzyme 2 (ACE2) from raccoon dog can serve as an efficient receptor for the spike protein of severe acute respiratory syndrome coronavirus

Imai, Y.; Kuba, K.; Ohto-Nakanishi, T.; Penninger, J.M., 2010:
Angiotensin-converting enzyme 2 (ACE2) in disease pathogenesis

Hou, Y.; Peng, C.; Yu, M.; Li, Y.; Han, Z.; Li, F.; Wang, L-Fa.; Shi, Z., 2010:
Angiotensin-converting enzyme 2 (ACE2) proteins of different bat species confer variable susceptibility to SARS-CoV entry

Palmer, B.R.; Jarvis, M.D.; Pilbrow, A.P.; Ellis, K.L.; Frampton, C.M.; Skelton, L.; Yandle, T.G.; Doughty, R.N.; Whalley, G.A.; Ellis, C.J.; Troughton, R.W.; Richards, A.Mark.; Cameron, V.A., 2008:
Angiotensin-converting enzyme 2 A1075G polymorphism is associated with survival in an acute coronary syndromes cohort

Veit, F.; Weissmann, N., 2013:
Angiotensin-converting enzyme 2 activation for treatment of pulmonary hypertension

Ferreira, A.J.; Shenoy, V.; Qi, Y.; Fraga-Silva, R.A.; Santos, R.A.S.; Katovich, M.J.; Raizada, M.K., 2011:
Angiotensin-converting enzyme 2 activation protects against hypertension-induced cardiac fibrosis involving extracellular signal-regulated kinases

Li, G.; Xu, Y-lin.; Ling, F.; Liu, A-jun.; Wang, D.; Wang, Q.; Liu, Y-long., 2012:
Angiotensin-converting enzyme 2 activation protects against pulmonary arterial hypertension through improving early endothelial function and mediating cytokines levels

Zhou, L.; Zhang, R.; Zhang, L.; Yao, W.; Li, J.; Yuan, Y., 2011:
Angiotensin-converting enzyme 2 acts as a potential molecular target for pancreatic cancer therapy

Lo, J.; Patel, V.B.; Wang, Z.; Levasseur, J.; Kaufman, S.; Penninger, J.M.; Oudit, G.Y., 2013:
Angiotensin-converting enzyme 2 antagonizes angiotensin II-induced pressor response and NADPH oxidase activation in Wistar-Kyoto rats and spontaneously hypertensive rats

Chamsi-Pasha, M.A.R.; Shao, Z.; Tang, W.H.Wilson., 2014:
Angiotensin-converting enzyme 2 as a therapeutic target for heart failure

Zhang, C.; Zhao, Y.Xia.; Zhang, Y.Hui.; Zhu, L.; Deng, B.Ping.; Zhou, Z.Li.; Li, S.Ying.; Lu, X.Ting.; Song, L.Li.; Lei, X.Ming.; Tang, W.Bo.; Wang, N.; Pan, C.Ming.; Song, H.Dong.; Liu, C.Xi.; Dong, B.; Zhang, Y.; Cao, Y., 2010:
Angiotensin-converting enzyme 2 attenuates atherosclerotic lesions by targeting vascular cells

Qian, Y-Rong.; Guo, Y.; Wan, H-Ying.; Fan, L.; Feng, Y.; Ni, L.; Xiang, Y.; Li, Q-Yun., 2013:
Angiotensin-converting enzyme 2 attenuates the metastasis of non-small cell lung cancer through inhibition of epithelial-mesenchymal transition

Thatcher, S.E.; Zhang, X.; Howatt, D.A.; Yiannikouris, F.; Gurley, S.B.; Ennis, T.; Curci, J.A.; Daugherty, A.; Cassis, L.A., 2015:
Angiotensin-converting enzyme 2 decreases formation and severity of angiotensin II-induced abdominal aortic aneurysms

Thatcher, S.E.; Zhang, X.; Howatt, D.A.; Lu, H.; Gurley, S.B.; Daugherty, A.; Cassis, L.A., 2011:
Angiotensin-converting enzyme 2 deficiency in whole body or bone marrow-derived cells increases atherosclerosis in low-density lipoprotein receptor-/- mice

Bharadwaj, M.S.; Strawn, W.B.; Groban, L.; Yamaleyeva, L.M.; Chappell, M.C.; Horta, C.; Atkins, K.; Firmes, L.; Gurley, S.B.; Brosnihan, K.Bridget., 2011:
Angiotensin-converting enzyme 2 deficiency is associated with impaired gestational weight gain and fetal growth restriction

Lai, Z.W.; Hanchapola, I.; Steer, D.L.; Smith, A.Ian., 2011:
Angiotensin-converting enzyme 2 ectodomain shedding cleavage-site identification: determinants and constraints

Wu, X-wei.; Lu, Z-qiang.; Gong, J-jing.; Wang, H-jun.; Xu, C-sheng.; Jin, X-qing., 2015:
Angiotensin-converting enzyme 2 gene transfer attenuates neointimal formation after carotid artery ischemia-reperfusion injury in rats

Xia, H.; Lazartigues, E., 2008:
Angiotensin-converting enzyme 2 in the brain: properties and future directions

Ni, J.; Lu, L-Min., 2014:
Angiotensin-converting enzyme 2 in the kidney

Patel, V.B.; Zhong, J-Chang.; Fan, D.; Basu, R.; Morton, J.S.; Parajuli, N.; McMurtry, M.Sean.; Davidge, S.T.; Kassiri, Z.; Oudit, G.Y., 2014:
Angiotensin-converting enzyme 2 is a critical determinant of angiotensin II-induced loss of vascular smooth muscle cells and adverse vascular remodeling

Tikellis, C.; Bernardi, S.; Burns, W.C., 2011:
Angiotensin-converting enzyme 2 is a key modulator of the renin-angiotensin system in cardiovascular and renal disease

Lambert, D.W.; Lambert, L.A.; Clarke, N.E.; Hooper, N.M.; Porter, K.E.; Turner, A.J., 2014:
Angiotensin-converting enzyme 2 is subject to post-transcriptional regulation by miR-421

Tikellis, C.; Brown, R.; Head, G.A.; Cooper, M.E.; Thomas, M.C., 2014:
Angiotensin-converting enzyme 2 mediates hyperfiltration associated with diabetes

Feng, Y.; Hans, C.; McIlwain, E.; Varner, K.J.; Lazartigues, E., 2013:
Angiotensin-converting enzyme 2 over-expression in the central nervous system reduces angiotensin-II-mediated cardiac hypertrophy

Grace, J.A.; Burrell, L.M.; Patel, S.K., 2013:
Angiotensin-converting enzyme 2 polymorphisms and cardiovascular risk

Bernardi, S.; Burns, W.C.; Toffoli, B.; Pickering, R.; Sakoda, M.; Tsorotes, D.; Grixti, E.; Velkoska, E.; Burrell, L.M.; Johnston, C.; Thomas, M.C.; Fabris, B.; Tikellis, C., 2012:
Angiotensin-converting enzyme 2 regulates renal atrial natriuretic peptide through angiotensin-(1-7)

Zhong, J.; Basu, R.; Guo, D.; Chow, F.L.; Byrns, S.; Schuster, M.; Loibner, H.; Wang, X-hua.; Penninger, J.M.; Kassiri, Z.; Oudit, G.Y., 2010:
Angiotensin-converting enzyme 2 suppresses pathological hypertrophy, myocardial fibrosis, and cardiac dysfunction

Haber, P.K.; Ye, M.; Wysocki, J.; Maier, C.; Haque, S.K.; Batlle, D., 2014:
Angiotensin-converting enzyme 2-independent action of presumed angiotensin-converting enzyme 2 activators: studies in vivo, ex vivo, and in vitro

Meng, Y.; Yu, C-Hui.; Li, W.; Li, T.; Luo, W.; Huang, S.; Wu, P-Sheng.; Cai, S-Xi.; Li, X., 2014:
Angiotensin-converting enzyme 2/angiotensin-(1-7)/Mas axis protects against lung fibrosis by inhibiting the MAPK/NF-κB pathway

Zucker, I.H., 2008:
Angiotensin-converting enzyme 2: a new player in central sympathetic regulation?

Feng, Y.; Xia, H.; Santos, R.A.; Speth, R.; Lazartigues, E., 2010:
Angiotensin-converting enzyme 2: a new target for neurogenic hypertension

Turner, A.J., 2008:
Angiotensin-converting enzyme 2: cardioprotective player in the renin-angiotensin system?

Xia, H.; Lazartigues, E., 2011:
Angiotensin-converting enzyme 2: central regulator for cardiovascular function

Ingelfinger, J.R., 2009:
Angiotensin-converting enzyme 2: implications for blood pressure and kidney disease

Wysocki, J.; González-Pacheco, F.R.; Batlle, D., 2008:
Angiotensin-converting enzyme 2: possible role in hypertension and kidney disease

Clarke, N.E.; Turner, A.J., 2011:
Angiotensin-converting enzyme 2: the first decade

Plunkett, A.; Agbeko, R.S.; Li, K.; Humphries, S.E.; Klein, N.J.; Peters, M.J., 2008:
Angiotensin-converting enzyme D allele does not influence susceptibility to acute hypoxic respiratory failure in children

Sun, L.; Lv, H.; Wei, W.; Zhang, D.; Guan, Y., 2010:
Angiotensin-converting enzyme D/I and plasminogen activator inhibitor-1 4G/5G gene polymorphisms are associated with increased risk of spontaneous abortions in polycystic ovarian syndrome

Ceyhan, K.; Kadi, H.; Celik, A.; Burucu, T.; Koc, F.; Sogut, E.; Sahin, S.; Onalan, O., 2013:
Angiotensin-converting enzyme DD polymorphism is associated with poor coronary collateral circulation in patients with coronary artery disease

Saber-Ayad, M.M.; Nassar, Y.S.; Latif, I.A., 2015:
Angiotensin-converting enzyme I/D gene polymorphism affects early cardiac response to professional training in young footballers

Huang, L-Gang.; Liu, D-Bo.; Wang, H-Qing., 2015:
Angiotensin-converting enzyme I/D polymorphism and aortic aneurysm risk: a meta-analysis

Li, Y.; Tong, N., 2016:
Angiotensin-converting enzyme I/D polymorphism and diabetic peripheral neuropathy in type 2 diabetes mellitus: A meta-analysis

Pabst, S.; Theis, B.; Gillissen, A.; Lennarz, M.; Tuleta, I.; Nickenig, G.; Skowasch, D.; Grohé, C., 2010:
Angiotensin-converting enzyme I/D polymorphism in chronic obstructive pulmonary disease

Li, W.; Lan, F.; Yan, F.; Shen, H., 2013:
Angiotensin-converting enzyme I/D polymorphism is associated with COPD risk in Asian population: evidence from a meta-analysis

Nie, W.; Zang, Y.; Chen, J.; Liu, T.; Xiao, L.; Xiu, Q., 2015:
Angiotensin-converting enzyme I/D polymorphism is associated with pneumonia risk: a meta-analysis

Li, P.; Xiao, H.D.; Xu, J.; Ong, F.S.; Kwon, M.; Roman, J.; Gal, A.; Bernstein, K.E.; Fuchs, S., 2010:
Angiotensin-converting enzyme N-terminal inactivation alleviates bleomycin-induced lung injury

Pedersen-Bjergaard, U.; Thomsen, C.E.; Høgenhaven, H.; Smed, A.; Kjaer, T.W.; Holst, J.J.; Dela, F.; Hilsted, L.; Frandsen, E.; Pramming, S.; Thorsteinsson, B., 2008:
Angiotensin-converting enzyme activity and cognitive impairment during hypoglycaemia in healthy humans

Zhang, L-Chao.; Li, Z-Zhen.; Yu, Y-Sheng.; Wang, Z-Bin.; Wei, X.; Su, D-Feng.; Li, L., 2011:
Angiotensin-converting enzyme and Angiotensin-converting enzyme 2 are involved in sinoaortic denervation-induced cardiovascular hypertrophy in rats

Mandò, C.; Antonazzo, P.; Tabano, S.; Zanutto, S.; Pileri, P.; Somigliana, E.; Colleoni, F.; Martinelli, A.; Zolin, A.; Benedetto, C.; Marozio, L.; Neri, I.; Facchinetti, F.; Miozzo, M.; Cetin, I., 2009:
Angiotensin-converting enzyme and adducin-1 polymorphisms in women with preeclampsia and gestational hypertension

Pedersen-Bjergaard, U.; Nielsen, Søren.L.; Akram, K.; Perrild, H.; Nordestgaard, Børge.G.; Montgomery, H.E.; Pramming, S.; Thorsteinsson, B., 2010:
Angiotensin-converting enzyme and angiotensin II receptor subtype 2 genotypes in type 1 diabetes and severe hypoglycaemia requiring emergency treatment: a case cohort study

Kawaguchi, H., 2003:
Angiotensin-converting enzyme and angiotensinogen gene polymorphism in hypertrophic cardiomyopathy

Nishio, K.; Kashiki, S.; Tachibana, H.; Kobayashi, Y., 2011:
Angiotensin-converting enzyme and bradykinin gene polymorphisms and cough: A meta-analysis

Grouzmann, E.; Livio, Fçoise.; Buclin, T., 2009:
Angiotensin-converting enzyme and dipeptidyl peptidase IV inhibitors: an increased risk of angioedema

Jochemsen, H.M.; Geerlings, M.I.; Grool, A.M.; Vincken, K.L.; Mali, W.Ptm.; van der Graaf, Y.; Muller, M., 2012:
Angiotensin-converting enzyme and progression of white matter lesions and brain atrophy--the SMART-MR study

Okwan-Duodu, D.; Landry, J.; Shen, X.Z.; Diaz, R., 2013:
Angiotensin-converting enzyme and the tumor microenvironment: mechanisms beyond angiogenesis

Zou, K.; Michikawa, M., 2009:
Angiotensin-converting enzyme as a potential target for treatment of Alzheimer's disease: inhibition or activation?

Zou, K.; Yamaguchi, H.; Akatsu, H.; Sakamoto, T.; Ko, M.; Mizoguchi, K.; Gong, J-Sheng.; Yu, W.; Yamamoto, T.; Kosaka, K.; Yanagisawa, K.; Michikawa, M., 2007:
Angiotensin-converting enzyme converts amyloid beta-protein 1-42 (Abeta(1-42)) to Abeta(1-40), and its inhibition enhances brain Abeta deposition

Jiang, M-Hui.; Su, Y-Min.; Tang, J-Zhong.; Shen, Y-Bo.; Deng, X-Tao.; Yuan, D-Shan.; Wu, J.; Pan, M.; Huang, Z-Wei., 2014:
Angiotensin-converting enzyme gene 2350 G/A polymorphism and susceptibility to atrial fibrillation in Han Chinese patients with essential hypertension

Pan, M.; Zhu, J-Hua.; Liu, Z-Hua.; Jiang, W-Ping.; Cui, Z-Chu.; Yu, X-Hong.; Li, H-Mei.; Yang, X-Jun., 2007:
Angiotensin-converting enzyme gene 2350 G/A polymorphism is associated with left ventricular hypertrophy but not essential hypertension

Oruc, N.; Papachristou, G.I.; Avula, H.; Slivka, A.; Lamb, J.; Whitcomb, D.C., 2009:
Angiotensin-converting enzyme gene DD genotype neither increases susceptibility to acute pancreatitis nor influences disease severity

Lian, L-H.; Lau, T-P.; Ching, A-S.; Chua, K-H., 2012 :
Angiotensin-converting enzyme gene I/D dimorphism does not play a major role in the susceptibility of Malaysian systemic lupus erythematosus patients

Liu, L-wei.; Liu, H.; Chen, G-Liang.; Huang, Y-ling.; Han, L-lu.; Xu, Z-min.; Jiang, X-jing.; Li, Y-shi., 2010:
Angiotensin-converting enzyme gene I/D genotype affected metoprolol-induced reduction in 24-hour average heart rate

Dursun, A.; Durakbasi-Dursun, H.Gul.; Dursun, R.; Baris, S.; Akduman, L., 2013:
Angiotensin-converting enzyme gene and endothelial nitric oxide synthase gene polymorphisms in Behçet's disease with or without ocular involvement

Yang, Y-Han.; Lai, C-Lian.; Tyan, Y-Chang.; Chou, M-Chuan.; Wang, L-Chun.; Yang, M-Hui.; Liu, C-Kuan., 2011:
Angiotensin-converting enzyme gene and plasma protein level in Alzheimer's disease in Taiwanese

Wipff, J.; Gallier, G.; Dieude, P.; Avouac, J.; Tiev, K.; Hachulla, E.; Granel, B.; Diot, E.; Sibilia, J.; Mouthon, L.; Meyer, O.; Kahan, A.; Varret, M.; Boileau, C.; Allanore, Y., 2009:
Angiotensin-converting enzyme gene does not contribute to genetic susceptibility to systemic sclerosis in European Caucasians

Yang, Y-Han.; Liu, C-Kuan., 2008:
Angiotensin-converting enzyme gene in Alzheimer's disease

Li, Y., 2013:
Angiotensin-converting enzyme gene insertion/deletion polymorphism and essential hypertension in the Chinese population: a meta-analysis including 21,058 participants

Prabhakar, P.; De, T.; Nagaraja, D.; Christopher, R., 2014:
Angiotensin-converting enzyme gene insertion/deletion polymorphism and small vessel cerebral stroke in Indian population

Camci, L.; Kilic, Z.; Dinleyici, E.Cagri.; Muslumanoglu, H.; Tepeli, E.; Ucar, B., 2010:
Angiotensin-converting enzyme gene insertion/deletion polymorphism frequency in normotensive children with a positive family history of essential hypertension

Settin, A.; Elbaz, R.; Abbas, A.; Abd-Al-Samad, A.; Noaman, A., 2009:
Angiotensin-converting enzyme gene insertion/deletion polymorphism in Egyptian patients with myocardial infarction

Tronvik, E.; Stovner, L.J.; Bovim, G.; White, L.R.; Gladwin, A.J.; Owen, K.; Schrader, H., 2008:
Angiotensin-converting enzyme gene insertion/deletion polymorphism in migraine patients

Mărginean, C.Oana.; Bănescu, C.; Duicu, C.; Voidăzan, S.; Mărginean, C., 2016:
Angiotensin-converting enzyme gene insertion/deletion polymorphism in nutritional disorders in children

Lukic, S.; Nikolic, A.; Alempijevic, T.; Popovic, D.; Sokic Milutinovic, A.; Ugljesic, M.; Knezevic, S.; Milicic, B.; Dinic, D.; Radojkovic, D., 2012:
Angiotensin-converting enzyme gene insertion/deletion polymorphism in patients with chronic pancreatitis and pancreatic cancer

Nadalin, S.; Buretić-Tomljanović, A.; Rubeša, G.; Jonovska, S.; Tomljanović, Dško.; Ristić, S., 2013:
Angiotensin-converting enzyme gene insertion/deletion polymorphism is not associated with schizophrenia in a Croatian population

Khan, I.A.; Jahan, P.; Hasan, Q.; Rao, P., 2015:
Angiotensin-converting enzyme gene insertion/deletion polymorphism studies in Asian Indian pregnant women biochemically identifies gestational diabetes mellitus

Simsek, S.; Tekes, S.; Turkyilmaz, A.; Tuzcu, A.K.; Kılıc, F.; Culcu, N.N.; Isık, B.; Akbas, H., 2014:
Angiotensin-converting enzyme gene insertion/deletion polymorphism with metabolic syndrome in Turkish patients

Guo, M.; Ma, J.; Han, Y.; Lu, L., 2015:
Angiotensin-converting enzyme gene insertion/deletion polymorphisms and the susceptibility to allergic rhinitis

Mohd, R.; Wahab, Z.Abdul.; Cader, R.; Gafor, H.A.; Radzi, A.Md.; Shah, S.Azhar.; Tong, N.Kong.Chiew., 2014:
Angiotensin-converting enzyme gene polymophism in adult primary focal segmental glomerulosclerosis

Pećin, I.; Cvorišćec, D.; Miletić-Medved, M.; Dika, Z.; Cvitković, A.; Vitale, K.; Leko, N.; Novaković, D.; Sertić, J.; Kos, J.; Jelaković, B., 2012:
Angiotensin-converting enzyme gene polymorphism and N-Acetyl-β-D-glucosaminidase excretion in endemic nephropathy

Rong, C.; Xing, Y.; Jiang, X.; Wang, J.; Gao, B.; Zhao, J.; Liu, K., 2013:
Angiotensin-converting enzyme gene polymorphism and middle cerebral artery stenosis in a Chinese Han population

Dimitriou, G.; Papakonstantinou, D.; Stavrou, E.F.; Tzifas, S.; Vervenioti, A.; Athanassiadou, A.; Mantagos, S., 2011:
Angiotensin-converting enzyme gene polymorphism and respiratory muscle function in infants

Celik, O.; Yesilada, E.; Hascalik, S.; Celik, N.; Sahin, I.; Keskin, L.; Ozerol, E., 2010:
Angiotensin-converting enzyme gene polymorphism and risk of insulin resistance in PCOS

Gheissari, A.; Salehi, M.; Dastjerdi, S.Bandi.; Jahangiri, M.; Hooman, N.; Otookesh, H.; Merikhipour, A.; Ajir, A.; Foroughmand, A.; Khatami, S.; Shahidi, S.; Atapour, A.; Seirafian, S.; Naeini, A.Emami., 2009:
Angiotensin-converting enzyme gene polymorphism and the progression rate of focal segmental glomerulosclerosis in Iranian children

Al-Awadhi, A.M.; Haider, M.Z.; Sharma, P.N.; Hasan, E.A.; Botaiban, F.; Al-Herz, A.; Nahar, I.; Al-Enezi, H.; Al-Saeid, K., 2007:
Angiotensin-converting enzyme gene polymorphism in Kuwaiti patients with systemic lupus erythematosus

Narasimhan, K.Laksmi.; Khullar, M.; Kaur, B., 2008:
Angiotensin-converting enzyme gene polymorphism in North-west Indian children with posterior urethral valves

Ozben, B.; Altun, I.; Sabri Hancer, V.; Bilge, A.Kaya.; Tanrikulu, A.Meryem.; Diz-Kucukkaya, R.; Fak, A.Serdar.; Yilmaz, E.; Adalet, K., 2009 :
Angiotensin-converting enzyme gene polymorphism in arrhythmogenic right ventricular dysplasia: is DD genotype helpful in predicting syncope risk?

Gupta, S.; Agrawal, B.K.; Goel, R.K.; Sehajpal, P.K., 2009:
Angiotensin-converting enzyme gene polymorphism in hypertensive rural population of Haryana, India

Akin, F.; Turgut, S.; Bastemir, M.; Turgut, G.; Kursunluoglu, R.; Karasu, U.; Guclu, A., 2010:
Angiotensin-converting enzyme gene polymorphism in overweight and obese Turkish patients with insulin resistance

Klupka-Sarić, I.; Peterlin, B.; Lovrečić, L.; Sinanović, O.; Vidović, M.; Sehanović, A.; Cizmarević, N.Starčević.; Sepčić, J.; Kapović, M.; Ristić, S., 2012:
Angiotensin-converting enzyme gene polymorphism in patients with multiple sclerosis from Bosnia and Herzegovina

Yaren, A.; Oztop, I.; Turgut, S.; Turgut, G.; Degirmencioglu, S.; Demirpence, M., 2007:
Angiotensin-converting enzyme gene polymorphism is associated with anemia in non small-cell lung cancer

Zhou, J-Bo.; Yang, J-Kui., 2011:
Angiotensin-converting enzyme gene polymorphism is associated with proliferative diabetic retinopathy: a meta-analysis

Zhou, J-Bo.; Yang, J-Kui.; Lu, J-Kai.; An, Y-Hua., 2010:
Angiotensin-converting enzyme gene polymorphism is associated with type 2 diabetes: a meta-analysis

Al-Harbi, E.M.; Farid, E.M.; Gumaa, K.A.; Masuadi, E.M.; Singh, J., 2011:
Angiotensin-converting enzyme gene polymorphisms and T2DM in a case-control association study of the Bahraini population

Zawilla, N.; Shaker, D.; Abdelaal, A.; Aref, W., 2014:
Angiotensin-converting enzyme gene polymorphisms and hypertension in occupational noise exposure in Egypt

Wang, X-Bin.; Cui, N-Hua.; Gao, J-Jia.; Qiu, X-Ping.; Yang, N.; Zheng, F., 2015:
Angiotensin-converting enzyme gene polymorphisms and risk for sporadic Alzheimer's disease: a meta-analysis

Rasyid, H.; Bakri, S.; Yusuf, I., 2013:
Angiotensin-converting enzyme gene polymorphisms, blood pressure and pulse pressure in subjects with essential hypertension in a South Sulawesi Indonesian population

Pulla Reddy, B.; Srikanth Babu, B.M.; Venkata Karunakar, K.; Yasovanthi, J.; Munshi, A.; Sampath Kumar, P.; Sharath, A.; Jyothy, A., 2010:
Angiotensin-converting enzyme gene variant and its levels: risk factors for myocardial infarction in a South Indian population

Cheema, B.Singh.; Kohli, H.Singh.; Sharma, R.; Shah, V.N.; Bhansali, A.; Khullar, M., 2013:
Angiotensin-converting enzyme gene variants interact with the renin-angiotensin system pathway to confer risk and protection against type 2 diabetic retinopathy

Wiwanitkit, S.; Wiwanitkit, V., 2015:
Angiotensin-converting enzyme genetic polymorphism

Albuquerque, F.Neves.de.; Brandão, Aéa.Araujo.; Silva, D.Aparecida.da.; Mourilhe-Rocha, R.; Duque, G.Salgado.; Gondar, A.Freitas.Pereira.; Neves, L.Maceira.de.Almeida.; Bittencourt, M.Imbroinise.; Pozzan, R.; Albuquerque, D.Campos.de., 2014:
Angiotensin-converting enzyme genetic polymorphism: its impact on cardiac remodeling

Costa, A.Matos.; Silva, Aónio.José.; Garrido, N.; Louro, H.; Marinho, D.Almeida.; Cardoso Marques, Mário.; Breitenfeld, L., 2009:
Angiotensin-converting enzyme genotype affects skeletal muscle strength in elite athletes

Tkacova, R.; Joppa, P., 2007:
Angiotensin-converting enzyme genotype and C-reactive protein in patients with COPD

Bigham, A.W.; Kiyamu, M.; León-Velarde, F.; Parra, E.J.; Rivera-Ch, M.; Shriver, M.D.; Brutsaert, T.D., 2008:
Angiotensin-converting enzyme genotype and arterial oxygen saturation at high altitude in Peruvian Quechua

Kehoe, A.D.; Nikiforov, A.M.; Alexanin, S.S.; Neronov, E.G.; Tikhomirova, O.V.; Shun'kov, V.B.; Makarova, N.V.; Rabinovich, E.; Usmanova, N.M.; Kazakov, V.I.; Slozina, N.M.; Montgomery, H.E., 2012:
Angiotensin-converting enzyme genotype and encephalopathy in Chernobyl cleanup workers

Hosseini-Khalili, A.Reza.; Thompson, J.; Kehoe, A.; Hopkinson, N.S.; Khoshbaten, A.; Soroush, M.Reza.; Humphries, S.E.; Montgomery, H.; Ghanei, M., 2008:
Angiotensin-converting enzyme genotype and late respiratory complications of mustard gas exposure

Tseng, C-Hsiao.; Tseng, F-Hsuan.; Chong, C-Khim.; Tseng, C-Ping.; Cheng, J-Chien., 2012:
Angiotensin-converting enzyme genotype and peripheral arterial disease in diabetic patients

Thompson, J.; Raitt, J.; Hutchings, L.; Drenos, F.; Bjargo, E.; Loset, A.; Grocott, M.; Montgomery, H., 2007:
Angiotensin-converting enzyme genotype and successful ascent to extreme high altitude

Kehoe, A.D.; Eleftheriou, K.I.; Heron, M.; Coats, T.J.; Montgomery, H.E., 2008:
Angiotensin-converting enzyme genotype may predict survival following major trauma

Jabaudon, M.; Constantin, J.M., 2014:
Angiotensin-converting enzyme in acute respiratory distress syndrome: from bed to bench first… and now back to bed?

Jochemsen, H.M.; van der Flier, W.M.; Ashby, E.L.; Teunissen, C.E.; Jones, R.E.; Wattjes, M.P.; Scheltens, P.; Geerlings, M.I.; Kehoe, P.G.; Muller, M., 2015:
Angiotensin-converting enzyme in cerebrospinal fluid and risk of brain atrophy

Gomes, R.Aparecida.da.Silva.; Teodoro, Lívia.das.Graças.Vieito.Lombardi.; Lopes, I.Cristina.Rezende.; Bersanetti, Pícia.Alessandra.; Carmona, A.Karaoglanovic.; Hial, V., 2008:
Angiotensin-converting enzyme in pericardial fluid: comparative study with serum activity

Dietze, G.J.; Henriksen, E.J., 2008:
Angiotensin-converting enzyme in skeletal muscle: sentinel of blood pressure control and glucose homeostasis

Duka, A.; Kintsurashvili, E.; Duka, I.; Ona, D.; Hopkins, T.A.; Bader, M.; Gavras, I.; Gavras, H., 2008:
Angiotensin-converting enzyme inhibition after experimental myocardial infarct: role of the kinin B1 and B2 receptors

Fleming, G.A.; Billings, F.T.; Klein, T.M.; Bichell, D.P.; Christian, K.G.; Pretorius, M., 2012:
Angiotensin-converting enzyme inhibition alters the inflammatory and fibrinolytic response to cardiopulmonary bypass in children

Ibrahim, M.A.; Ashour, O.M.; Ibrahim, Y.F.; El-Bitar, H.I.; Gomaa, W.; Abdel-Rahim, S.R., 2009:
Angiotensin-converting enzyme inhibition and angiotensin AT(1)-receptor antagonism equally improve doxorubicin-induced cardiotoxicity and nephrotoxicity

Schulte, E.; Ziegler, D.; Philippi-Höhne, C.; Kaczmarczyk, G.; Boemke, W., 2011:
Angiotensin-converting enzyme inhibition and blood pressure response during total intravenous anaesthesia for minor surgery

Cesari, M.; Kritchevsky, S.B.; Atkinson, H.H.; Penninx, B.W.; Di Bari, M.; Tracy, R.P.; Pahor, M., 2009:
Angiotensin-converting enzyme inhibition and novel cardiovascular risk biomarkers: results from the Trial of Angiotensin Converting Enzyme Inhibition and Novel Cardiovascular Risk Factors (TRAIN) study

Matsumoto, T.; Takashima, H.; Nakae, I.; Yamane, T.; Hayashi, H.; Horie, M., 2010:
Angiotensin-converting enzyme inhibition augments coronary release of tissue plasminogen activator in women but not in men

Brugts, J.J.; Ferrari, R.; Simoons, M.L., 2009:
Angiotensin-converting enzyme inhibition by perindopril in the treatment of cardiovascular disease

Carvalho Miranda, P.Augusto.; Simões E Silva, A.Cristina.; de Oliveira Longo, J.Ribeiro.; Magalhães Madureira, M.; Bastos Fóscolo, R.; Campos Machado, L.José.; Vilas Boas, Wíria.Wingester.; Dos Santos, R.Augusto.; Celso Coimbra, C.; Ribeiro-Oliveira, Aônio., 2011:
Angiotensin-converting enzyme inhibition changes the metabolic response to neuroglucopenic stress

Ishii, N.; Carmines, P.K.; Yokoba, M.; Imaizumi, H.; Ichikawa, T.; Ikenagasa, H.; Kodera, Y.; Oh-Ishi, M.; Aoki, Y.; Maeda, T.; Takenaka, T.; Katagiri, M., 2013:
Angiotensin-converting enzyme inhibition curbs tyrosine nitration of mitochondrial proteins in the renal cortex during the early stage of diabetes mellitus in rats

Abd Alla, J.; Langer, A.; Elzahwy, S.S.; Arman-Kalcek, Gökhan.; Streichert, T.; Quitterer, U., 2010:
Angiotensin-converting enzyme inhibition down-regulates the pro-atherogenic chemokine receptor 9 (CCR9)-chemokine ligand 25 (CCL25) axis

Schweizer, Júnia.R.O.L.; Miranda, P.A.C.; Fóscolo, R.B.; Lemos, J.P.M.; Paula, L.F.; Silveira, W.C.; Santos, R.A.S.; Pinheiro, Sérgio.V.B.; Coimbra, C.C.; Ribeiro-Oliveira, Aônio., 2014:
Angiotensin-converting enzyme inhibition increases glucose-induced insulin secretion in response to acute restraint

Pretorius, M.; Murray, K.T.; Yu, C.; Byrne, J.G.; Billings, F.T.; Petracek, M.R.; Greelish, J.P.; Hoff, S.J.; Ball, S.K.; Mishra, V.; Body, S.C.; Brown, N.J., 2012:
Angiotensin-converting enzyme inhibition or mineralocorticoid receptor blockade do not affect prevalence of atrial fibrillation in patients undergoing cardiac surgery

Leuschner, F.; Panizzi, P.; Chico-Calero, I.; Lee, W.Woo.; Ueno, T.; Cortez-Retamozo, V.; Waterman, P.; Gorbatov, R.; Marinelli, B.; Iwamoto, Y.; Chudnovskiy, A.; Figueiredo, J-Luiz.; Sosnovik, D.E.; Pittet, M.J.; Swirski, F.K.; Weissleder, R.; Nahrendorf, M., 2010:
Angiotensin-converting enzyme inhibition prevents the release of monocytes from their splenic reservoir in mice with myocardial infarction

Mul, J.D.; Seeley, R.J.; Woods, S.C.; Begg, D.P., 2014:
Angiotensin-converting enzyme inhibition reduces food intake and weight gain and improves glucose tolerance in melanocortin-4 receptor deficient female rats

Bertrand, M.E.; Fox, K.M.; Remme, W.J.; Ferrari, R.; Simoons, M.L., 2009:
Angiotensin-converting enzyme inhibition with perindopril in patients with prior myocardial infarction and/or revascularization: a subgroup analysis of the EUROPA trial

Symvoulakis, E.K.; Kyrmizakis, D.E.; Drivas, E.I.; Bizakis, J.; Velegrakis, G.A.; Lionis, C., 2008:
Angiotensin-converting enzyme inhibitor (ACE-I)- and angiotensin receptor blocker (ARB)-related angioedema: a neglected issue in daily practice in Greece

Matsuura-Hachiya, Y.; Arai, K.Y.; Ozeki, R.; Kikuta, A.; Nishiyama, T., 2014:
Angiotensin-converting enzyme inhibitor (enalapril maleate) accelerates recovery of mouse skin from UVB-induced wrinkles

Jain, A., 2011:
Angiotensin-converting enzyme inhibitor - An innocuous factor behind cardiac arrest following induction of anesthesia

Shukry, M.; de Armendi, A.J.; Cure, J.A., 2010:
Angiotensin-converting enzyme inhibitor and cardiac arrest following induction of anesthesia

Gray, S.L.; Boudreau, R.M.; Newman, A.B.; Studenski, S.A.; Shorr, R.I.; Bauer, D.C.; Simonsick, E.M.; Hanlon, J.T., 2012:
Angiotensin-converting enzyme inhibitor and statin use and incident mobility limitation in community-dwelling older adults: the Health, Aging and Body Composition study

Scott, R.L., 2008:
Angiotensin-converting enzyme inhibitor and/or angiotensin receptor antagonist for the postmyocardial infarction patient

Bolton, M.R.; Dooley-Hash, S.L., 2013:
Angiotensin-converting enzyme inhibitor angioedema

Chien, K-Liong., 2010:
Angiotensin-converting enzyme inhibitor as a marker, not a risk factor, for poor prognosis

Bangalore, S.; Kumar, S.; Messerli, F.H., 2010:
Angiotensin-converting enzyme inhibitor associated cough: deceptive information from the Physicians' Desk Reference

He, X.; Han, B.; Mura, M.; Xia, S.; Wang, S.; Ma, T.; Liu, M.; Liu, Z., 2007:
Angiotensin-converting enzyme inhibitor captopril prevents oleic acid-induced severe acute lung injury in rats

Li, T.; Zhou, R.; Yao, Y.; Yang, Q.; Zhou, C.; Wu, W.; Li, Q.; You, Z.; Zhao, X.; Yang, L.; Li, C.; Zhu, D.; Qiu, Y.; Luo, M.; Tan, Z.; Li, H.; Chen, Y.; Gong, G.; Feng, Y.; Dian, K.; Liu, J., 2015:
Angiotensin-converting enzyme inhibitor captopril reverses the adverse cardiovascular effects of polymerized hemoglobin

Ohnishi, K.; Murase, M.; Nakano, D.; Pelisch, N.; Hitomi, H.; Kobori, H.; Morimoto, S.; Mori, H.; Masaki, T.; Ohmori, K.; Kohno, M.; Ichihara, A.; Nishiyama, A., 2014:
Angiotensin-converting enzyme inhibitor does not suppress renal angiotensin II levels in angiotensin I-infused rats

Uzun, H.; Bitik, O.; Hekimoğlu, Rümeysa.; Atilla, P.; Kayikçioğlu, A.Uğur., 2013:
Angiotensin-converting enzyme inhibitor enalapril reduces formation of hypertrophic scars in a rabbit ear wounding model

Liao, X.; He, J.; Ma, H.; Tao, J.; Chen, W.; Leng, X.; Mai, W.; Zhen, W.; Liu, J.; Wang, L., 2007:
Angiotensin-converting enzyme inhibitor improves force and Ca2 +--frequency relationships in myocytes from rats with heart failure

Bas, M.; Kojda, G.; Stelter, K., 2012:
Angiotensin-converting enzyme inhibitor induced angioedema : new therapy options

Lindle, K.A.; Dinh, K.; Moffett, B.S.; Kyle, W.Buck.; Montgomery, N.M.; Denfield, S.D.; Knudson, J.D., 2014:
Angiotensin-converting enzyme inhibitor nephrotoxicity in neonates with cardiac disease

Hsu, C-Cheng.; Liu, J-Sin.; Tarng, D-Cherng., 2015 :
Angiotensin-converting enzyme inhibitor or Angiotensin receptor blocker use and renal outcomes-reply

Brackbill, M.L.; Bashaw-Keaton, R.; Sytsma, C.S., 2007:
Angiotensin-converting enzyme inhibitor or angiotensin receptor blocker adherence in patients with primary versus secondary diagnosis of heart failure

Tomlinson, L.; Smeeth, L., 2015:
Angiotensin-converting enzyme inhibitor or angiotensin receptor blocker use and renal outcomes: prevalent user designs may overestimate benefit

Sheng, H.; Zhu, J.; Wu, X.; Yang, D.; Zhang, J., 2008:
Angiotensin-converting enzyme inhibitor suppresses activation of calcineurin in renovascular hypertensive rats

Makar, G.A.; Holmes, J.H.; Yang, Y-Xiao., 2014:
Angiotensin-converting enzyme inhibitor therapy and colorectal cancer risk

Bach, D.S., 2009:
Angiotensin-converting enzyme inhibitor therapy at the time of coronary artery bypass surgery: when a friend turns mean-spirited

McConnell, K.J.; Zadvorny, E.B.; Denham, A.M.; Kasten, S.L.; Hutka, K.A.; Koetting, C.R.; Merenich, J.A., 2007:
Angiotensin-converting enzyme inhibitor therapy for coronary artery disease and diabetes mellitus

Wang, A.Y.; Bellomo, R.; Ninomiya, T.; Lo, S.; Cass, A.; Jardine, M.; Gallagher, M.; Bellomo, R.; Cass, A.; Cole, L.; Finfer, S.; Gallagher, M.; Lo, S.N.; McArthur, C.; McGuinness, S.; Myburgh, J.; Norton, R.; Scheinkestel, C.; Su, S.; Bellomo, R.; Ali, D.; Cass, A.; Cole, L.; Finfer, S.; Gallagher, M.; Goldsmith, D.; Lee, J.; Myburgh, J.; Norton, R.; Scheinkestel, C.; Bellomo, R.; Bhonagiri, A.Banerjee.Deepak.; Blythe, D.; Botha, J.; Cade, J.; Cole, L.; Dobb, G.; Eddington, J.; Finfer, S.; Flab, 2015:
Angiotensin-converting enzyme inhibitor usage and acute kidney injury: a secondary analysis of RENAL study outcomes

Gray, S.L.; LaCroix, A.Z.; Aragaki, A.K.; McDermott, M.; Cochrane, B.B.; Kooperberg, C.L.; Murray, A.M.; Rodriguez, B.; Black, H.; Woods, N.F., 2009:
Angiotensin-converting enzyme inhibitor use and incident frailty in women aged 65 and older: prospective findings from the Women's Health Initiative Observational Study

Buford, T.W.; Manini, T.M.; Hsu, F-Chi.; Cesari, M.; Anton, S.D.; Nayfield, S.; Stafford, R.S.; Church, T.S.; Pahor, M.; Carter, C.S., 2012:
Angiotensin-converting enzyme inhibitor use by older adults is associated with greater functional responses to exercise

Molnar, M.Z.; Kalantar-Zadeh, K.; Lott, E.H.; Lu, J.Ling.; Malakauskas, S.M.; Ma, J.Z.; Quarles, D.L.; Kovesdy, C.P., 2014:
Angiotensin-converting enzyme inhibitor, angiotensin receptor blocker use, and mortality in patients with chronic kidney disease

Zhang, J.L.; Rusinek, H.; Bokacheva, L.; Lim, R.P.; Chen, Q.; Storey, P.; Prince, K.; Hecht, E.M.; Kim, D.C.; Lee, V.S., 2009:
Angiotensin-converting enzyme inhibitor-enhanced MR renography: repeated measures of GFR and RPF in hypertensive patients

Bezalel, S.; Mahlab-Guri, K.; Asher, I.; Werner, B.; Sthoeger, Z.Moshe., 2015:
Angiotensin-converting enzyme inhibitor-induced angioedema

Bluestein, H.M.; Hoover, T.A.; Banerji, A.Suryadevara.; Camargo, C.A.; Reshef, A.; Herscu, P., 2010:
Angiotensin-converting enzyme inhibitor-induced angioedema in a community hospital emergency department

Rasmussen, E.R.; Mey, K.; Bygum, A., 2014:
Angiotensin-converting enzyme inhibitor-induced angioedema--a dangerous new epidemic

Scheirey, C.D.; Scholz, F.J.; Shortsleeve, M.J.; Katz, D.S., 2011:
Angiotensin-converting enzyme inhibitor-induced small-bowel angioedema: clinical and imaging findings in 20 patients

Kuhlen, J.Lee.; Forcucci, J., 2012:
Angiotensin-converting enzyme inhibitor-induced unilateral tongue angioedema

Gelée, B.; Michel, P.; Haas, R.; Boishardy, F., 2007:
Angiotensin-converting enzyme inhibitor-related angioedema: emergency treatment with complement C1 inhibitor concentrate

Liu, C-Lin.; Shau, W-Yi.; Wu, C-Shin.; Lai, M-Shu., 2013:
Angiotensin-converting enzyme inhibitor/angiotensin II receptor blockers and pneumonia risk among stroke patients

Izzo, J.L.; Weir, M.R., 2012:
Angiotensin-converting enzyme inhibitors

Vijan, S.G., 2009:
Angiotensin-converting enzyme inhibitors (ACEIs), not angiotensin receptor blockers (ARBs), are preferred and effective mode of therapy in high cardiovascular risk patients

Soto, M.E.; van Kan, G.Abellan.; Nourhashemi, F.; Gillette-Guyonnet, S.; Cesari, M.; Cantet, C.; Rolland, Y.; Vellas, B., 2013:
Angiotensin-converting enzyme inhibitors and Alzheimer's disease progression in older adults: results from the Réseau sur la Maladie d'Alzheimer Français cohort

Lin, F-Cheng.; Tsai, C-Piao.; Kuang-Wu Lee, J.; Wu, M-Tsang.; Tzu-Chi Lee, C., 2015:
Angiotensin-converting enzyme inhibitors and amyotrophic lateral sclerosis risk: a total population-based case-control study

Sánchez-Borges, M.; González-Aveledo, L.A., 2010:
Angiotensin-converting enzyme inhibitors and angioedema

Weber, M.A.; Messerli, F.H., 2008:
Angiotensin-converting enzyme inhibitors and angioedema: estimating the risk

Crowley, M.J.; Powers, B.J.; Myers, E.R.; McBroom, A.J.; Sanders, G.D., 2012:
Angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers for treatment of ischemic heart disease: Future research needs prioritization

Zheng, B.; Kang, J.; Tian, Y.; Tang, R.; Long, D.; Yu, R.; He, H.; Zhang, M.; Shi, L.; Tao, H.; Liu, X.; Dong, J.; Ma, C., 2010:
Angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers have no beneficial effect on ablation outcome in chronic persistent atrial fibrillation

Moser, M.; Rosendorff, C.; White, W.B., 2008:
Angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers: is there a difference in response and any advantage to using them together in the treatment of hypertension?

Morath, C.; Schmied, B.; Mehrabi, A.; Weitz, J.; Schmidt, J.; Werner, J.; Buchler, M.W.; Morcos, M.; Nawroth, P.P.; Schwenger, V.; Doehler, B.; Opelz, G.; Zeier, M., 2010:
Angiotensin-converting enzyme inhibitors and angiotensin II type 1 receptor blockers after renal transplantation

Huang, G.; Xu, J-bo.; Liu, J-xiong.; He, Y.; Nie, X-li.; Li, Q.; Hu, Y-mei.; Zhao, S-qin.; Wang, M.; Zhang, W-yong.; Liu, X-rong.; Wu, T.; Arkin, A.; Zhang, T-jie., 2011:
Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers decrease the incidence of atrial fibrillation: a meta-analysis

Sharma, P.; Blackburn, R.C.; Parke, C.L.; McCullough, K.; Marks, A.; Black, C., 2011:
Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for adults with early (stage 1 to 3) non-diabetic chronic kidney disease

Zhang, L.; Zeng, X.; Fu, P.; Wu, H.Mei., 2015:
Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for preserving residual kidney function in peritoneal dialysis patients

Gales, B.J.; Bailey, E.K.; Reed, A.N.; Gales, M.A., 2010:
Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for the prevention of migraines

Akbari, A.; Knoll, G.; Ferguson, D.; McCormick, B.; Davis, A.; Biyani, M., 2010:
Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in peritoneal dialysis: systematic review and meta-analysis of randomized controlled trials

Hernández, A.Alonso.; Moreso, F.; Bayés, B.; Lauzurica, R.; Sánz-Guajardo, Dámaso.; Gómez-Huertas, E.; Pereira, P.; Paul, J.; Crespo, J.; Amenábar, J.J.; Oliver, J.; Serón, D., 2010:
Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in renal transplantation between 1990 and 2002 in Spain

Cairns, J.A., 2008:
Angiotensin-converting enzyme inhibitors and angiotensin-receptor blockers in preventive cardiology: which drug to use and what to expect in light of the ONTARGET trial

Fayssoil, A., 2011:
Angiotensin-converting enzyme inhibitors and beta-blockers in cardiac asymptomatic patients with Duchenne muscular dystrophy

Sink, K.M.; Leng, X.; Williamson, J.; Kritchevsky, S.B.; Yaffe, K.; Kuller, L.; Yasar, S.; Atkinson, H.; Robbins, M.; Psaty, B.; Goff, D.C., 2009:
Angiotensin-converting enzyme inhibitors and cognitive decline in older adults with hypertension: results from the Cardiovascular Health Study

Donnelly, R.; Manning, G., 2007:
Angiotensin-converting enzyme inhibitors and coronary heart disease prevention

Bouzas-Mosquera, A.; Alvarez-García, N.; Peteiro, Jús., 2009:
Angiotensin-converting enzyme inhibitors and risk of acute kidney injury after cardiac surgery

Sjöberg, T.; García Rodríguez, L.A.; Lindblad, M., 2007:
Angiotensin-converting enzyme inhibitors and risk of esophageal and gastric cancer: a nested case-control study

Ebihara, S.; Ebihara, T.; Yamanda, S.; Asada, M.; Arai, H., 2007:
Angiotensin-converting enzyme inhibitors and smoking cessation

Keyhan, G.; Chen, S-Fu.; Pilote, L., 2007:
Angiotensin-converting enzyme inhibitors and survival in women and men with heart failure

Patel, K.; King, C.A.; Jovin, I.S., 2014:
Angiotensin-converting enzyme inhibitors and their effects on contrast-induced nephropathy after cardiac catheterization or percutaneous coronary intervention

Jao, G.; Lystash, J.; Sane, D., 2012:
Angiotensin-converting enzyme inhibitors can increase the transvalvular gradient among patients with aortic stenosis

Durán-Barragán, S.; McGwin, G.; Vilá, L.M.; Reveille, J.D.; Alarcón, G.S., 2008:
Angiotensin-converting enzyme inhibitors delay the occurrence of renal involvement and are associated with a decreased risk of disease activity in patients with systemic lupus erythematosus--results from LUMINA (LIX): a multiethnic US cohort

Stoevesandt, J.; Hain, J.; Stolze, I.; Kerstan, A.; Trautmann, A., 2014:
Angiotensin-converting enzyme inhibitors do not impair the safety of Hymenoptera venom immunotherapy build-up phase

Lee, H-Hao.; Tsan, Y-Tse.; Ho, W-Chao.; Lin, M-Hung.; Lee, C-Hsing.; Tseng, C-Den.; Guo, Y-Leon.; Wang, J-Der.; Chen, P-Chung., 2013:
Angiotensin-converting enzyme inhibitors enhance the effect of cyclooxygenase inhibitors on breast cancer: a nationwide case-control study

Hunter, M.R.; Cahoon, W.D.; Lowe, D.K., 2014:
Angiotensin-converting enzyme inhibitors for intermittent claudication associated with peripheral arterial disease

Zhang, X.; Li, Z-Zhuan.; Liu, D-Fang.; Xu, X.; Mei, Z-Chuan.; Shen, W., 2010:
Angiotensin-converting enzyme inhibitors improve hepatic steatosis by modulating expression of tumour necrosis factor-alpha, interleukin-6 and adiponectin receptor-2 in rats with type 2 diabetes

Lubarsky, L.; Coplan, N.L., 2007:
Angiotensin-converting enzyme inhibitors in acute myocardial infarction: a clinical approach

Parashar, A.; Varma, A., 2007:
Angiotensin-converting enzyme inhibitors in concomitant heart failure and depression

Pitt, B., 2009:
Angiotensin-converting enzyme inhibitors in patients with vascular disease

Knirsch, W.; Tlach, L.; Stambach, D.; Bauersfeld, U., 2010:
Angiotensin-converting enzyme inhibitors in pediatric patients with mitral valve regurgitation-case-control study and review of the literature

Croft, R.; Cook, G.; Washington, S., 2012:
Angiotensin-converting enzyme inhibitors in the perioperative period

Godilo-Godlevskiĭ, V.A.; Nagovitsyn, A.V.; Toporishcheva, O.S.; Vovkodav, V.S., 2009:
Angiotensin-converting enzyme inhibitors in the treatment of hypertension in Air Force personnel

White, W.B., 2007:
Angiotensin-converting enzyme inhibitors in the treatment of hypertension: an update

Kaura, V.; Kaura, N.V.; Kaura, B.N.; Kaura, C.S., 2013:
Angiotensin-converting enzyme inhibitors in the treatment of sarcoidosis and association with ACE gene polymorphism: case series

Lefebvre, H.P.; Brown, S.A.; Chetboul, V.; King, J.N.; Pouchelon, J-L.; Toutain, P.L., 2007:
Angiotensin-converting enzyme inhibitors in veterinary medicine

Al-Sayed, N.A.; Gao, T.; Wells, B.J.; Yu, C.; Zimmerman, R.S., 2014:
Angiotensin-converting enzyme inhibitors reduce albuminuria more than angiotensin receptor blockers in patients with type 2 diabetes

Takeshita, S.; Sakamoto, S.; Kitada, S.; Akutsu, K.; Hashimoto, H., 2008:
Angiotensin-converting enzyme inhibitors reduce long-term aortic events in patients with acute type B aortic dissection

van Vark, L.C.; Bertrand, M.; Akkerhuis, K.Martijn.; Brugts, J.J.; Fox, K.; Mourad, J-Jacques.; Boersma, E., 2012:
Angiotensin-converting enzyme inhibitors reduce mortality in hypertension: a meta-analysis of randomized clinical trials of renin-angiotensin-aldosterone system inhibitors involving 158,998 patients

Robles, Nás.Roberto.; Romero, B.; Fernandez-Carbonero, E.; Sánchez-Casado, E.; Cubero, J.Jose., 2010:
Angiotensin-converting enzyme inhibitors versus angiotensin receptor blockers for diabetic nephropathy: a retrospective comparison

Campbell, H.M.; Khan, N.; Raisch, D.W.; Borrego, M.E.; Sather, M.R.; Murata, G.H., 2014:
Angiotensin-converting enzyme inhibitors versus angiotensin receptor blockers for end-stage renal disease/mortality in type 2 diabetes

Padma, M.V., 2010:
Angiotensin-converting enzyme inhibitors will help in improving stroke outcome if given immediately after stroke

Bhatia, R., 2010:
Angiotensin-converting enzyme inhibitors will not help in improving stroke outcome if given immediately after stroke

Angeli, F.; Gentile, G.; Reboldi, G.; Verdecchia, P., 2008:
Angiotensin-converting enzyme inhibitors, angiotensin receptor blockers and protection from stroke

Young, J.B., 2007:
Angiotensin-converting enzyme inhibitors, angiotensin-receptor blockers, or both in chronic heart failure

Mitu, F.; Rădoi, D., 2011:
Angiotensin-converting enzyme inhibitors. Current indications

Dogan, M.; Yalcin, B.; Ozal, F.Guze.; Buyukcelik, A.; Utkan, G.; Icli, F.; Dogan, L., 2009:
Angiotensin-converting enzyme inhibitors: do they contribute to delayed chemotherapy induced nausea and vomiting?

Ruschitzka, F.; Taddei, S., 2012:
Angiotensin-converting enzyme inhibitors: first-line agents in cardiovascular protection?

Tundis, R.; Nadjafi, F.; Menichini, F., 2013:
Angiotensin-converting enzyme inhibitory activity and antioxidant properties of Nepeta crassifolia Boiss & Buhse and Nepeta binaludensis Jamzad

Chen, Y.; Liu, W.; Xue, J.; Yang, J.; Chen, X.; Shao, Y.; Kwok, L-yu.; Bilige, M.; Mang, L.; Zhang, H., 2015:
Angiotensin-converting enzyme inhibitory activity of Lactobacillus helveticus strains from traditional fermented dairy foods and antihypertensive effect of fermented milk of strain H9

Anne, A.; Peter, M.; Henning, A., 2011:
Angiotensin-converting enzyme inhibitory activity of Viscum triflorum is host plant-dependent

Rodríguez-Figueroa, J.C.; Reyes-Díaz, R.; González-Córdova, A.F.; Troncoso-Rojas, R.; Vargas-Arispuro, I.; Vallejo-Cordoba, B., 2011:
Angiotensin-converting enzyme inhibitory activity of milk fermented by wild and industrial Lactococcus lactis strains

Charles, R.Einstein.; Ponrasu, T.; Sivakumar, R.; Divakar, S., 2008:
Angiotensin-converting enzyme inhibitory and antioxidant activities of enzymatically synthesized phenolic and vitamin glycosides

Medina-Godoy, S.; Ambriz-Pérez, D.L.; Fuentes-Gutiérrez, C.I.; Germán-Báez, L.J.; Gutiérrez-Dorado, R.; Reyes-Moreno, Cémoc.; Valdez-Ortiz, A., 2012:
Angiotensin-converting enzyme inhibitory and antioxidative activities and functional characterization of protein hydrolysates of hard-to-cook chickpeas

Al Shukor, N.; Van Camp, J.; Gonzales, G.Bryan.; Staljanssens, D.; Struijs, K.; Zotti, M.J.; Raes, K.; Smagghe, G., 2014:
Angiotensin-converting enzyme inhibitory effects by plant phenolic compounds: a study of structure activity relationships

Li, H.; Ma, Y.; Fu, Q.; Wang, L., 2007:
Angiotensin-converting enzyme insertion/deletion (ACE I/D) and angiotensin II type 1 receptor (AT1R) gene polymorphism and its association with preeclampsia in Chinese women

Sierra Díaz, E.; Sánchez Corona, Jé.; Rosales Gómez, R.Carlos.; Gutierrez Rubio, S.Andrea.; Vázquez Camacho, Jé.Gonzalo.; Solano Moreno, Héctor.; Morán Moguel, Mía.Cristina., 2010:
Angiotensin-converting enzyme insertion/deletion and angiotensin type 1 receptor A1166C polymorphisms as genetic risk factors in benign prostatic hyperplasia and prostate cancer

Wang, N.; Yang, D.; Ji, B.; Li, J., 2016:
Angiotensin-converting enzyme insertion/deletion gene polymorphism and lung cancer risk: A meta-analysis

Pascuzzo-Lima, C.; Mendible, J.C.; Bonfante-Cabarcas, R.A., 2010:
Angiotensin-converting enzyme insertion/deletion gene polymorphism and progression of Chagas' cardiomyopathy

Mehri, S.; Baudin, B.; Mahjoub, S.; Zaroui, A.; Bénéteau-Burnat, Bénédicte.; Mechmeche, R.; Hammami, M.; Ben Arab, Sïda., 2010:
Angiotensin-converting enzyme insertion/deletion gene polymorphism in a Tunisian healthy and acute myocardial infarction population

Abdi Rad, I.; Bagheri, M., 2011:
Angiotensin-converting enzyme insertion/deletion gene polymorphism in general population of west Azarbaijan, Iran

Saibeni, S.; Spina, L.; Virgilio, T.; Folcioni, A.; Borsi, G.; de Franchis, R.; Cugno, M.; Vecchi, M., 2007:
Angiotensin-converting enzyme insertion/deletion gene polymorphism in inflammatory bowel diseases

Dević Pavlić, S.; Ristić, S.; Flego, V.; Kapović, M.; Radojčić Badovinac, Ađelka., 2012:
Angiotensin-converting enzyme insertion/deletion gene polymorphism in lung cancer patients

Altas, M.; Bayrak, O.F.; Cerci, A.; Isik, N.; Celik, M.; Culha, M.; Sahin, F.; Elmaci, I., 2010:
Angiotensin-converting enzyme insertion/deletion gene polymorphism in patients with familial multiple cerebral cavernous malformations

Shinjo, S.K.; Uno, M.; Oba-Shinjo, S.M.; Marie, S.K.N., 2016:
Angiotensin-converting enzyme insertion/deletion gene polymorphism is associated with dermatomyositis

Lian, M.; Jiang, H.; Wang, H.; Guo, S., 2016:
Angiotensin-converting enzyme insertion/deletion gene polymorphisms is associated with risk of glioma in a Chinese population

Chen, Y.; Dong, S.; He, M.; Qi, T.; Zhu, W., 2013:
Angiotensin-converting enzyme insertion/deletion polymorphism and risk of myocardial infarction in an updated meta-analysis based on 34993 participants

Davis, W.A.; Brown, S.G.A.; Jacobs, I.G.; Bulsara, M.; Beilby, J.; Bruce, D.G.; Davis, T.M.E., 2011:
Angiotensin-converting enzyme insertion/deletion polymorphism and severe hypoglycemia complicating type 2 diabetes: the Fremantle Diabetes Study

Huang, R-Fei.; Dong, P.; Zhang, T-Zhen.; Ying, X-Jiang.; Hu, H., 2016:
Angiotensin-converting enzyme insertion/deletion polymorphism and susceptibility to allergic rhinitis in Chinese populations: a systematic review and meta-analysis

Song, G.G.; Lee, Y.H., 2015:
Angiotensin-converting enzyme insertion/deletion polymorphism and susceptibility to systemic sclerosis: a meta-analysis

Munshi, A.; Sultana, S.; Kaul, S.; Reddy, B.Pulla.; Alladi, S.; Jyothy, A., 2008:
Angiotensin-converting enzyme insertion/deletion polymorphism and the risk of ischemic stroke in a South Indian population

Hu, Z.; Jin, X.; Kang, Y.; Liu, C.; Zhou, Y.; Wu, X.; Liu, J.; Zhong, M.; Luo, C.; Deng, L.; Deng, Y.; Xie, X.; Zhang, Z.; Zhou, Y.; Liao, X., 2010 :
Angiotensin-converting enzyme insertion/deletion polymorphism associated with acute respiratory distress syndrome among caucasians

Lin, H.; Lin, D.; Zheng, C-Quan., 2015:
Angiotensin-converting enzyme insertion/deletion polymorphism associated with allergic rhinitis susceptibility: evidence from 1410 subjects

Lin, C.; Yang, H-Yi.; Wu, C-Chao.; Lee, H-Sheng.; Lin, Y-Feng.; Lu, K-Cheng.; Chu, C-Ming.; Lin, F-Huang.; Kao, S-Yeong.; Su, S-Lung., 2014:
Angiotensin-converting enzyme insertion/deletion polymorphism contributes high risk for chronic kidney disease in Asian male with hypertension--a meta-regression analysis of 98 observational studies

Zhang, Z.; Xu, G.; Liu, D.; Fan, X.; Zhu, W.; Liu, X., 2013:
Angiotensin-converting enzyme insertion/deletion polymorphism contributes to ischemic stroke risk: a meta-analysis of 50 case-control studies

Saracevic, A.; Simundic, A-Maria.; Celap, I.; Luzanic, V., 2014:
Angiotensin-converting enzyme insertion/deletion polymorphism genotyping error: the cause and a possible solution to the problem

Tascilar, N.; Dursun, A.; Ankarali, H.; Mungan, G.; Ekem, S.; Baris, S., 2010:
Angiotensin-converting enzyme insertion/deletion polymorphism has no effect on the risk of atherosclerotic stroke or hypertension

Hucl, T.; Kylanpää, M-Leena.; Künzli, B.; Witt, H.; Lempinen, M.; Schneider, A.; Kemppainen, E.; Löhr, M.; Haas, S.L.; Friess, H.; Ockenga, J.; Rosendahl, J.; Schulz, H-Ulrich.; Gress, T.; Singer, M.V.; Pfützer, R.H., 2010:
Angiotensin-converting enzyme insertion/deletion polymorphism in patients with acute and chronic pancreatitis

Wang, X-bin.; Cui, N-hua.; Yang, J.; Qiu, X-ping.; Gao, J-jia.; Yang, N.; Zheng, F., 2016:
Angiotensin-converting enzyme insertion/deletion polymorphism is not a major determining factor in the development of sporadic Alzheimer disease: evidence from an updated meta-analysis

Villar, Jús.; Flores, C.; Pérez-Méndez, L.; Maca-Meyer, N.; Espinosa, E.; Blanco, Jús.; Sangüesa, R.; Muriel, A.; Tejera, P.; Muros, M.; Slutsky, A.S.; Villar, J.; Espinosa, E.; Sangüesa, R.; Muros, M.; Pérez-Méndez, L.; Lubillo, S.; Blanco, J.; Muriel, A.; Sagrado, V.; Ballesteros, J.C.; Taboada, F.; Muñiz, G.; Gandía, F.; Bobillo, F.; Tamayo, L.; Labattut, A.G.; Collado, J.; Valledor, M.; Antuña, M.T.; López, M.J.; Cortina, J.J.; Saldaña, T.; Caballero, A.; Alvarez, T.; De Frutos,, 2007:
Angiotensin-converting enzyme insertion/deletion polymorphism is not associated with susceptibility and outcome in sepsis and acute respiratory distress syndrome

Liu, X.; Bellamy, C.O.C.; Bailey, M.A.; Mullins, L.J.; Dunbar, D.R.; Kenyon, C.J.; Brooker, G.; Kantachuvesiri, S.; Maratou, K.; Ashek, A.; Clark, A.F.; Fleming, S.; Mullins, J.J., 2009:
Angiotensin-converting enzyme is a modifier of hypertensive end organ damage

Lin, C.; Datta, V.; Okwan-Duodu, D.; Chen, X.; Fuchs, S.; Alsabeh, R.; Billet, S.; Bernstein, K.E.; Shen, X.Z., 2011:
Angiotensin-converting enzyme is required for normal myelopoiesis

Miners, S.; Ashby, E.; Baig, S.; Harrison, R.; Tayler, H.; Speedy, E.; Prince, J.A.; Love, S.; Kehoe, P.G., 2009:
Angiotensin-converting enzyme levels and activity in Alzheimer's disease: differences in brain and CSF ACE and association with ACE1 genotypes

Okwan-Duodu, D.; Datta, V.; Shen, X.Z.; Goodridge, H.S.; Bernstein, E.A.; Fuchs, S.; Liu, G.Y.; Bernstein, K.E., 2011:
Angiotensin-converting enzyme overexpression in mouse myelomonocytic cells augments resistance to Listeria and methicillin-resistant Staphylococcus aureus

Bernstein, K.E.; Gonzalez-Villalobos, R.A.; Giani, J.F.; Shah, K.; Bernstein, E.; Janjulia, T.; Koronyo, Y.; Shi, P.D.; Koronyo-Hamaoui, M.; Fuchs, S.; Shen, X.Z., 2015:
Angiotensin-converting enzyme overexpression in myelocytes enhances the immune response

Bernstein, K.E.; Koronyo, Y.; Salumbides, B.C.; Sheyn, J.; Pelissier, L.; Lopes, D.H.J.; Shah, K.H.; Bernstein, E.A.; Fuchs, D-Trang.; Yu, J.J-Y.; Pham, M.; Black, K.L.; Shen, X.Z.; Fuchs, S.; Koronyo-Hamaoui, M., 2014:
Angiotensin-converting enzyme overexpression in myelomonocytes prevents Alzheimer's-like cognitive decline

Fudalej, S.; Fudalej, M.; Kostrzewa, G.; Kuźniar, P.; Franaszczyk, M.; Wojnar, M.; Krajewski, Pł.; Płoski, Rł., 2009 :
Angiotensin-converting enzyme polymorphism and completed suicide: an association in Caucasians and evidence for a link with a method of self-injury

Andersen, M.L.; Guindalini, C.; Santos-Silva, R.; Bittencourt, L.R.A.; Tufik, S., 2011:
Angiotensin-converting enzyme polymorphism and erectile dysfunction complaints in the Brazilian population

Kucukali, C.Ismail.; Aydin, M.; Ozkok, E.; Bilge, E.; Zengin, A.; Cakir, U.; Kara, I., 2010:
Angiotensin-converting enzyme polymorphism in schizophrenia, bipolar disorders, and their first-degree relatives

Chen, C-M.; Chen, Y-C.; Wu, Y-R.; Hu, F-J.; Lyu, R-K.; Chang, H-S.; Ro, L-S.; Hsu, W-C.; Chen, S-T.; Lee-Chen, G-J., 2008:
Angiotensin-converting enzyme polymorphisms and risk of spontaneous deep intracranial hemorrhage in Taiwan

Orlova, M.A.; Kost, O.A.; Nikol'skaia, I.I.; Kuznetsov, D.A.; Troshina, N.N., 2009:
Angiotensin-converting enzyme stability in the presence of zinc-ions different concentrations

Dardiotis, E.; Jagiella, J.; Xiromerisiou, G.; Dardioti, M.; Vogiatzi, C.; Urbanik, A.; Paterakis, K.; Komnos, A.; Fountas, K.N.; Slowik, A.; Hadjigeorgiou, G.M., 2011:
Angiotensin-converting enzyme tag single nucleotide polymorphisms in patients with intracerebral hemorrhage

Woods, D., 2009:
Angiotensin-converting enzyme, renin-angiotensin system and human performance

Xue, T.; Wei, N.; Xin, Z.; Qingyu, X., 2014:
Angiotensin-converting enzyme-2 overexpression attenuates inflammation in rat model of chronic obstructive pulmonary disease

Dong, B.; Yu, Q.Tao.; Dai, H.Yan.; Gao, Y.Yan.; Zhou, Z.Li.; Zhang, L.; Jiang, H.; Gao, F.; Li, S.Ying.; Zhang, Y.Hui.; Bian, H.Jun.; Liu, C.Xi.; Wang, N.; Xu, H.; Pan, C.Ming.; Song, H.Dong.; Zhang, C.; Zhang, Y., 2012:
Angiotensin-converting enzyme-2 overexpression improves left ventricular remodeling and function in a rat model of diabetic cardiomyopathy

Gonzalez-Villalobos, R.A.; Satou, R.; Seth, D.M.; Semprun-Prieto, L.C.; Katsurada, A.; Kobori, H.; Navar, L.Gabriel., 2009:
Angiotensin-converting enzyme-derived angiotensin II formation during angiotensin II-induced hypertension

Tseng, D.S.; Kwong, J.; Rezvani, F.; Coates, A.O., 2010:
Angiotensin-converting enzyme-related cough among Chinese-Americans

Micheli, M.Levi.; Gulisano, M.; Morucci, G.; Punzi, T.; Ruggiero, M.; Ceroti, M.; Marella, M.; Castellini, E.; Pacini, S., 2011:
Angiotensin-converting enzyme/vitamin D receptor gene polymorphisms and bioelectrical impedance analysis in predicting athletic performances of Italian young soccer players

Rivière, G., 2010:
Angiotensin-converting enzyme: a protein conserved during evolution

Larrinaga, G.; Pérez, I.; Sanz, Bña.; Blanco, L.; López, J.I.; Cándenas, M.Luz.; Pinto, F.M.; Gil, J.; Irazusta, J.; Varona, A., 2011:
Angiotensin-converting enzymes (ACE and ACE2) are downregulated in renal tumors

Shi, L.; Mao, C.; Xu, Z.; Zhang, L., 2010:
Angiotensin-converting enzymes and drug discovery in cardiovascular diseases

Pan, P-Pei.; Zhan, Q-Tao.; Le, F.; Zheng, Y-Ming.; Jin, F., 2014:
Angiotensin-converting enzymes play a dominant role in fertility

Osterreicher, C.H.; Taura, K.; De Minicis, S.; Seki, E.; Penz-Osterreicher, M.; Kodama, Y.; Kluwe, J.; Schuster, M.; Oudit, G.Y.; Penninger, J.M.; Brenner, D.A., 2009:
Angiotensin-converting-enzyme 2 inhibits liver fibrosis in mice

Busquets, X.; MacFarlane, N.G.; Heine-Suñer, Dà.; Morlá, M.; Torres-Juan, L.; Iglesias, A.; Lladó, J.; Sauleda, J.; Agustí, A.G.N., 2008:
Angiotensin-converting-enzyme gene polymorphisms, smoking and chronic obstructive pulmonary disease

Marampon, F.; Gravina, G.L.; Scarsella, L.; Festuccia, C.; Lovat, F.; Ciccarelli, C.; Zani, B.M.; Polidoro, L.; Grassi, D.; Desideri, G.; Evangelista, S.; Ferri, C., 2014:
Angiotensin-converting-enzyme inhibition counteracts angiotensin II-mediated endothelial cell dysfunction by modulating the p38/SirT1 axis

Chabrier, Séphane.; Desguerre, I.; Porte, Mélanie.; Payet, C.; Rivier, Fçois., 2011:
Angiotensin-converting-enzyme inhibitors versus steroids as first-line drug treatment in Duchenne muscular dystrophy

Kuniyoshi, A.Kazuo.; Rocha, M.; Cajado Carvalho, D.; Juliano, M.Aparecida.; Juliano Neto, L.; Tambourgi, D.Vilarinho.; Portaro, F.Calheta.Vieira., 2012:
Angiotensin-degrading serine peptidase: a new chymotrypsin-like activity in the venom of Bothrops jararaca partially blocked by the commercial antivenom

Chan, S.H.H.; Chan, J.Y.H., 2014:
Angiotensin-generated reactive oxygen species in brain and pathogenesis of cardiovascular diseases

Arellano-Plancarte, A.; Hernandez-Aranda, J.; Catt, K.J.; Olivares-Reyes, J.Alberto., 2010:
Angiotensin-induced EGF receptor transactivation inhibits insulin signaling in C9 hepatic cells

Prins, P.A.; Hill, M.F.; Airey, D.; Nwosu, S.; Perati, P.R.; Tavori, H.; F Linton, M.; Kon, V.; Fazio, S.; Sampson, U.K., 2014:
Angiotensin-induced abdominal aortic aneurysms in hypercholesterolemic mice: role of serum cholesterol and temporal effects of exposure

Johnson, A.K.; Ian Phillips, M.; Mohring, J.; Gantev, D., 1977:
Angiotensin-induced drinking in rats with hereditary hypothalamic diabetes insipidus

Nangaku, M.; Inagi, R.; Miyata, T.; Fujita, T., 2008:
Angiotensin-induced hypoxia in the kidney: functional and structural changes of the renal circulation

Thornton, S.Nigel., 2009:
Angiotensin-induced metabolic dysfunction

McMurray, J.J.V.; Packer, M.; Desai, A.S.; Gong, J.; Lefkowitz, M.P.; Rizkala, A.R.; Rouleau, J.L.; Shi, V.C.; Solomon, S.D.; Swedberg, K.; Zile, M.R.; McMurray, J.; Packer, M.; Rouleau, J.; Solomon, S.; Swedberg, K.; Zile, M.; Lefkowitz, M.; Martinez, F.; Vanhaecke, J.; Ramires, F.; Katova, T.; Arnold, M.; Huang, J.; Gomez, E.; Belohlavek, J.; Refsgaard, J.; Lederballe, O.; Gonzalez, A.; Duarte, Y.Carlo.; Rosenthal, A.; Peuhkurinen, K.; Hagege, A-Alain.; Böhm, M.; Arango, J.Luis.; Merkely, B.;, 2014:
Angiotensin-neprilysin inhibition versus enalapril in heart failure

Sipahi, I.; Debanne, S.M.; Rowland, D.Y.; Simon, D.I.; Fang, J.C., 2010:
Angiotensin-receptor blockade and risk of cancer: meta-analysis of randomised controlled trials

Rajendran, S.P., 2011:
Angiotensin-receptor blockade in acute stroke

Kohno, T.; Anzai, T.; Naito, K.; Sugano, Y.; Maekawa, Y.; Takahashi, T.; Yoshikawa, T.; Ogawa, S., 2008:
Angiotensin-receptor blockade reduces border zone myocardial monocyte chemoattractant protein-1 expression and macrophage infiltration in post-infarction ventricular remodeling

Böhm, M.; Laufs, U.; Pfreundschuh, M., 2010:
Angiotensin-receptor blockade, cancer, and concerns

Meredith, P.A.; McInnes, G.T., 2010:
Angiotensin-receptor blockade, cancer, and concerns

Nissen, S.E., 2010:
Angiotensin-receptor blockers and cancer: urgent regulatory review needed

Hsu, C-Yi.; Huang, C-Chou.; Chan, W-Leong.; Huang, P-Hsun.; Chiang, C-Hung.; Chen, T-Ji.; Chung, C-Min.; Lin, S-Jong.; Chen, J-Wen.; Leu, H-Bang., 2013:
Angiotensin-receptor blockers and risk of Alzheimer's disease in hypertension population--a nationwide cohort study

Georgescu, E.Florin.; Ionescu, R.; Niculescu, M.; Mogoanta, L.; Vancica, L., 2009:
Angiotensin-receptor blockers as therapy for mild-to-moderate hypertension-associated non-alcoholic steatohepatitis

Gillis, A.M., 2009:
Angiotensin-receptor blockers for prevention of atrial fibrillation--a matter of timing or target?

Saha, S.A., 2010:
Angiotensin-receptor blockers for the management of hypertension: new insights, new challenges

Teo, K.K., 2009:
Angiotensin-receptor blockers in prevention of cardiovascular events: are they as effective as angiotensin-converting enzyme inhibitors?

Parfrey, P.S., 2009:
Angiotensin-receptor blockers in the prevention or treatment of microalbuminuria

Katayama, T.; Hasebe, N., 2013:
Angiotensin-receptor blockers, hypertension and Alzheimer disease--the entangled relationship

Lalla, D., 2011:
Angiotensin-receptor-blocker research blocked by too many assumptions

Nabbi, R.; Riess, M.L.; Woehlck, H.J., 2012:
Angiotensin-receptor-blocker-induced refractory hypotension responds to methylene blue

Flores-Muñoz, M.; Smith, N.J.; Haggerty, C.; Milligan, G.; Nicklin, S.A., 2012:
Angiotensin1-9 antagonises pro-hypertrophic signalling in cardiomyocytes via the angiotensin type 2 receptor

Che, Y.; Yi, L.; Akhtar, J.; Bing, C.; Ruiyu, Z.; Qiang, W.; Rong, W., 2014:
AngiotensinII induces HuR shuttling by post-transcriptional regulated CyclinD1 in human mesangial cells

Guan, A.; Zou, Y.; Gong, H.; Niu, Y.; Ye, Y.; Jia, J.; Li, B.; Zhang, G.; Qian, S.; Ge, J., 2012:
AngiotensinII preconditioning promotes angiogenesis in vitro via ERKs phosphorylation

Sawhney, J.P.S., 2013:
Angiotensine converting enzyme inhibitors In acute myocardial infarction--a review

Niederhofer, H., 2007:
Angiotensine converting enzyme inhibitors/estrogen/cortisol: maybe an additional option in the treatment of psychiatrically disordered patients?

Roncari, C.F.; David, R.B.; Johnson, R.F.; De Paula, P.M.; Colombari, D.S.A.; De Luca, L.A.; Johnson, A.K.; Colombari, E.; Menani, J.V., 2014:
Angiotensinergic and cholinergic receptors of the subfornical organ mediate sodium intake induced by GABAergic activation of the lateral parabrachial nucleus

Patil, J.; Stucki, S.; Nussberger, J.; Schaffner, T.; Gygax, S.; Bohlender, J.; Imboden, H., 2011:
Angiotensinergic and noradrenergic neurons in the rat and human heart

Bohlender, Jürgen.; Pfarrer, B.; Patil, J.; Nussberger, Jürg.; Thalmann, G.N.; Imboden, H., 2013:
Angiotensinergic innervation of the kidney: Localization and relationship with catecholaminergic postganglionic and sensory nerve fibers

Busnardo, C.; Tavares, R.F.; Correa, F.M.A., 2015:
Angiotensinergic neurotransmission in the paraventricular nucleus of the hypothalamus modulates the pressor response to acute restraint stress in rats

Bohlender, J.; Imboden, H., 2012:
Angiotensinergic neurotransmission in the peripheral autonomic nervous system

Ferguson, A.V., 2010:
Angiotensinergic regulation of autonomic and neuroendocrine outputs: critical roles for the subfornical organ and paraventricular nucleus

Grobe, J.L.; Buehrer, B.A.; Hilzendeger, A.M.; Liu, X.; Davis, D.R.; Xu, D.; Sigmund, C.D., 2011:
Angiotensinergic signaling in the brain mediates metabolic effects of deoxycorticosterone (DOCA)-salt in C57 mice

Urushihara, M.; Kobori, H., 2012:
Angiotensinogen Expression Is Enhanced in the Progression of Glomerular Disease

Lung, F-Wey.; Chang, W-To.; Kao, W-Tsung., 2008:
Angiotensinogen M235T associated with mitral valve prolapse in young Han Chinese male

Başarici, I.; Süleymanlar, Gültekin., 2007:
Angiotensinogen M235T gene polymorphism in essential hypertension/angiotensinogen M235T polymorphism and left ventricular indices in treated hypertensive patients with normal coronary arteries

Olcay, A.; Nişanci, Y.; Ekmekçi, C.Gökhan.; Ozbek, Uğur.; Sezer, M.; Umman, B.; Buğra, Z., 2007:
Angiotensinogen M235T polymorphism and left ventricular indices in treated hypertensive patients with normal coronary arteries

López-León, S.; Janssens, A.Cecile.J.W.; Tiemeier, H.; Hofman, A.; Aulchenko, Y.S.; Snijders, P.J.L.M.; Claes, S.; Oostra, B.A.; van Duijn, C.M., 2008:
Angiotensinogen M235T polymorphism and symptoms of depression in a population-based study and a family-based study

Yuan, J.; Tang, W.; Chun, Y.; Ying, H.; Yang, Y.; Xiao, C., 2009:
Angiotensinogen T174M and M235T variants and hypertension in the Hani and Yi minority groups of China

Barbaro, N.Ruggeri.; Fontana, V.; Moreno, H., 2014:
Angiotensinogen Variants among Resistant Hypertensive Patients

Lee, Y-Ting.; Chiu, H-Chia.; Su, H-Ming.; Voon, W-Chol.; Lin, T-Hsien.; Lai, W-Ter.; Sheu, S-Hsiung., 2008:
Angiotensinogen and angiotensin II type 1 receptor gene polymorphisms and changes in repolarization parameters in elderly Chinese: a 4-year follow-up study

Krskova, K.; Filipcik, P.; Zilka, N.; Olszanecki, R.; Korbut, R.; Gajdosechova, L.; Zorad, S., 2012:
Angiotensinogen and angiotensin-converting enzyme mRNA decrease and AT1 receptor mRNA and protein increase in epididymal fat tissue accompany age-induced elevation of adiposity and reductions in expression of GLUT4 and peroxisome proliferator-activated receptor (PPARγ)

Vincent, Fçois.; Bonnin, P.; Clemessy, M.; Contrerès, J-Olivier.; Lamandé, Nël.; Gasc, J-Marie.; Vilar, Jé.; Hainaud, P.; Tobelem, Gérard.; Corvol, P.; Dupuy, E., 2009:
Angiotensinogen delays angiogenesis and tumor growth of hepatocarcinoma in transgenic mice

Molina-Molina, M.; Xaubet, A.; Li, X.; Abdul-Hafez, A.; Friderici, K.; Jernigan, K.; Fu, W.; Ding, Q.; Pereda, J.; Serrano-Mollar, A.; Casanova, A.; Rodríguez-Becerra, E.; Morell, F.; Ancochea, J.; Picado, C.; Uhal, B.D., 2008:
Angiotensinogen gene G-6A polymorphism influences idiopathic pulmonary fibrosis disease progression

Wang, Y-Jing.; Pan, Y., 2013:
Angiotensinogen gene M235T polymorphism and risk of coronary artery disease: a meta-analysis

Brugts, J.J.; de Maat, M.P.M.; den Uil, C.A.; Danser, J.A.H., 2008:
Angiotensinogen gene haplotypes in hypertension

Sposito, A.C.; Santos, R.D., 2013:
Angiotensinogen gene polymorphism and HDL2 are linked to coronary artery calcification in individuals with family history of early coronary disease

Wang, S.; Zeng, R.; Lei, L.; Huang, J., 2013:
Angiotensinogen gene polymorphism and ischemic stroke in East Asians: A meta-analysis

Nakase, T.; Mizuno, T.; Harada, S.; Yamada, K.; Nishimura, T.; Ozasa, K.; Watanabe, Y.; Nagata, K., 2007:
Angiotensinogen gene polymorphism as a risk factor for ischemic stroke

Mehri, S.; Mahjoub, S.; Farhati, A.; Bousaada, R.; Ben Arab, Sïda.; Baudin, B.; Hammami, M., 2011:
Angiotensinogen gene polymorphism in acute myocardial infarction patients

Cho, J-Jang.; Hwang, W-Jun.; Hong, S-Heon.; Jeong, H-Ja.; Lee, H-Jung.; Kim, H-Min.; Um, J-Young., 2008:
Angiotensinogen gene polymorphism predicts hypertension, and iridological constitutional classification enhances the risk for hypertension in Koreans

Carroll, W.X.; Kalupahana, N.S.; Booker, S.L.; Siriwardhana, N.; Lemieux, M.; Saxton, A.M.; Moustaid-Moussa, N., 2013:
Angiotensinogen gene silencing reduces markers of lipid accumulation and inflammation in cultured adipocytes

Alvi, F.M.; Hasnain, S., 2008:
Angiotensinogen gene variants in a Pakistani hypertensive population of Punjab

Bujak-Gizycka, B.; Olszanecki, R.; Suski, M.; Madek, J.; Stachowicz, A.; Korbut, R., 2011:
Angiotensinogen metabolism in rat aorta: robust formation of proangiotensin-12

Wang, Q-Shan.; Li, Y-Gang.; Chen, X-Dong.; Yu, J-Fei.; Wang, J.; Sun, J.; Lu, S-Biao.; Jin, L.; Wang, X-Feng., 2010:
Angiotensinogen polymorphisms and acquired atrial fibrillation in Chinese

Lee, S.ra.; Moon, J.Young.; Lee, S.Ho.; Ihm, C.Gyoo.; Lee, T.Won.; Kim, S.Kang.; Chung, J-Ho.; Kang, S.Woo.; Kim, T.Hee.; Park, S.Ju.; Kim, Y.Hoon.; Jeong, K.Hwan., 2014:
Angiotensinogen polymorphisms and post-transplantation diabetes mellitus in Korean renal transplant subjects

Altarescu, G.; Haim, S.; Elstein, D., 2014:
Angiotensinogen promoter and angiotensinogen II receptor type 1 gene polymorphisms and incidence of ischemic stroke and neurologic phenotype in Fabry disease

Özdemir, B.H.; Özdemir, F.N.; Ataç, F.B.; Özdemir, A.A.; Haberal, M., 2011:
Angiotensinogen t235 and angiotensin-converting enzyme insertion/deletion polymorphisms associated with the development of posttransplantation diabetes mellitus in renal allograft recipients

Azarpira, N.; Bagheri, M.; Raisjalali, G.A.; Aghdaie, M.H.; Behzadi, S.; Salahi, H.; Rahsaz, M.; Darai, M.; Ashraf, M.J.; Geramizadeh, B., 2008:
Angiotensinogen, angiotensine converting enzyme and plasminogen activator inhibitor-1 gene polymorphism in chronic allograft dysfunction

Delles, C., 2010:
Angiotensinogen, birth weight and diabetes: will genetics provide a link?

Kehoe, P.G., 2009:
Angiotensins and Alzheimer's disease: a bench to bedside overview

Kuśmirowska, K.; Kowalski, A.; Rebas, E., 2013:
Angiotensins as neuromodulators

Kehoe, P.G.; Miners, S.; Love, S., 2010:
Angiotensins in Alzheimer's disease - friend or foe?

Ptasinska-Wnuk, D.; Lawnicka, H.; Mucha, S.; Kunert-Radek, J.; Pawlikowski, M.; Stepien, H., 2012:
Angiotensins inhibit cell growth in GH3 lactosomatotroph pituitary tumor cell culture: a possible involvement of the p44/42 and p38 MAPK pathways

Yu, W.; Zhao, Y-Yuan.; Zhang, Z-Wen.; Guo, Y-Lu.; Jin, J., 2007:
Angiotension II receptor 1 blocker modifies the expression of apoptosis-related proteins and transforming growth factor-beta1 in prostate tissue of spontaneously hypertensive rats

Chiu, W-Che.; Ho, W-Chao.; Lin, M-Hung.; Lee, H-Hao.; Yeh, Y-Chi.; Wang, J-Der.; Chen, P-Chung., 2014 :
Angiotension receptor blockers reduce the risk of dementia

Salgado, O.J.; Chacón, R.E.; Mora, E.; Mora-LaCruz, E., 2007:
Angiotomographically-proven left innominate vein occlusion in dialysis patients with prior left internal jugular vein catheterization presenting with arm swelling after ipsilateral access creation: report of four cases

Quadri, A.M.; Sylvester, S.; Verma, S.; Bareford, D.; Spychal, R.T.; Jones, E.L.; Ganesan, R., 2007:
Angiotropic large cell lymphoma presenting as intestinal obstruction

Mandal, A.K.J.; Savvidou, L.; Slater, R.M.; Cockett, W.; Wiggins, J.; Missouris, C.G., 2007:
Angiotropic lymphoma: Associated chromosomal abnormalities

Lugassy, C.; Barnhill, R.L., 2007:
Angiotropic melanoma and extravascular migratory metastasis: a review

Yang, H.Jie.; Lee, E-Mi.; Kim, A-Young.; Lee, E-Joo.; Hong, I-Hwa.; Huh, S-Oh.; Jeong, K-Shik., 2012:
Angiotropic metastatic malignant melanoma in a canine mammary gland

Barnhill, R.L.; Chastain, M.A.; Jerdan, M.S.; Lebbé, Céleste.; Janin, A.; Lugassy, C., 2010:
Angiotropic neonatal congenital melanocytic nevus: how extravascular migration of melanocytes may explain the development of congenital nevi

Hung, T.; Morin, J.; Munday, W.R.; Mackenzie, I.R.A.; Lugassy, C.; Barnhill, R.L., 2013:
Angiotropism in primary cutaneous melanoma with brain metastasis: a study of 20 cases

Van Es, S.L.; Colman, M.; Thompson, J.F.; McCarthy, S.W.; Scolyer, R.A., 2008:
Angiotropism is an independent predictor of local recurrence and in-transit metastasis in primary cutaneous melanoma

Lugassy, C.; Zadran, S.; Bentolila, L.A.; Wadehra, M.; Prakash, R.; Carmichael, S.Thomas.; Kleinman, H.K.; Péault, B.; Larue, L.; Barnhill, R.L., 2014:
Angiotropism, pericytic mimicry and extravascular migratory metastasis in melanoma: an alternative to intravascular cancer dissemination

Gass, P.A.; Sambles, J.R., 1993:
Angle - frequency relationship for a practical acousto-optic deflector

Barbosa, V.Leal.Tavares., 2014:
Angle Class I malocclusion treated with lower incisor extraction

Pithon, M.Melo., 2014:
Angle Class I malocclusion with anterior open bite treated with extraction of permanent teeth

Chiqueto, K.; Henriques, Jé.Fernando.Castanha.; Barros, Sérgio.Estelita.Cavalcante.; Janson, G., 2014:
Angle Class II correction with MARA appliance

Barreto, G.Mattos., 2014:
Angle Class II malocclusion treated with extraction of permanent teeth

Moshirfar, M.; Hoggan, R.N.; Muthappan, V., 2014:
Angle Kappa and its importance in refractive surgery

Shapley, R.; Maertens, M., 2008:
Angle alignment evokes perceived depth and illusory surfaces

d'Errico, F.; Ciolini, R.; Di Fulvio, A.; Reginatto, M.; Esposito, J.; Ceballos Sánchez, C.; Colautti, P., 2009:
Angle and energy differential neutron spectrometry for the SPES BNCT facility

Hong, S.Hwan.; Choi, H-Yong., 2013:
Angle and frequency dependence of self-energy from spin fluctuation mediated d-wave pairing for high temperature superconductors

Baskaran, M.; Perera, S.A.; Nongpiur, M.E.; Tun, T.A.; Park, J.; Kumar, R.S.; Friedman, D.S.; Aung, T., 2012:
Angle assessment by EyeCam, goniophotography, and gonioscopy

Hara, M.; Watanabe, T.; Okumura, A.; Kato, K.; Mohri, N.; Ishikawa, M.; Mizuno, A.; Takeyama, H., 2009:
Angle between 1 and 4 min gives the most significant difference in time-intensity curves between benign disease and breast cancer: analysis of dynamic magnetic resonance imaging in 103 patients with breast lesions

Cho, W-S.; Kang, H-S.; Kim, J.E.; Kwon, O-K.; Oh, C.W.; Cho, Y.D.; Han, M.H., 2014:
Angle change of the parent arteries after stent-assisted coil embolization of wide-necked intracranial bifurcation aneurysms

Tai, M-Cheng.; Chien, K-Hung.; Lu, D-Wen.; Chen, J-Torng., 2010:
Angle changes before and after cataract surgery assessed by Fourier-domain anterior segment optical coherence tomography

Panarelli, J.F.; Ko, A.; Sidoti, P.A.; Garcia, J.P.; Banitt, M.R., 2014:
Angle closure after Boston keratoprosthesis

Casson, R.J., 2011:
Angle closure and the lens

Prata, T.S.; Biteli, L.G.; Dorairaj, S., 2014:
Angle closure associated with a cobblestone iris configuration: clinical and imaging description

Cheung, J.J.C.; Pong, J.C.F.; Chan, C.H.Y.; Lai, J.S.M., 2009:
Angle closure glaucoma

Nazm, N.; Gandhi, M.; Dubey, S.; Pegu, J., 2009:
Angle closure glaucoma

Talajic, J.C.; Assalian, A.; Roy, D.; Harasymowycz, P.J., 2010:
Angle closure glaucoma after angiography of carotid-cavernous fistula--a case report

Hussin, H.M.; Majid, M.A., 2009:
Angle closure glaucoma and lens subluxation secondary to eye rubbing in a patient with mycosis fungoides

Nongpiur, M.E.; Ku, J.Y.F.; Aung, T., 2011:
Angle closure glaucoma: a mechanistic review

Barkana, Y.; Dekel, I.; Goldich, Y.; Morad, Y.; Avni, I.; Zadok, D., 2012:
Angle closure in Caucasians--a pilot, general ophthalmology clinic-based study

Senthil, S.; Garudadri, C.; Khanna, R.C.; Sannapaneni, K., 2010:
Angle closure in the Andhra Pradesh Eye Disease Study

Kim, Y.Yeon.; Lee, J.Hwa.; Ahn, M.Douk.; Kim, C.Yun.; Ahn, B-Heon.; Ahn, M.Douk.; Baek, N.Ho.; Choi, K-Ryong.; Ha, S-Joo.; Han, G-Heon.; Hong, Y.Jae.; Kang, J-Heon.; Kee, C.; Kee, H-Seok.; Kim, C-Sik.; Kim, C.Yun.; Kim, H-Ki.; Kim, J-Mo.; Kim, S-.Hwan.; Kim, T-Woo.; Kim, Y.Yeon.; Kook, M.Scott.; Lee, J.Hwa.; Lee, K-Wha.; Lee, S-Hyuck.; Moon, J-Il.; Park, C.Kee.; Park, H.Joon.; Park, K.Ho.; Seong, G.Je.; Sohn, Y.Ho.; Uhm, K-Bang., 2012:
Angle closure in the Namil study in central South Korea

George, R.; Vijaya, L., 2012:
Angle closure in the developing world: what does the future hold?

Ruma, M.S.; Swartz, A.E.; Kim, E.; Herring, A.H.; Menard, M.Kathryn.; Moise, K.J., 2009:
Angle correction can be used to measure peak systolic velocity in the fetal middle cerebral artery

Merlo, J.M.; Aguilar, J.F.; Martí-Panameño, E.; Cortés, R.; Coello, V., 2011:
Angle dependence of the interaction distance in the shear force technique

Pinchuk, A.O., 2009 :
Angle dependent collective surface plasmon resonance in an array of silver nanoparticles

Hubbard, G.; Nasir, M.E.; Shields, P.; Bowen, C.R.; Satka, A.; Parsons, K.P.; Holmes, N.H.; Allsopp, D.W.E., 2012:
Angle dependent optical properties of polymer films with a biomimetic anti-reflecting surface replicated from cylindrical and tapered nanoporous alumina

Réhault, J.; Helbing, J., 2012:
Angle determination and scattering suppression in polarization-enhanced two-dimensional infrared spectroscopy in the pump-probe geometry

Wijntjes, M.W.A.; Kappers, A.M.L., 2007:
Angle discrimination in raised-line drawings

Casciaro, M.E.; Ritacco, L.E.; Milano, F.; Risk, M.; Craiem, D., 2011:
Angle estimation of human femora in a three-dimensional virtual environment

Stančin, S.; Tomažič, Sšo., 2012:
Angle estimation of simultaneous orthogonal rotations from 3D gyroscope measurements

Osa, A.; Nagata, K.; Honda, Y.; Ichikawa, M.; Matsuda, K.; Miike, H., 2012:
Angle illusion in a straight road

Hammad, S.; Kennedy, J.M.; Juricevic, I.; Rajani, S., 2008:
Angle illusion on a picture's surface

Quek, D.T.L.; Nongpiur, M.E.; Perera, S.A.; Aung, T., 2011:
Angle imaging: advances and challenges

Blatter, C.; Grajciar, B.; Schmetterer, L.; Leitgeb, R.A., 2014:
Angle independent flow assessment with bidirectional Doppler optical coherence tomography

Luo, C.; Xiang, M., 2012:
Angle inequality for judging the transition from Cassie-Baxter to Wenzel states when a water drop contacts bottoms of grooves between micropillars

Silbert, G.R., 2012:
Angle involvement and glaucoma in patients with biopsy-proven iris melanoma: a response

Khan, S.; Finger, P.T.; Yu, G-Pei.; Razzaq, L.; Jager, M.J.; de Keizer, R.J.W.; Sandkull, P.; Seregard, S.; Gologorsky, D.; Schefler, A.C.; Murray, T.G.; Kivelä, T.; Giuliari, G.Paolo.; McGowan, H.; Simpson, E.Rand.; Corriveau, C.; Coupland, S.E.; Damato, B.E., 2013:
Angle involvement and glaucoma in patients with biopsy-proven iris melanoma: a response-reply

Huang, P.S.; Ni, J., 1995:
Angle measurement based on the internal-reflection effect and the use of right-angle prisms

Huang, P.S.; Ni, J., 1996:
Angle measurement based on the internal-reflection effect using elongated critical-angle prisms

Huang, P.S.; Kiyono, S.; Kamada, O., 1992:
Angle measurement based on the internal-reflection effect: a new method

Ilharreborde, B.; Steffen, J.Sebastien.; Nectoux, E.; Vital, J.Marc.; Mazda, K.; Skalli, W.; Obeid, I., 2012:
Angle measurement reproducibility using EOS three-dimensional reconstructions in adolescent idiopathic scoliosis treated by posterior instrumentation

Chen, W.; Zhang, S.; Long, X., 2013:
Angle measurement with laser feedback instrument

Cui, L.; Xue, B.; Cao, X.; Zhou, F., 2014:
Angle of arrival fluctuations considering turbulence outer scale for optical waves' propagation through moderate-to-strong non-Kolmogorov turbulence

Milović, I.; Oluić, D., 1989:
Angle of caudal declination of the ribs and its changes in children with pectus excavatum

Alhazmi, M.; El-Mowafy, O.; Zahran, M.H.; Uctasli, S.; Alkumru, H.; Nada, K., 2013:
Angle of convergence of posterior crown preparations made by predoctoral dental students

Saigal, N.; Mukherjee, A.; Sugunakar, V.; Ghosh, S., 2014:
Angle of incidence averaging in reflectance measurements with optical microscopes for studying layered two-dimensional materials

Unna, P.J.H., 2018:
Angle of incidence of the sun's rays

Knell, S.C.; Kircher, P.; Dennler, M.; Montavon, P.M.; Voss, K.; Hurter, K., 2012:
Angle of insertion and confirmation of angles measured after in vitro implantation during laminar vertebral stabilization in vertebral columns obtained from canine cadavers

Karbanova, J.; Landsmanova, J.; Novotny, Z., 2010:
Angle of mediolateral episiotomy using the ischial tuberosity as a reference point

Tóth-Boconádi, R.; Taneva, S.G.; Keszthelyi, L., 1989:
Angle of the retinal of bacteriorhodopsin in blue membrane

Ibrahim, B.Haj.; Hatit, S.Ben.; De Martino, A., 2009:
Angle resolved Mueller polarimetry with a high numerical aperture and characterization of transparent biaxial samples

Neuman, M.; Coppel, L.G.; Edström, P., 2011:
Angle resolved color of bulk scattering media

Kondo, T.; Sakurai, M.; Matsushima, T.; Nakamura, J., 2010 :
Angle resolved intensity and velocity distributions of N2 desorbed by N2O decomposition on Rh(110)

Petroff, Y.; Thiry, P., 1980:
Angle resolved photoemission in solids

Gao, J.; Havlin, S.; Xu, X.; Stanley, H.Eugene., 2011:
Angle restriction enhances synchronization of self-propelled objects

Hansen, J.P.; Madhu, S., 1972:
Angle scintillations in the laser return from a retroreflector

Barnoski, M.K.; Morrison, R.J., 1976:
Angle selective fiber coupler

Zhu, X.; Ge, X.; Li, N.; Wu, L-Fei.; Luo, C.; Ouyang, Q.; Tu, Y.; Chen, G., 2015:
Angle sensing in magnetotaxis of Magnetospirillum magneticum AMB-1

Zocchi, F.E., 2009:
Angle spread function degradation by surface roughness in imaging optics

Horn, J.; J, H.; Linke, B.; B, L.; Höntzsch, D.; D, Höntzsch.; Gueorguiev, B.; B, G.; Schwieger, K.; K, S., 2010:
Angle stable interlocking screws improve construct stability of intramedullary nailing of distal tibia fractures: a biomechanical study

Kubacki, M.R.; Verioti, C.A.; Patel, S.D.; Garlock, A.N.; Fernandez, D.; Atkinson, P.J., 2014:
Angle stable nails provide improved healing for a complex fracture model in the femur

Riggsbee, A.G., 1983:
Angle your cybex recorder for improved results

Zhang, X-ge.; Yang, F.; Chen, L.; Chen, S.; Chen, Y-xi., 2015:
Angle's class II malocclusion: a report of seven cases in one family

Katz, M.I., 2007:
Angle's classification revisited

Shao, L.; Woo, K.Choi.; Chen, H.; Jin, Z.; Wang, J.; Lin, H-Qing., 2010:
Angle- and energy-resolved plasmon coupling in gold nanorod dimers

King, N.S.; Li, Y.; Ayala-Orozco, C.; Brannan, T.; Nordlander, P.; Halas, N.J., 2011:
Angle- and spectral-dependent light scattering from plasmonic nanocups

Liberman, V.; Adato, R.; Mertiri, A.; Yanik, A.A.; Chen, K.; Jeys, T.H.; Erramilli, S.; Altug, H., 2011:
Angle-and polarization-dependent collective excitation of plasmonic nanoarrays for surface enhanced infrared spectroscopy

Xiao, H.; Liu, X.; Huang, J.; Zhong, Y., 2008:
Angle-closed glaucoma secondary to bilateral spontaneous zonular laxity

Low, S.; Harsum, S.; Chang, L.; Foster, P.J.; Khaw, P.T., 2008:
Angle-closure

Prata, T.; Kanadani, F.; Simões, R.; Bernardo, W., 2015:
Angle-closure Glaucoma: treatment

Patel, K.; Patel, S., 2014:
Angle-closure glaucoma

García-Feijo, J.; Saenz-Frances, F.; Martinez-De-La-Casa, J.M.; Mendez-Hernandez, C.; Fernandez-Vidal, A.; Elias-de-Tejada, M.; Reche-Frutos, J.; Garcia-Sanchez, J., 2008:
Angle-closure glaucoma after piggyback intraocular lens implantation

Lim, L.Thai.; Agarwal, P.Kumar.; Rotchford, A., 2011:
Angle-closure glaucoma due to suprachoroidal hemorrhage secondary to disseminated intravascular coagulation

Zheng, L.; Azar, D., 2015:
Angle-closure glaucoma following periorbital botulinum toxin injection

Turnbull, A.M.J.; Smith, M.; Ramchandani, M., 2015:
Angle-closure glaucoma on long-haul flights

Násser, L.Sólia.; Liendo da Costa, V.Lucia.; Taniguchi, M.Papa.; Bolanho, A.; Petrilli, A.Maria.Noriega., 2008:
Angle-closure glaucoma secondary to nonspecific orbital inflammatory: case report

Quigley, H.A., 2009:
Angle-closure glaucoma-simpler answers to complex mechanisms: LXVI Edward Jackson Memorial Lecture

Giampani, J.; Simões, R.; Bernardo, W.Marques., 2015:
Angle-closure glaucoma: diagnosis

Tarongoy, P.; Ho, C.Lin.; Walton, D.S., 2009:
Angle-closure glaucoma: the role of the lens in the pathogenesis, prevention, and treatment

Amerasinghe, N.; Aung, T., 2008:
Angle-closure: risk factors, diagnosis and treatment

Windig, W.; Keenan, M.R., 2011:
Angle-constrained alternating least squares